| DISEASE | TITLE OF PUBLICATION | LINK TO PUBMED |
| Aberrant Crypt Foci | Fluoxetine induces preventive and complex effects against colon cancer development in epithelial and stromal areas in rats. | PubMed |
| Abortion, Habitual | Effect of the functional VEGFA-583C/T variant on vascular endothelial growth factor levels and the risk of recurrent spontaneous miscarriage. | PubMed |
| Abortion, Habitual | Vascular endothelial growth factor gene polymorphisms and idiopathic recurrent pregnancy loss. | PubMed |
| Abortion, Habitual | Vascular endothelial growth factor gene polymorphisms in North Indian patients with recurrent miscarriages. | PubMed |
| Abortion, Missed | Soluble fms-Like Tyrosine Kinase-1 (sFlt-1) and Serum Placental Growth Factor (PlGF) as Biomarkers for Ectopic Pregnancy and Missed Abortion. | PubMed |
| Abortion, Spontaneous | Assessment of the transcription levels for the complement activation control system in eutopic endometrium in women with two or more consecutive miscarriages of unknown etiology. | PubMed |
| Abortion, Spontaneous | Association of Vascular Endothelial Growth Factor Gene Polymorphisms with Recurrent Spontaneous Abortion in Chinese Han Women. | PubMed |
| Abortion, Spontaneous | Association study of vascular endothelial growth factor polymorphisms with the risk of recurrent spontaneous abortion. | PubMed |
| Abortion, Spontaneous | Complement activation induces dysregulation of angiogenic factors and causes fetal rejection and growth restriction. | PubMed |
| Abortion, Spontaneous | Effect of the functional VEGFA-583C/T variant on vascular endothelial growth factor levels and the risk of recurrent spontaneous miscarriage. | PubMed |
| Abortion, Spontaneous | Elevation of Adipsin, a Complement Activating Factor, in the Mouse Placenta During Spontaneous Abortion. | PubMed |
| Abortion, Spontaneous | Identification of specific vascular endothelial growth factor susceptible and protective haplotypes associated with recurrent spontaneous miscarriages. | PubMed |
| Abortion, Spontaneous | Involvement of heparanase in vaginal and cesarean section deliveries. | PubMed |
| Abortion, Spontaneous | Maternal serum vascular endothelial growth factor levels in early ectopic and intrauterine pregnancies after in vitro fertilization treatment. | PubMed |
| Abortion, Spontaneous | Production of vascular endothelial growth factor and endothelin in the placenta and umbilical cord during normal and complicated pregnancy. | PubMed |
| Abortion, Spontaneous | Regulation of Complement Activity via the Alternative Pathway in Placentas of Mouse Spontaneous Abortions. | PubMed |
| Abortion, Spontaneous | Regulation of natural-killer cell cytotoxicity and enhancement of complement factors in the spontaneously aborted mouse placenta. | PubMed |
| Abortion, Spontaneous | Soluble Flt-1 and PlGF: New Markers of Early Pregnancy Loss? | PubMed |
| Abortion, Spontaneous | The value of vascular endothelial growth factor, pregnancy-associated plasma protein-A, and progesterone for early differentiation of ectopic pregnancies, normal intrauterine pregnancies, and spontaneous miscarriages. | PubMed |
| Abortion, Spontaneous | Vascular Endothelial Growth Factor (VEGF) and the VEGF Soluble Receptor-1 (sFlt-1) in Chorionic Villus Tissue from Chinese Women with Early Recurrent Spontaneous Abortion. | PubMed |
| Abortion, Spontaneous | Vascular endothelial growth factor and recurrent spontaneous abortion: A meta-analysis. | PubMed |
| Abortion, Spontaneous | Vascular endothelial growth factor gene polymorphisms and recurrent pregnancy loss. | PubMed |
| Abortion, Spontaneous | [Growth factors are markers of placental insufficiency in third-trimester miscarriage]. | PubMed |
| Abortion, Threatened | Production of vascular endothelial growth factor and endothelin in the placenta and umbilical cord during normal and complicated pregnancy. | PubMed |
| Abscess | Imaging vascular endothelial growth factor (VEGF) receptors in turpentine-induced sterile thigh abscesses with radiolabeled single-chain VEGF. | PubMed |
| Acidosis | Acidosis inhibits endothelial cell apoptosis and function and induces basic fibroblast growth factor and vascular endothelial growth factor expression. | PubMed |
| Acidosis | Hypoxia and acidosis independently up-regulate vascular endothelial growth factor transcription in brain tumors in vivo. | PubMed |
| Acidosis | Regulation of vascular endothelial growth factor expression by acidosis in human cancer cells. | PubMed |
| Acquired Immunodeficiency Syndrome | AIDS-associated Kaposi's sarcoma cells in culture express vascular endothelial growth factor. | PubMed |
| Acquired Immunodeficiency Syndrome | Complement levels and circulating immune complexes in a controlled, longitudinal, multicentre study on effects of intravenous immunoglobulin in adults with AIDS-related complex/Walter-Reed 5. The ARC-IVIG Study Group. | PubMed |
| Acquired Immunodeficiency Syndrome | Concentrations of adipsin in blood and rates of adipsin secretion by adipose tissue in humans with normal, elevated and diminished adipose tissue mass. | PubMed |
| Acquired Immunodeficiency Syndrome | Expression of vascular endothelial growth factor receptor-3 and podoplanin suggests a lymphatic endothelial cell origin of Kaposi's sarcoma tumor cells. | PubMed |
| Acquired Immunodeficiency Syndrome | Involvement of vascular endothelial growth factor in Kaposi's sarcoma associated with acquired immunodeficiency syndrome. | PubMed |
| Acquired Immunodeficiency Syndrome | Kaposi sarcoma herpesvirus-induced cellular reprogramming contributes to the lymphatic endothelial gene expression in Kaposi sarcoma. | PubMed |
| Acquired Immunodeficiency Syndrome | Sequential delivery of vascular endothelial growth factor and sphingosine 1-phosphate for angiogenesis. | PubMed |
| Acquired Immunodeficiency Syndrome | Vascular endothelial growth factor (VEGF165) plasma level increase with immunodepression in AIDS patients with Kaposi's sarcoma. | PubMed |
| Acromegaly | Plasma levels of vascular endothelial growth factor in patients with acromegaly. | PubMed |
| Acromegaly | Reductions of circulating matrix metalloproteinase 2 and vascular endothelial growth factor levels after treatment with pegvisomant in subjects with acromegaly. | PubMed |
| Acromegaly | The effects of growth hormone status on circulating levels of vascular growth factors. | PubMed |
| Acute Coronary Syndrome | Association of vascular endothelial growth factor gene polymorphism with myocardial infarction in patients with type 2 diabetes. | PubMed |
| Acute Coronary Syndrome | Increased circulating placental growth factor during percutaneous coronary intervention is associated with applied radiocontrast agent. | PubMed |
| Acute Coronary Syndrome | Measurement of the soluble angiopoietin receptor tie-2 in patients with coronary artery disease: development and application of an immunoassay. | PubMed |
| Acute Coronary Syndrome | Plasma angiopoietin-1, angiopoietin-2, angiopoietin receptor tie-2, and vascular endothelial growth factor levels in acute coronary syndromes. | PubMed |
| Acute Coronary Syndrome | Plasma haemoxygenase-1 in coronary artery disease. A comparison with angiogenin, matrix metalloproteinase-9, tissue inhibitor of metalloproteinase-1 and vascular endothelial growth factor. | PubMed |
| Acute Coronary Syndrome | Prognostic value of placental growth factor in patients with acute chest pain. | PubMed |
| Acute Kidney Injury | Complement depletion during haemofiltration with polyacrilonitrile membranes. | PubMed |
| Acute Kidney Injury | Effect of erythropoietin therapy on the progression of cisplatin induced renal injury in rats. | PubMed |
| Acute Kidney Injury | Effects of histamine and the h2 receptor antagonist ranitidine on ischemia-induced acute renal failure: involvement of IL-6 and vascular endothelial growth factor. | PubMed |
| Acute Kidney Injury | Impaired endothelial proliferation and mesenchymal transition contribute to vascular rarefaction following acute kidney injury. | PubMed |
| Acute Kidney Injury | Plasma protein extravasation and vascular endothelial growth factor expression with endothelial nitric oxide synthase induction in gentamicin-induced acute renal failure in rats. | PubMed |
| Acute Kidney Injury | Significant reduction of factor D and immunosuppressive complement fragment Ba by hemofiltration. | PubMed |
| Acute Lung Injury | Bone marrow-derived mononuclear cell therapy in experimental pulmonary and extrapulmonary acute lung injury. | PubMed |
| Acute Lung Injury | Paxillin is involved in the differential regulation of endothelial barrier by HGF and VEGF. | PubMed |
| Acute Lung Injury | Protective role of vascular endothelial growth factor in endotoxin-induced acute lung injury in mice. | PubMed |
| Acute Lung Injury | Pulmonary microvascular hyperpermeability and expression of vascular endothelial growth factor in smoke inhalation- and pneumonia-induced acute lung injury. | PubMed |
| Acute Lung Injury | Reduced vascular endothelial growth factor correlates with alveolar epithelial damage after experimental ischemia and reperfusion. | PubMed |
| Acute Lung Injury | Regulation of vascular endothelial growth factor bioactivity in patients with acute lung injury. | PubMed |
| Acute Lung Injury | The early responses of VEGF and its receptors during acute lung injury: implication of VEGF in alveolar epithelial cell survival. | PubMed |
| Acute Lung Injury | Variations in the Vascular Endothelial Growth Factor Pathway Predict Pulmonary Complications. | PubMed |
| Acute Lung Injury | Vascular endothelial growth factor (VEGF) in acute lung injury (ALI) and acute respiratory distress syndrome (ARDS): paradox or paradigm? | PubMed |
| Acute Lung Injury | Vascular endothelial growth factor and related molecules in acute lung injury. | PubMed |
| Acute Lung Injury | Vascular endothelial growth factor synthesis in the acute phase of experimental and clinical lung injury. | PubMed |
| Acute Lung Injury | VEGF levels in the alveolar compartment do not distinguish between ARDS and hydrostatic pulmonary oedema. | PubMed |
| Acute Lung Injury | [The protective effect of angiopoietin-1 on early acute lung injury induced by oleic acid in mice] | PubMed |
| Adenocarcinoma | 17beta-estradiol inhibits forskolin-induced vascular endothelial growth factor promoter in MCF-7 breast adenocarcinoma cells. | PubMed |
| Adenocarcinoma | A case of adenocarcinoma of the endometrial type mixed with a clear cell component that metastasized to the vagina. | PubMed |
| Adenocarcinoma | A case of pulmonary adenocarcinoma associated with hypertrophic osteoarthropathy due to vascular endothelial growth factor. | PubMed |
| Adenocarcinoma | A multicenter, phase 2 study of vascular endothelial growth factor trap (Aflibercept) in platinum- and erlotinib-resistant adenocarcinoma of the lung. | PubMed |
| Adenocarcinoma | A murine vascular endothelial growth factor antibody inhibits in vivo growth of human Caki-I renal adenocarcinoma. | PubMed |
| Adenocarcinoma | A novel angiogenic role for prostaglandin F2alpha-FP receptor interaction in human endometrial adenocarcinomas. | PubMed |
| Adenocarcinoma | Activation of STAT3 signaling in human stomach adenocarcinoma drug-resistant cell line and its relationship with expression of vascular endothelial growth factor. | PubMed |
| Adenocarcinoma | Adenovirus-mediated delivery of a soluble form of the VEGF receptor Flk1 delays the growth of murine and human pancreatic adenocarcinoma in mice. | PubMed |
| Adenocarcinoma | Angiogenesis and cathepsin expression are prognostic factors in pancreatic adenocarcinoma after curative resection. | PubMed |
| Adenocarcinoma | Angiogenesis and phenotypic alteration of alveolar capillary endothelium in areas of neoplastic cell spread in primary lung adenocarcinoma. | PubMed |
| Adenocarcinoma | Angiogenesis correlates with vascular endothelial growth factor expression but not with Ki-ras oncogene activation in non-small cell lung carcinoma. | PubMed |
| Adenocarcinoma | Angiogenesis in normal tissue adjacent to colon cancer. | PubMed |
| Adenocarcinoma | Angiogenic factors in normal endometrium and endometrial adenocarcinoma. | PubMed |
| Adenocarcinoma | Angiogenic markers, neovascularization and malignant deformation of Barrett's esophagus. | PubMed |
| Adenocarcinoma | Angiogenic switch in Barrett's adenocarcinoma: the role of vascular endothelial growth factor. | PubMed |
| Adenocarcinoma | Angiotensin II induces vascular endothelial growth factor in pancreatic cancer cells through an angiotensin II type 1 receptor and ERK1/2 signaling. | PubMed |
| Adenocarcinoma | Antihypertensives as novel antineoplastics: angiotensin-I-converting enzyme inhibitors and angiotensin II type 1 receptor blockers in pancreatic ductal adenocarcinoma. | PubMed |
| Adenocarcinoma | AP23846, a novel and highly potent Src family kinase inhibitor, reduces vascular endothelial growth factor and interleukin-8 expression in human solid tumor cell lines and abrogates downstream angiogenic processes. | PubMed |
| Adenocarcinoma | Assessment of VEGF-D expression measured by immunohistochemical staining and F-18 FDG uptake on PET as biological prognostic factors for recurrence in patients with surgically resected lung adenocarcinoma. | PubMed |
| Adenocarcinoma | Association of VEGF genotype with mRNA level in colorectal adenocarcinomas. | PubMed |
| Adenocarcinoma | Betulinic acid inhibits the expression of hypoxia-inducible factor 1alpha and vascular endothelial growth factor in human endometrial adenocarcinoma cells. | PubMed |
| Adenocarcinoma | Bile acids induce overexpression of homeobox gene CDX-2 and vascular endothelial growth factor (VEGF) in human Barrett's esophageal mucosa and adenocarcinoma cell line. | PubMed |
| Adenocarcinoma | Blockage of the vascular endothelial growth factor stress response increases the antitumor effects of ionizing radiation. | PubMed |
| Adenocarcinoma | Branched ?-(1,4) glucans from Lentinula edodes (L10) in combination with radiation enhance cytotoxic effect on human lung adenocarcinoma through the Toll-like receptor 4 mediated induction of THP-1 differentiation/activation. | PubMed |
| Adenocarcinoma | Cancer gene therapy with iCaspase-9 transcriptionally targeted to tumor endothelial cells. | PubMed |
| Adenocarcinoma | Celecoxib inhibits vascular endothelial growth factor expression in and reduces angiogenesis and metastasis of human pancreatic cancer via suppression of Sp1 transcription factor activity. | PubMed |
| Adenocarcinoma | Changes in tumorigenesis- and angiogenesis-related gene transcript abundance profiles in ovarian cancer detected by tailored high density cDNA arrays. | PubMed |
| Adenocarcinoma | Cholesteryl oligoarginine delivering vascular endothelial growth factor sirna effectively inhibits tumor growth in colon adenocarcinoma. | PubMed |
| Adenocarcinoma | Clinical and biological impact of EphA2 overexpression and angiogenesis in endometrial cancer. | PubMed |
| Adenocarcinoma | Clinical significance of immunohistochemical expression of hypoxia-inducible factor-1alpha as a prognostic marker in rectal adenocarcinoma. | PubMed |
| Adenocarcinoma | Clinical significance of serum CA-125 and soluble tumor necrosis factor receptor type I in cervical adenocarcinoma patients. | PubMed |
| Adenocarcinoma | Coexpression of vascular endothelial growth factor and its receptor KDR on gastric adenocarcinoma MGC803 cell line and stimulation of exogenous VEGF(165) to MGC803 cells. | PubMed |
| Adenocarcinoma | Computed tomographic images reflect the biologic behavior of small lung adenocarcinoma: they correlate with cell proliferation, microvascularization, cell adhesion, degradation of extracellular matrix, and K-ras mutation. | PubMed |
| Adenocarcinoma | Constitutive Sp1 activity is essential for differential constitutive expression of vascular endothelial growth factor in human pancreatic adenocarcinoma. | PubMed |
| Adenocarcinoma | Correlation between lymph node metastasis and the expression of VEGF-C, VEGF-D and VEGFR-3 in T1 lung adenocarcinoma. | PubMed |
| Adenocarcinoma | Correlation between the immunohistochemical expressions of MMP-1, MMP-7 and VEGF and prognostic factors in colorectal adenocarcinoma. | PubMed |
| Adenocarcinoma | Cyclooxygenase Isoenzyme-2 and Vascular Endothelial Growth Factor are Associated with Poor Prognosis in Esophageal Adenocarcinoma. | PubMed |
| Adenocarcinoma | Deregulation of EGFR/VEGF/HIF-1a signaling pathway in colon adenocarcinoma based on tissue microarrays analysis. | PubMed |
| Adenocarcinoma | Dual inhibition of epidermal growth factor receptor and vascular endothelial growth factor receptor phosphorylation by AEE788 reduces growth and metastasis of human colon carcinoma in an orthotopic nude mouse model. | PubMed |
| Adenocarcinoma | Elevated prostaglandin EP2 receptor in endometrial adenocarcinoma cells promotes vascular endothelial growth factor expression via cyclic 3',5'-adenosine monophosphate-mediated transactivation of the epidermal growth factor receptor and extracellular signal-regulated kinase 1/2 signaling pathways. | PubMed |
| Adenocarcinoma | Endoglin (CD105) and vascular endothelial growth factor as prognostic markers in esophageal adenocarcinoma. | PubMed |
| Adenocarcinoma | Endoglin (CD105) and vascular endothelial growth factor as prognostic markers in prostatic adenocarcinoma. | PubMed |
| Adenocarcinoma | Enhancement of prostate cancer xenograft growth with whole-body radiation and vascular endothelial growth factor. | PubMed |
| Adenocarcinoma | Esophageal Adenocarcinoma: Treatment Modalities in the Era of Targeted Therapy. | PubMed |
| Adenocarcinoma | Estrogen enhances angiogenesis through a pathway involving platelet-activating factor-mediated nuclear factor-kappaB activation. | PubMed |
| Adenocarcinoma | Evaluation of angiogenesis using micro-computed tomography in a xenograft mouse model of lung cancer. | PubMed |
| Adenocarcinoma | Evaluation of angiogenesis, p-53 tissue protein expression and serum VEGF in patients with endometrial cancer. | PubMed |
| Adenocarcinoma | Evaluation of VEGF A expression and microvascular density as prognostic factors in extrahepatic cholangiocarcinoma. | PubMed |
| Adenocarcinoma | Expression and localization of endocrine gland-derived vascular endothelial growth factor (EG-VEGF) in human pancreas and pancreatic adenocarcinoma. | PubMed |
| Adenocarcinoma | Expression levels and significance of hypoxia inducible factor-1 alpha and vascular endothelial growth factor in human colorectal adenocarcinoma. | PubMed |
| Adenocarcinoma | Expression of angiopoietin-2 is correlated with vascularization and tumor size in human colorectal adenocarcinoma. | PubMed |
| Adenocarcinoma | Expression of angiostatic platelet factor-4var/CXCL4L1 counterbalances angiogenic impulses of vascular endothelial growth factor, interleukin-8/CXCL8, and stromal cell-derived factor 1/CXCL12 in esophageal and colorectal cancer. | PubMed |
| Adenocarcinoma | Expression of cyclo-oxygenase 1 and 2, prostaglandin E synthase and transforming growth factor beta1, and their relationship with vascular endothelial growth factors A and C, in primary adenocarcinoma of the small intestine. | PubMed |
| Adenocarcinoma | Expression of IL-6 receptor in pancreatic cancer: involvement in VEGF induction. | PubMed |
| Adenocarcinoma | Expression of liver-type fatty-acid-binding protein, fatty acid synthase and vascular endothelial growth factor in human lung carcinoma. | PubMed |
| Adenocarcinoma | Expression of NOS and VEGF in feline mammary tumours and their correlation with angiogenesis. | PubMed |
| Adenocarcinoma | Expression of the vascular endothelial growth factor receptor-3 (VEGFR-3) and its ligand VEGF-C in human colorectal adenocarcinoma. | PubMed |
| Adenocarcinoma | Expression of vascular endothelial growth factor and basic fibroblast growth factor in small adenocarcinomas. | PubMed |
| Adenocarcinoma | Expression of vascular endothelial growth factor and its receptors in the rat ventral prostate and Dunning R3327 PAP adenocarcinoma before and after castration. | PubMed |
| Adenocarcinoma | Expression of vascular endothelial growth factor in adenocarcinomas of the uterine cervix and its relation to angiogenesis and p53 and c-erbB-2 protein expression. | PubMed |
| Adenocarcinoma | Expression of vascular endothelial growth factors A, B, C, and D and their relationships to lymph node status in lung adenocarcinoma. | PubMed |
| Adenocarcinoma | Expression of vascular endothelial growth factors-C and -D correlate with evidence of lymphangiogenesis and angiogenesis in pancreatic adenocarcinoma. | PubMed |
| Adenocarcinoma | Expression of VEGF, EGFR, and IL-6 in Gastric Adenomas and Adenocarcinomas by Endoscopic Submucosal Dissection. | PubMed |
| Adenocarcinoma | Genetic polymorphisms of VEGF, interactions with cigarette smoking exposure and esophageal adenocarcinoma risk. | PubMed |
| Adenocarcinoma | Genomic and proteomic analyses of vascular endothelial growth factor and insulin-like growth factor-binding protein 3 in lung adenocarcinomas. | PubMed |
| Adenocarcinoma | Hepatocyte Growth Factor Mediated Cell Invasion in Pancreatic Cancer Cells Is Dependent on Neuropilin-1. | PubMed |
| Adenocarcinoma | High expression of vascular endothelial growth factor is associated with liver metastasis and a poor prognosis for patients with ductal pancreatic adenocarcinoma. | PubMed |
| Adenocarcinoma | High expression of vascular endothelial growth factor predicts early recurrence and poor prognosis after curative resection for ductal adenocarcinoma of the pancreas. | PubMed |
| Adenocarcinoma | High serum levels of Transforming Growth Factor-b1, Interleukin-10 and Vascular Endothelial Growth Factor in pancreatic adenocarcinoma patients. | PubMed |
| Adenocarcinoma | Hypoxia in human colorectal adenocarcinoma: Comparison between extrinsic and potential intrinsic hypoxia markers. | PubMed |
| Adenocarcinoma | Hypoxia inducible factor 1 alpha and 2 alpha expression is independent of anemia in patients with stage I endometrial cancer. | PubMed |
| Adenocarcinoma | Immunohistochemical expression of vascular endothelial growth factor and vascular endothelial growth factor receptor-2 in canine simple mammary gland adenocarcinomas. | PubMed |
| Adenocarcinoma | Immunohistochemical expression of vascular endothelial growth factor can predict response to 5-fluorouracil and cisplatin in patients with gastric adenocarcinoma. | PubMed |
| Adenocarcinoma | Immunohistochemical study of vascular endothelial growth factor (VEGF) and matrilysin (MMP-7) in T1 adenocarcinoma of the colon and rectum to predict lymph node metastases or distant metastases. | PubMed |
| Adenocarcinoma | Increased expression of alpha-1-antitrypsin, glutathione S-transferase pi and vascular endothelial growth factor in human pancreatic adenocarcinoma. | PubMed |
| Adenocarcinoma | Increased expression of hypoxia-inducible factor 1alpha in type I and type II endometrial carcinomas. | PubMed |
| Adenocarcinoma | Inhibition of expression of vascular endothelial growth factor and its receptors in pulmonary adenocarcinoma cell by TNP-470 in combination with gemcitabine. | PubMed |
| Adenocarcinoma | Insulin up-regulates vascular endothelial growth factor and stabilizes its messengers in endometrial adenocarcinoma cells. | PubMed |
| Adenocarcinoma | International, Randomized, Placebo-Controlled, Double-Blind Phase III Study of Motesanib Plus Carboplatin/Paclitaxel in Patients With Advanced Nonsquamous Non-Small-Cell Lung Cancer: MONET1. | PubMed |
| Adenocarcinoma | Interrelationships between dietary restriction, the IGF-I axis, and expression of vascular endothelial growth factor by prostate adenocarcinoma in rats. | PubMed |
| Adenocarcinoma | Lack of immunohistochemical detection of VEGF in prostate carcinoma. | PubMed |
| Adenocarcinoma | Lactate dehydrogenase 5 (LDH5) relates to up-regulated hypoxia inducible factor pathway and metastasis in colorectal cancer. | PubMed |
| Adenocarcinoma | Lymphangiogenesis of normal endometrium and endometrial adenocarcinoma. | PubMed |
| Adenocarcinoma | Lymphatic vessel density in pulmonary adenocarcinoma immunohistochemically evaluated with anti-podoplanin or anti-D2-40 antibody is correlated with lymphatic invasion or lymph node metastases. | PubMed |
| Adenocarcinoma | Macrophage migration inhibitory factor up-regulates alpha(v)beta(3) integrin and vascular endothelial growth factor expression in endometrial adenocarcinoma cell line Ishikawa. | PubMed |
| Adenocarcinoma | Markers of tumour angiogenesis and tumour cells in bone marrow in gastric cancer patients. | PubMed |
| Adenocarcinoma | Mast cells correlate with angiogenesis and poor outcome in stage I lung adenocarcinoma. | PubMed |
| Adenocarcinoma | Measurement of circulating levels of VEGF-A, -C, and -D and their receptors, VEGFR-1 and -2 in gastric adenocarcinoma. | PubMed |
| Adenocarcinoma | Mesenchymal stem cells stimulate angiogenesis in a murine xenograft model of A549 human adenocarcinoma through an LPA1 receptor-dependent mechanism. | PubMed |
| Adenocarcinoma | Meta-analysis of immunohistochemical prognostic markers in resected pancreatic cancer. | PubMed |
| Adenocarcinoma | Molecular determinants in targeted therapy for esophageal adenocarcinoma. | PubMed |
| Adenocarcinoma | Molecular profiling of angiogenesis markers. | PubMed |
| Adenocarcinoma | Mucinous colon carcinomas with microsatellite instability have a lower microvessel density and lower vascular endothelial growth factor expression. | PubMed |
| Adenocarcinoma | Neoadjuvant therapy and biliary decompression lower biliary and pancreatic juice vascular endothelial growth factor levels in patients with periampullary adenocarcinoma. | PubMed |
| Adenocarcinoma | Neoangiogenesis and expression of hypoxia-inducible factor 1alpha, vascular endothelial growth factor, and glucose transporter-1 in endometrioid type endometrium adenocarcinomas. | PubMed |
| Adenocarcinoma | Neoangiogenesis and relationship to nuclear p53 accumulation and vascular endothelial growth factor expression in advanced gastric carcinoma. | PubMed |
| Adenocarcinoma | Neuroendocrine cell differentiation of poorly differentiated colorectal adenocarcinoma correlates with liver metastasis. | PubMed |
| Adenocarcinoma | Nitroglycerin treatment may enhance chemosensitivity to docetaxel and carboplatin in patients with lung adenocarcinoma. | PubMed |
| Adenocarcinoma | Nuclear, compared with combined nuclear and cytoplasmic expression of maspin, is linked in lung adenocarcinoma to reduced VEGF-A levels and in Stage I, improved survival. | PubMed |
| Adenocarcinoma | Plasma concentrations of angiogenetic factors and angiogenetic inhibitors in patients with ductal pancreatic neoplasms. A pilot study. | PubMed |
| Adenocarcinoma | Predictive significance of preoperative serum VEGF-C and VEGF-D, independently and combined with Ca19-9, for the presence of malignancy and lymph node metastasis in patients with gastric cancer. | PubMed |
| Adenocarcinoma | Progestins activate vascular endothelial growth factor gene transcription in endometrial adenocarcinoma cells. | PubMed |
| Adenocarcinoma | Prognostic impact of survivin, cyclin D1, integrin beta1, and VEGF in patients with small adenocarcinoma of stage I lung cancer. | PubMed |
| Adenocarcinoma | Prognostic Role of Protease-Activated Receptors 1 and 4 in Resected Stage IB Non-Small-Cell Lung Cancer. | PubMed |
| Adenocarcinoma | Prognostic significance of epidermal growth factor receptor and vascular endothelial growth factor receptor in colorectal adenocarcinoma. | PubMed |
| Adenocarcinoma | Prognostic significance of HER2/neu, p53, and vascular endothelial growth factor expression in early stage conventional adenocarcinoma and bronchioloalveolar carcinoma of the lung. | PubMed |
| Adenocarcinoma | Prognostic significance of microvessel density, vascular cuffing and vascular endothelial growth factor expression in ovarian carcinoma: a special review for clear cell adenocarcinoma. | PubMed |
| Adenocarcinoma | Prognostic significance of p53, Ki-67, VEGF and Glut-1 in resected stage I adenocarcinoma of the lung. | PubMed |
| Adenocarcinoma | Pulmonary adenocarcinoma angiogenesis. | PubMed |
| Adenocarcinoma | Regulation of vascular endothelial growth factor expression by insulin-like growth factor-I in endometrial adenocarcinoma cells. | PubMed |
| Adenocarcinoma | Relationship and prognostic significance of SPARC and VEGF protein expression in colon cancer. | PubMed |
| Adenocarcinoma | Relationship between the expression of vascular endothelial growth factor and the density of dendritic cells in gastric adenocarcinoma tissue. | PubMed |
| Adenocarcinoma | Secretion of vascular endothelial growth factor in adenocarcinoma and squamous cell carcinoma of the uterine cervix. | PubMed |
| Adenocarcinoma | Selective blockade of vascular endothelial growth factor receptor 2 with an antibody against tumor-derived vascular endothelial growth factor controls the growth of human pancreatic adenocarcinoma xenografts. | PubMed |
| Adenocarcinoma | Significance of vascular endothelial growth factor messenger RNA expression in primary lung cancer. | PubMed |
| Adenocarcinoma | SU5416 selectively impairs angiogenesis to induce prostate cancer-specific apoptosis. | PubMed |
| Adenocarcinoma | The ?-adrenoceptor antagonist, propranolol, induces human gastric cancer cell apoptosis and cell cycle arrest via inhibiting nuclear factor ?B signaling. | PubMed |
| Adenocarcinoma | The expression of basic fibroblast growth factor and vascular endothelial growth factor in prostatic adenocarcinoma: correlation with neovascularization. | PubMed |
| Adenocarcinoma | The relationship between microvessel count and the expression of vascular endothelial growth factor, p53, and K-ras in non-small cell lung cancer. | PubMed |
| Adenocarcinoma | The use of molecular markers as a method to predict the response to neoadjuvant therapy for advanced stage rectal adenocarcinoma. | PubMed |
| Adenocarcinoma | Therapeutic strategy targeting the mTOR-HIF-1alpha-VEGF pathway in ovarian clear cell adenocarcinoma. | PubMed |
| Adenocarcinoma | Thymidine phosphorylase and vascular endothelial growth factor in patients with Stage I lung adenocarcinoma. | PubMed |
| Adenocarcinoma | Thymidine phosphorylase-mediated angiogenesis regulated by thymidine phosphorylase inhibitor in human ovarian cancer cells in vivo. | PubMed |
| Adenocarcinoma | Tumor angiogenesis and vascular endothelial growth factor expression in stage I lung adenocarcinoma. | PubMed |
| Adenocarcinoma | Tumor anti-angiogenic effect and mechanism of action of delta-tocotrienol. | PubMed |
| Adenocarcinoma | Tumor-Infiltrating Lymphocytes Express Vascular Endothelial Growth Factor in Renal Cell Carcinomas. | PubMed |
| Adenocarcinoma | Vascular endothelial growth factor (VEGF) genotype and serum concentration in patients with pancreatic adenocarcinoma and chronic pancreatitis. | PubMed |
| Adenocarcinoma | Vascular endothelial growth factor (VEGF) upregulates BCL-2 and inhibits apoptosis in human and murine mammary adenocarcinoma cells. | PubMed |
| Adenocarcinoma | Vascular endothelial growth factor and basic fibroblast growth factor expression in esophageal adenocarcinoma and Barrett esophagus. | PubMed |
| Adenocarcinoma | Vascular endothelial growth factor and basic fibroblast growth factor in primary lung carcinomas and the incidence of metastases. | PubMed |
| Adenocarcinoma | Vascular endothelial growth factor and its receptor correlate with angiogenesis and survival in pulmonary adenocarcinoma. | PubMed |
| Adenocarcinoma | Vascular endothelial growth factor and osteopontin in stage I lung adenocarcinoma. | PubMed |
| Adenocarcinoma | Vascular endothelial growth factor and soluble intercellular adhesion molecule-1 in lung adenocarcinoma with malignant pleural effusion: correlations with patient survival and pleural effusion control. | PubMed |
| Adenocarcinoma | Vascular endothelial growth factor and survivin immunostaining in gastric adenocarcinoma. | PubMed |
| Adenocarcinoma | Vascular endothelial growth factor content in metastasizing and nonmetastasizing Dunning prostatic adenocarcinoma. | PubMed |
| Adenocarcinoma | Vascular Endothelial Growth Factor Expression and Neovascularization in Non-Small Cell Lung Carcinoma. | PubMed |
| Adenocarcinoma | Vascular endothelial growth factor is induced in response to transforming growth factor-beta in fibroblastic and epithelial cells. | PubMed |
| Adenocarcinoma | Vascular endothelial growth factor is up-regulated in the early pre-malignant stage of colorectal tumour progression. | PubMed |
| Adenocarcinoma | Vascular endothelial growth factor mediated angiogenic potential of pancreatic ductal carcinomas enhanced by hypoxia: an in vitro and in vivo study. | PubMed |
| Adenocarcinoma | Vascular endothelial growth factor receptor 2-targeted chemoprevention of murine lung tumors. | PubMed |
| Adenocarcinoma | Vascular endothelial growth factor, c-erbB-2 and c-erbB-3 expression in colorectal adenoma and adenocarcinoma. | PubMed |
| Adenocarcinoma | Vascular endothelial growth factor-D and its receptor VEGFR-3: two novel independent prognostic markers in gastric adenocarcinoma. | PubMed |
| Adenocarcinoma | Vascular endothelial growth factor: acting as an autocrine growth factor for human gastric adenocarcinoma cell MGC803. | PubMed |
| Adenocarcinoma | VEGF-A and i-NOS expression are prognostic factors in serous epithelial ovarian carcinomas after complete surgical resection. | PubMed |
| Adenocarcinoma | VEGF-A and its isoform VEGF(121) mRNA expression measured by quantitative real-time RT-PCR: correlation with F-18 FDG uptake and aggressiveness of lung adenocarcinoma: preliminary study. | PubMed |
| Adenocarcinoma | Vessel counts and vascular endothelial growth factor expression in pancreatic adenocarcinoma. | PubMed |
| Adenocarcinoma | [Comparison of the characteristics in recurrence and metastasis between bronchioloalveolar carcinoma and other lung adenocarcinomas] | PubMed |
| Adenocarcinoma | [Correlation of VEGF and Ki67 expression with sensitivity to neoadjuvant chemoradiation in rectal adenocarcinoma] | PubMed |
| Adenocarcinoma | [Overexpression of p73 gene inhibits VEGF and bFGF mRNA expression in lung adenocarcinoma cell.] | PubMed |
| Adenocarcinoma | [Relation of vascular endothelial growth factor-D expression to microvessel density, microlymphatic vessel density, and lymph-node metastasis of lung adenocarcinoma] | PubMed |
| Adenocarcinoma | [Relationship of hypoxia-inducible factor 1 alpha (HIF-1alpha) gene expression with vascular endothelial growth factor (VEGF) and microvessel density (MVD) in human colorectal adenoma and adenocarcinoma] | PubMed |
| Adenocarcinoma | [The effect of TNP-470 on the proliferation and apoptosis of lung adenocarcinoma cells] | PubMed |
| Adenocarcinoma | [The relationship of MMP-9, VEGF and PCNA expressions and their clinical significance in gastric adenocarcinoma] | PubMed |
| Adenocarcinoma | [VEGF-D expression in lung adenocarcinoma with or without acquired resistance to gefitinib and normal lung tissue.] | PubMed |
| Adenocarcinoma, Bronchiolo-Alveolar | Prognostic significance of HER2/neu, p53, and vascular endothelial growth factor expression in early stage conventional adenocarcinoma and bronchioloalveolar carcinoma of the lung. | PubMed |
| Adenocarcinoma, Bronchiolo-Alveolar | Stimulation of vascular endothelial growth factor gene transcription by all trans retinoic acid through Sp1 and Sp3 sites in human bronchioloalveolar carcinoma cells. | PubMed |
| Adenocarcinoma, Bronchiolo-Alveolar | [Comparison of the characteristics in recurrence and metastasis between bronchioloalveolar carcinoma and other lung adenocarcinomas] | PubMed |
| Adenocarcinoma, Clear Cell | A case of adenocarcinoma of the endometrial type mixed with a clear cell component that metastasized to the vagina. | PubMed |
| Adenocarcinoma, Clear Cell | Prognostic significance of microvessel density, vascular cuffing and vascular endothelial growth factor expression in ovarian carcinoma: a special review for clear cell adenocarcinoma. | PubMed |
| Adenocarcinoma, Clear Cell | Therapeutic strategy targeting the mTOR-HIF-1alpha-VEGF pathway in ovarian clear cell adenocarcinoma. | PubMed |
| Adenocarcinoma, Follicular | Interactions between sphingosine-1-phosphate and vascular endothelial growth factor signalling in ML-1 follicular thyroid carcinoma cells. | PubMed |
| Adenocarcinoma, Follicular | S1P1 and VEGFR-2 form a signaling complex with extracellularly regulated kinase 1/2 and protein kinase C-alpha regulating ML-1 thyroid carcinoma cell migration. | PubMed |
| Adenocarcinoma, Mucinous | Thymidine phosphorylase-mediated angiogenesis regulated by thymidine phosphorylase inhibitor in human ovarian cancer cells in vivo. | PubMed |
| Adenoma | An immunohistochemical and ultrastructural study of pancreatic microcystic serous cyst adenoma with special reference to tumor-associated microvasculature and vascular endothelial growth factor in tumor cells. | PubMed |
| Adenoma | Angiogenesis and lymphangiogenesis in thyroid proliferative lesions: relationship to type and tumour behaviour. | PubMed |
| Adenoma | Combination of sorafenib and everolimus impacts therapeutically on adrenocortical tumor models. | PubMed |
| Adenoma | Concurrent expression of angiogenic growth factors and neovascularization during tumourigenesis in colorectal carcinoma patients. | PubMed |
| Adenoma | Effect of gamma knife radiosurgery on a pituitary gonadotroph adenoma: a histologic, immunohistochemical and electron microscopic study. | PubMed |
| Adenoma | Effects of vandetanib on adenoma formation in a dextran sodium sulphate enhanced Apc(MIN/+) mouse model. | PubMed |
| Adenoma | Endoglin (CD105) expression in angiogenesis of colon cancer: analysis using tissue microarrays and comparison with other endothelial markers. | PubMed |
| Adenoma | Expression of the von Hippel-Lindau Tumor Suppressor Gene in Nonneoplastic and Neoplastic Lesions of the Thyroid. | PubMed |
| Adenoma | Frequent nitric oxide synthase-2 expression in human colon adenomas: implication for tumor angiogenesis and colon cancer progression. | PubMed |
| Adenoma | Inhibiting vascular endothelial growth factor receptor-2 signaling reduces tumor burden in the ApcMin/+ mouse model of early intestinal cancer. | PubMed |
| Adenoma | Mutated K-ras(Asp12) promotes tumourigenesis in Apc(Min) mice more in the large than the small intestines, with synergistic effects between K-ras and Wnt pathways. | PubMed |
| Adenoma | The angiogenic switch for vascular endothelial growth factor (VEGF)-A, VEGF-B, VEGF-C, and VEGF-D in the adenoma-carcinoma sequence during colorectal cancer progression. | PubMed |
| Adenoma | Vascular endothelial growth factor 1498C/T, 936C/T polymorphisms associated with increased risk of colorectal adenoma: a Chinese case-control study. | PubMed |
| Adenoma | Vascular endothelial growth factor, c-erbB-2 and c-erbB-3 expression in colorectal adenoma and adenocarcinoma. | PubMed |
| Adenoma | Vascular endothelial growth factor-D expression is an independent prognostic marker for survival in colorectal carcinoma. | PubMed |
| Adenoma | [Association of vascular endothelial growth factor 936C/T polymorphism and the susceptibility to colorectal adenoma.] | PubMed |
| Adenoma | [Relationship of hypoxia-inducible factor 1 alpha (HIF-1alpha) gene expression with vascular endothelial growth factor (VEGF) and microvessel density (MVD) in human colorectal adenoma and adenocarcinoma] | PubMed |
| Adenoma, Pleomorphic | Aggressive silent corticotroph adenoma progressing to pituitary carcinoma: the role of temozolomide therapy. | PubMed |
| Adenoma, Pleomorphic | The role of the VEGF-C/-D/flt-4 autocrine loop in the pathogenesis of salivary neoplasms. | PubMed |
| Adenoma, Pleomorphic | Vascular endothelial growth factor in salivary pleomorphic adenomas: one of the reasons for their poorly vascularized stroma. | PubMed |
| Adenomatous Polyposis Coli | Colon cancer: a civilization disorder. | PubMed |
| Adenomatous Polyps | VEGF-A, VEGF-C, and VEGF-D in colorectal cancer progression. | PubMed |
| Adenomyosis | Effect of GnRHa on apoptosis and release of VEGF in endometrial cell cultures from patients with adenomyosis. | PubMed |
| Adenomyosis | Effects of levonorgestrel-releasing intra-uterine system on the expression of vascular endothelial growth factor and adrenomedullin in the endometrium in adenomyosis. | PubMed |
| Adenomyosis | Expression of Vascular Endothelial Growth Factor (VEGF), Hypoxia Inducible Factor-1alpha (HIF-1alpha), and Microvessel Density in Endometrial Tissue in Women With Adenomyosis. | PubMed |
| Adenomyosis | Vascular endothelial growth factor gene polymorphisms are associated with the risk of developing adenomyosis. | PubMed |
| Adenomyosis | [Study on the expression of vascular endothelial growth factor in patients with adenomyosis of the uterus] | PubMed |
| Adrenal Insufficiency | Reduction of maternal adrenal steroids results in increased VEGF protein without increased eNOS in the ovine placenta. | PubMed |
| Adrenocortical Carcinoma | Significance of heparanase-1 and vascular endothelial growth factor in adrenocortical carcinoma angiogenesis: potential for therapy. | PubMed |
| Airway Obstruction | Combined neuronal and inducible nitric oxide synthase inhibition in ovine acute lung injury. | PubMed |
| Airway Obstruction | Effects of pranlukast administration on vascular endothelial growth factor levels in asthmatic patients. | PubMed |
| Airway Obstruction | Remodeling in asthma and chronic obstructive pulmonary disease. | PubMed |
| Albuminuria | Angiopoietins: vascular growth factors looking for roles in glomeruli. | PubMed |
| Albuminuria | Attenuation of extracellular matrix accumulation in diabetic nephropathy by the advanced glycation end product cross-link breaker ALT-711 via a protein kinase C-alpha-dependent pathway. | PubMed |
| Albuminuria | Blockade of vascular endothelial growth factor signaling ameliorates diabetic albuminuria in mice. | PubMed |
| Albuminuria | Combination therapy with the advanced glycation end product cross-link breaker, alagebrium, and angiotensin converting enzyme inhibitors in diabetes: synergy or redundancy? | PubMed |
| Albuminuria | Different roles for TGF-beta and VEGF in the pathogenesis of the cardinal features of diabetic nephropathy. | PubMed |
| Albuminuria | Evidence linking glycated albumin to altered glomerular nephrin and VEGF expression, proteinuria, and diabetic nephropathy. | PubMed |
| Albuminuria | Interference with TGF-beta signaling by Smad3-knockout in mice limits diabetic glomerulosclerosis without affecting albuminuria. | PubMed |
| Albuminuria | Loss of ACE2 accelerates time-dependent glomerular and tubulointerstitial damage in streptozotocin-induced diabetic mice. | PubMed |
| Albuminuria | Mesangial immune complex glomerulonephritis due to complement factor D deficiency. | PubMed |
| Albuminuria | Podocyte-derived vascular endothelial growth factor mediates the stimulation of alpha3(IV) collagen production by transforming growth factor-beta1 in mouse podocytes. | PubMed |
| Albuminuria | Rapamycin prevents early steps of the development of diabetic nephropathy in rats. | PubMed |
| Albuminuria | Role of Complement Component C1q in the Onset of Preeclampsia in Mice. | PubMed |
| Albuminuria | Silencing of hypoxia-inducible factor-1? gene attenuated angiotensin II-induced renal injury in Sprague-Dawley rats. | PubMed |
| Albuminuria | The role of vascular endothelial growth factor +405 G/C polymorphism and albuminuria in patients with type 2 diabetes mellitus. | PubMed |
| Albuminuria | Urocortin 1 improves renal function in rats with streptozotocin-induced diabetes by inhibiting overproduction of TGF-beta1 and VEGF. | PubMed |
| Alopecia | Loss of vascular endothelial growth factor in human alopecia hair follicles. | PubMed |
| Alopecia | Vascular endothelial growth factor and its receptor may be one molecular mechanism for androgenetic alopecia. | PubMed |
| Alopecia Areata | Expression of vascular endothelial growth factor, apoptosis inhibitors (survivin and p16) and CCL27 in alopecia areata before and after diphencyprone treatment: an immunohistochemical study. | PubMed |
| Altitude Sickness | B-type natriuretic peptide, vascular endothelial growth factor, endothelin-1, and nitric oxide synthase in chronic mountain sickness. | PubMed |
| Altitude Sickness | Cerebrovascular dynamics and vascular endothelial growth factor in acute mountain sickness. | PubMed |
| Altitude Sickness | Change in plasma vascular endothelial growth factor during onset and recovery from acute mountain sickness. | PubMed |
| Altitude Sickness | Greater free plasma VEGF and lower soluble VEGF receptor-1 in acute mountain sickness. | PubMed |
| Altitude Sickness | No correlation between plasma levels of vascular endothelial growth factor or its soluble receptor and acute mountain sickness. | PubMed |
| Altitude Sickness | Plasma vascular endothelial growth factor in acute mountain sickness. | PubMed |
| Altitude Sickness | Polymorphisms of human vascular endothelial growth factor gene in high-altitude pulmonary oedema susceptible subjects. | PubMed |
| Altitude Sickness | Variability in pulmonary function following rapid altitude ascent to the Amundsen-Scott South Pole station. | PubMed |
| Altitude Sickness | Vascular endothelial growth factor and acute mountain sickness. | PubMed |
| Alzheimer Disease | -1154G/A and -2578C/A polymorphisms of the vascular endothelial growth factor gene in Tunisian Alzheimer patients in relation to beta-amyloid (1-42) and total tau protein. | PubMed |
| Alzheimer Disease | Amyloid-?(25-35), an amyloid-?(1-42) surrogate, and proinflammatory cytokines stimulate VEGF-A secretion by cultured, early passage, normoxic adult human cerebral astrocytes. | PubMed |
| Alzheimer Disease | Association between promoter polymorphisms of vascular endothelial growth factor gene and sporadic Alzheimer's disease among Northern Chinese Han. | PubMed |
| Alzheimer Disease | Association study of the vascular endothelial growth factor gene with the risk of developing Alzheimer's disease. | PubMed |
| Alzheimer Disease | Case-control study of vascular endothelial growth factor (VEGF) genetic variability in Alzheimer's disease. | PubMed |
| Alzheimer Disease | Co-accumulation of vascular endothelial growth factor with beta-amyloid in the brain of patients with Alzheimer's disease. | PubMed |
| Alzheimer Disease | Decreased release of the angiogenic peptide vascular endothelial growth factor in Alzheimer's disease: recovering effect with insulin and DHEA sulfate. | PubMed |
| Alzheimer Disease | Dynamics of a heparin-binding domain of VEGF(165) complexed with its inhibitor triamterene. | PubMed |
| Alzheimer Disease | Encapsulated VEGF-Secreting Cells Enhance Proliferation of Neuronal Progenitors in the Hippocampus of A?PP/Ps1 Mice. | PubMed |
| Alzheimer Disease | From angiogenesis to neuropathology. | PubMed |
| Alzheimer Disease | Increased intrathecal levels of the angiogenic factors VEGF and TGF-beta in Alzheimer's disease and vascular dementia. | PubMed |
| Alzheimer Disease | Low serum VEGF levels are associated with Alzheimer's disease. | PubMed |
| Alzheimer Disease | No Association of VEGF Polymorphims with Alzheimer's Disease. | PubMed |
| Alzheimer Disease | The Amyloid-?42 Proxy, Amyloid-?25-35, Induces Normal Human Cerebral Astrocytes to Produce Amyloid-?42. | PubMed |
| Alzheimer Disease | Vascular endothelial growth factor in Alzheimer's disease and experimental cerebral ischemia. | PubMed |
| Alzheimer Disease | VEGF gene and phenotype relation with Alzheimer's disease and mild cognitive impairment. | PubMed |
| Alzheimer Disease | VEGF-induced angiogenesis ameliorates the memory impairment in APP transgenic mouse model of Alzheimer's disease. | PubMed |
| Ameloblastoma | Association between vascular endothelial growth factor (VEGF) expression and tumor angiogenesis in ameloblastomas. | PubMed |
| Ameloblastoma | Expression of inducible nitric oxide synthase and vascular endothelial growth factor in ameloblastoma. | PubMed |
| Amyloid Neuropathies | Serum vascular endothelial growth factor (VEGF) in the differential diagnosis of amyloid neuropathy and POEMS syndrome. | PubMed |
| Amyloidosis | Effect of large-size dialysis membrane and hemofiltration/hemodiafiltration methods on long-term dialysis patients. | PubMed |
| Amyloidosis | Vascular endothelial growth factor helps differentiate neuropathies in rare plasma cell dyscrasias. | PubMed, PubMed |
| Amyotrophic Lateral Sclerosis | Association of polymorphisms in vascular endothelial growth factor gene with the age of onset of amyotrophic lateral sclerosis. | PubMed |
| Amyotrophic Lateral Sclerosis | Cerebrospinal fluid vascular endothelial growth factor in patients with amyotrophic lateral sclerosis. | PubMed |
| Amyotrophic Lateral Sclerosis | Clinical and fundamental aspects of angiogenesis and anti-angiogenesis. | PubMed |
| Amyotrophic Lateral Sclerosis | Delayed administration of VEGF rescues spinal motor neurons from death with a short effective time frame in excitotoxic experimental models in vivo. | PubMed |
| Amyotrophic Lateral Sclerosis | Effects of vascular endothelial growth factor (VEGF) on motor neuron degeneration. | PubMed |
| Amyotrophic Lateral Sclerosis | Expression of vascular endothelial growth factor and its receptors in the central nervous system in amyotrophic lateral sclerosis. | PubMed |
| Amyotrophic Lateral Sclerosis | Genetically modified human umbilical cord blood cells expressing vascular endothelial growth factor and fibroblast growth factor 2 differentiate into glial cells after transplantation into amyotrophic lateral sclerosis transgenic mice. | PubMed |
| Amyotrophic Lateral Sclerosis | Human umbilical cord blood cells transfected with VEGF and L(1)CAM do not differentiate into neurons but transform into vascular endothelial cells and secrete neuro-trophic factors to support neuro-genesis-a novel approach in stem cell therapy. | PubMed |
| Amyotrophic Lateral Sclerosis | Immunohistochemical localization of vascular endothelial growth factor receptors-1, -2 and -3 in human spinal cord: altered expression in amyotrophic lateral sclerosis. | PubMed |
| Amyotrophic Lateral Sclerosis | Immunohistochemical studies of vascular endothelial growth factor in skin of patients with amyotrophic lateral sclerosis. | PubMed |
| Amyotrophic Lateral Sclerosis | Mutant copper-zinc superoxide dismutase associated with amyotrophic lateral sclerosis binds to adenine/uridine-rich stability elements in the vascular endothelial growth factor 3'-untranslated region. | PubMed |
| Amyotrophic Lateral Sclerosis | Mutant Cu/Zn-superoxide dismutase associated with amyotrophic lateral sclerosis destabilizes vascular endothelial growth factor mRNA and downregulates its expression. | PubMed |
| Amyotrophic Lateral Sclerosis | Screening of the regulatory and coding regions of vascular endothelial growth factor in amyotrophic lateral sclerosis. | PubMed |
| Amyotrophic Lateral Sclerosis | Vascular Endothelial Growth Factor Attenuates Neurodegenerative Changes in the NSC-34 Motor Neuron Cell Line Induced by Cerebrospinal Fluid of Sporadic Amyotrophic Lateral Sclerosis Patients. | PubMed |
| Amyotrophic Lateral Sclerosis | Vascular endothelial growth factor counteracts the loss of phospho-Akt preceding motor neurone degeneration in amyotrophic lateral sclerosis. | PubMed |
| Amyotrophic Lateral Sclerosis | Vascular endothelial growth factor in amyotrophic lateral sclerosis and other neurodegenerative diseases. | PubMed |
| Amyotrophic Lateral Sclerosis | Vascular endothelial growth factor overexpression delays neurodegeneration and prolongs survival in amyotrophic lateral sclerosis mice. | PubMed |
| Amyotrophic Lateral Sclerosis | Vascular endothelial growth factor prevents paralysis and motoneuron death in a rat model of excitotoxic spinal cord neurodegeneration. | PubMed |
| Amyotrophic Lateral Sclerosis | VEGF and ALS. | PubMed |
| Amyotrophic Lateral Sclerosis | VEGF is increased in serum but not in spinal cord from patients with amyotrophic lateral sclerosis. | PubMed |
| Amyotrophic Lateral Sclerosis | VEGF protects spinal motor neurons against chronic excitotoxic degeneration in vivo by activation of PI3-K pathway and inhibition of p38MAPK. | PubMed |
| Anaplasia | Prognostic significance of anaplasia and angiogenesis in childhood medulloblastoma: a pediatric oncology group study. | PubMed |
| Anaplasia | Tenascin in meningioma: expression is correlated with anaplasia, vascular endothelial growth factor expression, and peritumoral edema but not with tumor border shape. | PubMed |
| Anastomotic Leak | [Association between vascular endothelial growth factor gene 936 T/C polymorphism and colorectal cancer together with anastomotic leakage] | PubMed |
| Anemia | Anemia and elevated systemic levels of vascular endothelial growth factor (VEGF). | PubMed |
| Anemia | Cardiac hypertrophy in chronically anemic fetal sheep: Increased vascularization is associated with increased myocardial expression of vascular endothelial growth factor and hypoxia-inducible factor 1. | PubMed |
| Anemia | Effect of large-size dialysis membrane and hemofiltration/hemodiafiltration methods on long-term dialysis patients. | PubMed |
| Anemia | Human recombinant erythropoietic agents do not induce changes in circulating levels of endoglin and vascular endothelial growth factor in anemic cancer patients. | PubMed |
| Anemia | Impaired angiogenic potency of bone marrow cells from patients with advanced age, anemia, and renal failure. | PubMed |
| Anemia | Low hemoglobin is associated with increased serum levels of vascular endothelial growth factor (VEGF) in cancer patients. Does anemia stimulate angiogenesis? | PubMed |
| Anemia | Myocardial vascular and metabolic adaptations in chronically anemic fetal sheep. | PubMed |
| Anemia | Possibility of enhanced risk of retinal neovascularization in repeated blood donors: blood donation and retinal alteration. | PubMed |
| Anemia | Sickle cell anemia as a possible state of enhanced anti-apoptotic tone: survival effect of vascular endothelial growth factor on circulating and unanchored endothelial cells. | PubMed |
| Anemia | Vasculogenic mimicry by bone marrow macrophages in patients with multiple myeloma. | PubMed |
| Anemia | [A case of POEMS syndrome associated with Waldenström's macroglobulinemia and treated with lenalidomide]. | PubMed |
| Anemia | [Molecular factors of angiogenesis in renal tissue of patients with chronic glomerulonephritis: association with nephrosclerosis and anemia] | PubMed |
| Anemia, Aplastic | Cytokine signature profiles in acquired aplastic anemia and myelodysplastic syndromes. | PubMed |
| Anemia, Aplastic | Evaluation of angiogenesis and vascular endothelial growth factor expression in the bone marrow of patients with aplastic anemia. | PubMed |
| Anemia, Aplastic | Vascular endothelial growth factor corrected for platelet count and hematocrit is associated with the clinical course of aplastic anemia in children. | PubMed |
| Anemia, Aplastic | [Bone marrow microvessel density and vascular endothelial growth factor expression in patients with aplastic anemia] | PubMed |
| Anemia, Aplastic | [Expression of vascular endothelial growth factor in patients with aplastic anemia and its significance] | PubMed |
| Anemia, Aplastic | [Serum Levels of sVCAM-1, IL-18 and VEGF in Patients with Aplastic Anemia and Their Clinical Significance.] | PubMed |
| Anemia, Hemolytic | Effects of experimental asthma on inflammation and lung mechanics in sickle cell mice. | PubMed |
| Anemia, Iron-Deficiency | Possibility of enhanced risk of retinal neovascularization in repeated blood donors: blood donation and retinal alteration. | PubMed |
| Anemia, Sickle Cell | Angiogenic and inflammatory markers of cardiopulmonary changes in children and adolescents with sickle cell disease. | PubMed |
| Anemia, Sickle Cell | Association of single nucleotide polymorphisms in klotho with priapism in sickle cell anaemia. | PubMed |
| Anemia, Sickle Cell | Clinical relevance of vascular endothelial growth factor levels in sickle cell disease. | PubMed |
| Anemia, Sickle Cell | Cytokines and plasma factors in sickle cell disease. | PubMed |
| Anemia, Sickle Cell | Sickle cell anemia as a possible state of enhanced anti-apoptotic tone: survival effect of vascular endothelial growth factor on circulating and unanchored endothelial cells. | PubMed |
| Anemia, Sickle Cell | Soluble P-selectin and vascular endothelial growth factor in steady state sickle cell disease: relationship to genotype. | PubMed |
| Anemia, Sickle Cell | The angiopoietin/Tie-2 system in proliferative sickle retinopathy: relation to vascular endothelial growth factor, its soluble receptor Flt-1 and von Willebrand factor, and to the effects of laser treatment. | PubMed |
| Anemia, Sickle Cell | The relation of vascular endothelial growth factor (VEGF) gene polymorphisms on VEGF levels and the risk of vasoocclusive crisis in sickle cell disease. | PubMed |
| Aneurysm | Abdominal aortic aneurysm rupture is associated with increased medial neovascularization and overexpression of proangiogenic cytokines. | PubMed |
| Aneurysm | Delivery of human vascular endothelial growth factor with platinum coils enhances wall thickening and coil impregnation in a rat aneurysm model. | PubMed |
| Aneurysm | Embolization of a common carotid aneurysm with rhVEGF coupled to a pH-responsive chitosan in a rat model. | PubMed |
| Aneurysm | Endovascular treatment of aneurysms: healing mechanisms in a Swine model are associated with increased expression of matrix metalloproteinases, vascular cell adhesion molecule-1, and vascular endothelial growth factor, and decreased expression of tissue inhibitors of matrix metalloproteinases. | PubMed |
| Aneurysm | Expression of angiogenesis factors and selected vascular wall matrix proteins in intracranial saccular aneurysms. | PubMed |
| Aneurysm | Vascular endothelial growth factor enhances angiotensin II-induced aneurysm formation in apolipoprotein E-deficient mice. | PubMed |
| Aneurysm | Vascular endothelial growth factor immobilized on platinum microcoils for the treatment of intracranial aneurysms: experimental rat model study. | PubMed |
| Aneurysm, Ruptured | Implications of vascular endothelial growth factor, sFlt-1, and sTie-2 in plasma, serum and cerebrospinal fluid during cerebral ischemia in man. | PubMed |
| Angina Pectoris | Intraoperative multiplane transesophageal echocardiography for guiding direct myocardial gene transfer of vascular endothelial growth factor in patients with refractory angina pectoris. | PubMed |
| Angina Pectoris | Marked elevation of vascular endothelial growth factor and basic fibroblast growth factor in pericardial fluid of patients with angina pectoris. | PubMed |
| Angina Pectoris | Serum levels of vascular endothelial growth factor in patients with angina pectoris and acute myocardial infarction. | PubMed |
| Angina, Stable | Interleukin-8 is associated with circulating CD133+ progenitor cells in acute myocardial infarction. | PubMed |
| Angina, Stable | Nitroglycerin treatment may enhance chemosensitivity to docetaxel and carboplatin in patients with lung adenocarcinoma. | PubMed |
| Angina, Stable | Relation of various plasma growth factor levels in patients with stable angina pectoris and total occlusion of a coronary artery to the degree of coronary collaterals. | PubMed |
| Angina, Unstable | Elevated basic fibroblast growth factor in pericardial fluid of patients with unstable angina. | PubMed |
| Angina, Unstable | Expression of angiogenic factors during acute coronary syndromes in human type 2 diabetes. | PubMed |
| Angina, Unstable | Influence of preinfarction angina on the release kinetics of endothelial progenitor cells and cytokines during the week after infarction. | PubMed |
| Angina, Unstable | Marked elevation of vascular endothelial growth factor and basic fibroblast growth factor in pericardial fluid of patients with angina pectoris. | PubMed |
| Angiodysplasia | Increased expression of angiogenic factors in human colonic angiodysplasia. | PubMed |
| Angiodysplasia | Increased plasma vascular endothelial growth factor levels in patients with angiodysplasia. | PubMed |
| Angiodysplasia | The role of VEGF in angiodysplasia: an intervention study with thalidomide. | PubMed |
| Angioedema | Vascular endothelial growth factor is involved in angioedema associated with eosinophilia. | PubMed |
| Angiofibroma | Molecular angiogenic signaling in angiofibromas after embolization: implications for therapy. | PubMed |
| Angiofibroma | Vessel density, proliferation, and immunolocalization of vascular endothelial growth factor in juvenile nasopharyngeal angiofibromas. | PubMed |
| Angiolipoma | Angiolipoma of the buccal mucosa: a possible role of mast cell-derived VEGF in its enhanced vascularity. | PubMed |
| Angiomatosis, Bacillary | Differential effects of Bartonella henselae on human and feline macro- and micro-vascular endothelial cells. | PubMed |
| Angiomyolipoma | Tuberous sclerosis-associated lesions of the kidney, brain, and skin are angiogenic neoplasms. | PubMed |
| Anthrax | A 'dock and lock' approach to preparation of targeted liposomes. | PubMed |
| Anthrax | Anthrax Lethal Toxin Inhibits Growth of and Vascular Endothelial Growth Factor Release from Endothelial Cells Expressing the Human Herpes Virus 8 Viral G Protein Coupled Receptor. | PubMed |
| Anthrax | Self-assembled 'dock and lock' system for linking payloads to targeting proteins. | PubMed |
| Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis | Elevated soluble Flt1 inhibits endothelial repair in PR3-ANCA-associated vasculitis. | PubMed |
| Antiphospholipid Syndrome | Role of the Vitamin D in Leprosy. | PubMed |
| Antiphospholipid Syndrome | Vascular endothelial growth factor expression in monocytes from patients with primary antiphospholipid syndrome. | PubMed |
| Antiphospholipid Syndrome | Vascular endothelial growth factor plasma levels in patients with systemic lupus erythematosus and primary antiphospholipid syndrome. | PubMed |
| Aortic Aneurysm, Abdominal | Expression and localization of vascular endothelial growth factor in normal abdominal aorta and abdominal aortic aneurysm. | PubMed |
| Aortic Aneurysm, Abdominal | Expression of angiogenesis and angiogenic factors in human aortic vascular disease. | PubMed |
| Aortic Aneurysm, Abdominal | Vascular endothelial growth factor enhances angiotensin II-induced aneurysm formation in apolipoprotein E-deficient mice. | PubMed |
| Aortic Valve Stenosis | Chemically modified tetracyclines (CMT-3 and CMT-8) enable control of the pathologic remodellation of human aortic valve stenosis via MMP-9 and VEGF inhibition. | PubMed |
| Arterial Occlusive Diseases | Designer zinc-finger proteins and their applications. | PubMed |
| Arterial Occlusive Diseases | Oxidative stress and increase of vascular endothelial growth factor in plasma of patients with peripheral arterial occlusive disease. | PubMed |
| Arterial Occlusive Diseases | Vascular endothelial growth factor overexpression in ischemic skeletal muscle enhances myoglobin expression in vivo. | PubMed |
| Arteriosclerosis | Angiopoietin-1 protects against the development of cardiac allograft arteriosclerosis. | PubMed |
| Arteriosclerosis | Molecular imaging of vascular endothelial growth factor receptors in graft arteriosclerosis. | PubMed |
| Arteriosclerosis | Vascular endothelial growth factor enhances cardiac allograft arteriosclerosis. | PubMed |
| Arteriosclerosis | Vascular endothelial growth factor is necessary in the development of arteriosclerosis by recruiting/activating monocytes in a rat model of long-term inhibition of nitric oxide synthesis. | PubMed |
| Arteriosclerosis | [Effects of simvastatin on vasa vasorum and aortic endothelial function in rats] | PubMed |
| Arteriovenous Fistula | Effects of brachytherapy on intimal hyperplasia in arteriovenous fistulas in a porcine model. | PubMed |
| Arteriovenous Fistula | Evaluation of circulating vascular endothelial growth factor and soluble adhesion molecules as reliable predictors of native arteriovenous fistula thrombosis in chronic hemodialysis patients. | PubMed |
| Arteriovenous Malformations | Bevacizumab attenuates VEGF-induced angiogenesis and vascular malformations in the adult mouse brain. | PubMed |
| Arteriovenous Malformations | Effects of VEGF on phenotypic severity in children with hereditary hemorrhagic telangiectasia. | PubMed |
| Arteriovenous Malformations | Expression of endothelial cell angiogenesis receptors in human cerebrovascular malformations. | PubMed |
| Arteriovenous Malformations | Expression of platelet-derived growth factor ligand and receptor in cerebral arteriovenous and cavernous malformations. | PubMed |
| Arteriovenous Malformations | Matrix metalloproteinase-9 inhibition attenuates vascular endothelial growth factor-induced intracerebral hemorrhage. | PubMed |
| Arteriovenous Malformations | Neurological surgery at the National Institutes of Health. | PubMed |
| Arteriovenous Malformations | Perlecan domain V is upregulated in human brain arteriovenous malformation and could mediate the vascular endothelial growth factor effect in lesional tissue. | PubMed |
| Arteriovenous Malformations | Polymorphisms of the vascular endothelial growth factor A gene and susceptibility to sporadic brain arteriovenous malformation in a Chinese population. | PubMed |
| Arteriovenous Malformations | Polymorphisms of VEGFA gene and susceptibility to hemorrhage risk of brain arteriovenous malformations in a Chinese population. | PubMed |
| Arteritis | A functional variant of vascular endothelial growth factor is associated with severe ischemic complications in giant cell arteritis. | PubMed |
| Arteritis | Formation of new vasa vasorum in vasculitis. Production of angiogenic cytokines by multinucleated giant cells. | PubMed |
| Arteritis | Increased serum vascular endothelial growth factor level in Churg-Strauss syndrome. | PubMed |
| Arteritis | Selective up-regulation of the soluble pattern-recognition receptor pentraxin 3 and of vascular endothelial growth factor in giant cell arteritis: Relevance for recent optic nerve ischemia. | PubMed |
| Arteritis | Vascular endothelial growth factor gene polymorphisms in giant cell arteritis. | PubMed |
| Arthritis | Angiogenesis markers (VEGF, soluble receptor of VEGF and angiopoietin-1) in very early arthritis and their association with inflammation and joint destruction. | PubMed |
| Arthritis | Baseline serum adipokine levels predict radiographic progression in early rheumatoid arthritis. | PubMed |
| Arthritis | Biomarkers of inflammation in patients with unclassified polyarthritis and early rheumatoid arthritis. Relationship to disease activity and radiographic outcome. | PubMed |
| Arthritis | Complement factor D in serum. An indicator of glomerular filtration rate in chronic inflammatory arthritis. | PubMed |
| Arthritis | Expression levels and association of gelatinases MMP-2 and MMP-9 and collagenases MMP-1 and MMP-13 with VEGF in synovial fluid of patients with arthritis. | PubMed |
| Arthritis | Expression of type IV collagenase correlates with the expression of vascular endothelial growth factor in primary non-small cell lung cancer. | PubMed |
| Arthritis | Extracellular high mobility group box chromosomal protein 1 is a coupling factor for hypoxia and inflammation in arthritis. | PubMed |
| Arthritis | Ganglioside GM3 inhibits VEGF/VEGFR-2-mediated angiogenesis: direct interaction of GM3 with VEGFR-2. | PubMed |
| Arthritis | Imatinib mesylate both prevents and treats the arthritis induced by type II collagen antibody in mice. | PubMed |
| Arthritis | Inhibition of histone deacetylase down-regulates the expression of hypoxia-induced vascular endothelial growth factor by rheumatoid synovial fibroblasts. | PubMed |
| Arthritis | Inhibitory effect of bone resorption and inflammation with etidronate therapy in patients with rheumatoid arthritis for 3 years and in vitro assay in arthritis models. | PubMed |
| Arthritis | Intra-articular injection of platelet-richplasma reduces inflammation in a house swine model of rheumatoid arthritisof the knee joint. | PubMed |
| Arthritis | Involvement of sphingosine-1-phosphate and S1P1 in angiogenesis: analyses using a new S1P1 antagonist of non-sphingosine-1-phosphate analog. | PubMed |
| Arthritis | Placenta growth factor is not required for exercise-induced angiogenesis. | PubMed |
| Arthritis | Raised serum vascular endothelial growth factor levels are associated with destructive change in inflammatory arthritis. | PubMed |
| Arthritis | Serum and synovial fluid concentration of vascular endothelial growth factor in juvenile idiopathic arthritides. | PubMed |
| Arthritis | Sphingosine-1-phosphate modulates expression of vascular endothelial growth factor in human articular chondrocytes: a possible new role in arthritis. | PubMed |
| Arthritis | Synovial concentrations of the angiogenic peptides bFGF and VEGF do not discriminate rheumatoid arthritis from other forms of inflammatory arthritis. | PubMed |
| Arthritis | The angiogenic pathway 'vascular endothelial growth factor/flk-1(KDR)-receptor' in rheumatoid arthritis and osteoarthritis. | PubMed |
| Arthritis | The Hypoxic Synovial Environment Regulates Expression of Vascular Endothelial Growth Factor and Osteopontin in Juvenile Idiopathic Arthritis. | PubMed |
| Arthritis | The role of hypoxia and HIF-dependent signalling events in rheumatoid arthritis. | PubMed |
| Arthritis | Vascular endothelial growth factor and its inhibitors. | PubMed |
| Arthritis | Vascular endothelial growth factor C attenuates joint damage in chronic inflammatory arthritis by accelerating local lymphatic drainage in mice. | PubMed |
| Arthritis | Vascular endothelial growth factor expression in arthritic joint is regulated by SAF-1 transcription factor. | PubMed |
| Arthritis | Vascular endothelial growth factor. A cytokine modulating endothelial function in rheumatoid arthritis. | PubMed |
| Arthritis | Vegfb gene knockout mice display reduced pathology and synovial angiogenesis in both antigen-induced and collagen-induced models of arthritis. | PubMed |
| Arthritis | ZM323881, a novel inhibitor of vascular endothelial growth factor-receptor-2 tyrosine kinase activity. | PubMed |
| Arthritis | [Relationship of tetramethylpyrazine on expression of vascular endothelial growth factor and development of adjuvant-induced arthritis in rats] | PubMed |
| Arthritis, Experimental | An angiogenesis inhibitor, 2-methoxyestradiol, involutes rat collagen-induced arthritis and suppresses gene expression of synovial vascular endothelial growth factor and basic fibroblast growth factor. | PubMed |
| Arthritis, Experimental | Effects of cold-damp and hot-damp environment on VEGF and IL-1 expression in joint cartilage cells in adjuvant arthritis in rats. | PubMed |
| Arthritis, Experimental | Neutralization of vascular endothelial growth factor prevents collagen-induced arthritis and ameliorates established disease in mice. | PubMed |
| Arthritis, Experimental | Suppression of collagen-induced arthritis by an angiogenesis inhibitor, AGM-1470, in combination with cyclosporin: reduction of vascular endothelial growth factor (VEGF). | PubMed |
| Arthritis, Experimental | Vascular endothelial growth factor expression and regulation of murine collagen-induced arthritis. | PubMed |
| Arthritis, Experimental | Vegfb gene knockout mice display reduced pathology and synovial angiogenesis in both antigen-induced and collagen-induced models of arthritis. | PubMed |
| Arthritis, Infectious | TLR-2-mediated induction of vascular endothelial growth factor (VEGF) in cartilage in septic joint disease. | PubMed |
| Arthritis, Juvenile Rheumatoid | Increased circulating vascular endothelial growth factor is correlated with disease activity in polyarticular juvenile rheumatoid arthritis. | PubMed |
| Arthritis, Juvenile Rheumatoid | Serum and synovial fluid concentration of vascular endothelial growth factor in juvenile idiopathic arthritides. | PubMed |
| Arthritis, Juvenile Rheumatoid | The Hypoxic Synovial Environment Regulates Expression of Vascular Endothelial Growth Factor and Osteopontin in Juvenile Idiopathic Arthritis. | PubMed |
| Arthritis, Psoriatic | Pathogenesis of psoriatic arthritis. | PubMed |
| Arthritis, Psoriatic | Vascular endothelial growth factor in patients with psoriatic arthritis. | PubMed |
| Arthritis, Rheumatoid | A new approach to studying angiogenesis in rheumatoid arthritis by means of power Doppler ultrasonography and measurement of serum vascular endothelial growth factor. | PubMed |
| Arthritis, Rheumatoid | A study on vascular endothelial growth factor and endothelin-1 in patients with extra-articular involvement of rheumatoid arthritis. | PubMed |
| Arthritis, Rheumatoid | Adeno-associated virus-delivered polycistronic microRNA-clusters for knockdown of vascular endothelial growth factor in vivo. | PubMed |
| Arthritis, Rheumatoid | Adiponectin may contribute to synovitis and joint destruction in rheumatoid arthritis by stimulating vascular endothelial growth factor, matrix metalloproteinase-1, and matrix metalloproteinase-13 expression in fibroblast-like synoviocytes more than proinflammatory mediators. | PubMed |
| Arthritis, Rheumatoid | Age at onset of rheumatoid arthritis: association with polymorphisms in the vascular endothelial growth factor A(VEGFA) gene and an intergenic locus between matrix metalloproteinase (MMP) 1 and 3 genes. | PubMed |
| Arthritis, Rheumatoid | Amelioration of collagen-induced arthritis in rats by nanogold. | PubMed |
| Arthritis, Rheumatoid | An angiogenesis inhibitor, 2-methoxyestradiol, involutes rat collagen-induced arthritis and suppresses gene expression of synovial vascular endothelial growth factor and basic fibroblast growth factor. | PubMed |
| Arthritis, Rheumatoid | An antagonistic vascular endothelial growth factor (VEGF) variant inhibits VEGF-stimulated receptor autophosphorylation and proliferation of human endothelial cells. | PubMed |
| Arthritis, Rheumatoid | Analysis of vascular endothelial growth factor (VEGF) functional variants in rheumatoid arthritis. | PubMed |
| Arthritis, Rheumatoid | Anti-interleukin-6 receptor antibody therapy reduces vascular endothelial growth factor production in rheumatoid arthritis. | PubMed |
| Arthritis, Rheumatoid | Anti-TNF-alpha antibody Infliximab and glucocorticoids reduce serum vascular endothelial growth factor levels in patients with rheumatoid arthritis: a pilot study. | PubMed |
| Arthritis, Rheumatoid | Arginine-rich anti-vascular endothelial growth factor (anti-VEGF) hexapeptide inhibits collagen-induced arthritis and VEGF-stimulated productions of TNF-alpha and IL-6 by human monocytes. | PubMed |
| Arthritis, Rheumatoid | Biomarkers of inflammation in patients with unclassified polyarthritis and early rheumatoid arthritis. Relationship to disease activity and radiographic outcome. | PubMed |
| Arthritis, Rheumatoid | Blockade of vascular endothelial growth factor receptor I (VEGF-RI), but not VEGF-RII, suppresses joint destruction in the K/BxN model of rheumatoid arthritis. | PubMed |
| Arthritis, Rheumatoid | Body composition and serum levels of adiponectin, vascular endothelial growth factor, and interleukin-6 in patients with rheumatoid arthritis. | PubMed |
| Arthritis, Rheumatoid | CD147 induces angiogenesis through vascular endothelial growth factor and hypoxiainducible transcription factor 1?-mediated pathway in rheumatoid arthritis. | PubMed |
| Arthritis, Rheumatoid | Circulating VEGF as a biological marker in patients with rheumatoid arthritis? Preanalytical and biological variability in healthy persons and in patients. | PubMed |
| Arthritis, Rheumatoid | Clinical Significance of Serum Levels of Vascular Endothelial Growth Factor, Angiopoietin-1, and Angiopoietin-2 in Patients with Rheumatoid Arthritis. | PubMed |
| Arthritis, Rheumatoid | Cocoa polyphenols suppress TNF-?-induced vascular endothelial growth factor expression by inhibiting phosphoinositide 3-kinase (PI3K) and mitogen-activated protein kinase kinase-1 (MEK1) activities in mouse epidermal cells. | PubMed |
| Arthritis, Rheumatoid | Correlation between synovial blood flow signals and serum vascular endothelial growth factor levels in patients with refractory rheumatoid arthritis. | PubMed |
| Arthritis, Rheumatoid | Effect of electro-acupuncture on tumor necrosis factor-? and vascular endothelial growth factor in peripheral blood and joint synovia of patients with rheumatoid arthritis. | PubMed |
| Arthritis, Rheumatoid | Effect of etanercept on serum levels of soluble cell adhesion molecules (sICAM-1, sVCAM-1, and sE-selectin) and vascular endothelial growth factor in patients with rheumatoid arthritis. | PubMed |
| Arthritis, Rheumatoid | Effect of interleukin-4 on vascular endothelial growth factor production in rheumatoid synovial fibroblasts. | PubMed |
| Arthritis, Rheumatoid | Effects of combinations of anti-rheumatic drugs on the production of vascular endothelial growth factor and basic fibroblast growth factor in cultured synoviocytes and patients with rheumatoid arthritis. | PubMed |
| Arthritis, Rheumatoid | Elevated levels of vascular endothelial growth factor in the sera of patients with rheumatoid arthritis correlation with disease activity. | PubMed |
| Arthritis, Rheumatoid | Engagement of toll-like receptor 3 induces vascular endothelial growth factor and interleukin-8 in human rheumatoid synovial fibroblasts. | PubMed |
| Arthritis, Rheumatoid | Expression of platelet-derived growth factors C and D in the synovial membrane of patients with rheumatoid arthritis and osteoarthritis. | PubMed |
| Arthritis, Rheumatoid | Expression of vascular endothelial growth factor by synovial fluid neutrophils in rheumatoid arthritis (RA). | PubMed |
| Arthritis, Rheumatoid | Expression of vascular endothelial growth factor isoforms and their receptors Flt-1, KDR, and neuropilin-1 in synovial tissues of rheumatoid arthritis. | PubMed |
| Arthritis, Rheumatoid | Gliostatin/thymidine phosphorylase-regulated vascular endothelial growth-factor production in human fibroblast-like synoviocytes. | PubMed |
| Arthritis, Rheumatoid | Heterogeneous requirement of IkappaB kinase 2 for inflammatory cytokine and matrix metalloproteinase production in rheumatoid arthritis: implications for therapy. | PubMed |
| Arthritis, Rheumatoid | IL-17 increased the production of vascular endothelial growth factor in rheumatoid arthritis synoviocytes. | PubMed |
| Arthritis, Rheumatoid | IL-17, IL-1beta and TNF-alpha stimulate VEGF production by dedifferentiated chondrocytes. | PubMed |
| Arthritis, Rheumatoid | Imbalance in production between vascular endothelial growth factor and endostatin in patients with rheumatoid arthritis. | PubMed |
| Arthritis, Rheumatoid | Immunohistochemical analysis of vascular endothelial growth factor expression in severe and destructive rheumatoid arthritis. | PubMed |
| Arthritis, Rheumatoid | Increased serum levels of vascular endothelial growth factor in patients with inflammatory bowel disease. | PubMed |
| Arthritis, Rheumatoid | Infliximab: a review of its use in the management of rheumatoid arthritis. | PubMed |
| Arthritis, Rheumatoid | Inhibition of histone deacetylase down-regulates the expression of hypoxia-induced vascular endothelial growth factor by rheumatoid synovial fibroblasts. | PubMed |
| Arthritis, Rheumatoid | Inhibitory effects of anti-rheumatic drugs on vascular endothelial growth factor in cultured rheumatoid synovial cells. | PubMed |
| Arthritis, Rheumatoid | Interaction Between Smoking and Polymorphism in the Promoter Region of the VEGFA Gene Is Associated with Ischemic Heart Disease and Myocardial Infarction in Rheumatoid Arthritis. | PubMed |
| Arthritis, Rheumatoid | Interleukin-18 induces the production of vascular endothelial growth factor (VEGF) in rheumatoid arthritis synovial fibroblasts via AP-1-dependent pathways. | PubMed |
| Arthritis, Rheumatoid | Modification of pro- and antiinflammatory cytokines and vascular-related molecules by tumor necrosis factor-a blockade in patients with rheumatoid arthritis. | PubMed |
| Arthritis, Rheumatoid | Modulation of angiogenic vascular endothelial growth factor by tumor necrosis factor alpha and interleukin-1 in rheumatoid arthritis. | PubMed |
| Arthritis, Rheumatoid | Neutralization of vascular endothelial growth factor prevents collagen-induced arthritis and ameliorates established disease in mice. | PubMed |
| Arthritis, Rheumatoid | Novel splice variants derived from the receptor tyrosine kinase superfamily are potential therapeutics for rheumatoid arthritis. | PubMed |
| Arthritis, Rheumatoid | Overexpression of vascular permeability factor (VPF/VEGF) and its endothelial cell receptors in delayed hypersensitivity skin reactions. | PubMed |
| Arthritis, Rheumatoid | Peripheral blood mononuclear cells from patients with rheumatoid arthritis spontaneously secrete vascular endothelial growth factor (VEGF): specific up-regulation by tumour necrosis factor-alpha (TNF-alpha) in synovial fluid. | PubMed |
| Arthritis, Rheumatoid | Polymorphism in the vascular endothelial growth factor A (VEGFA) gene is associated with serum VEGF-A level and disease activity in rheumatoid arthritis: differential effect of cigarette smoking. | PubMed |
| Arthritis, Rheumatoid | Preclinical pharmacokinetics, interspecies scaling, and tissue distribution of a humanized monoclonal antibody against vascular endothelial growth factor. | PubMed |
| Arthritis, Rheumatoid | Production of cytokines, vascular endothelial growth factor, matrix metalloproteinases, and tissue inhibitor of metalloproteinases 1 by tenosynovium demonstrates its potential for tendon destruction in rheumatoid arthritis. | PubMed |
| Arthritis, Rheumatoid | Proinflammatory role of vascular endothelial growth factor in the pathogenesis of rheumatoid arthritis: prospects for therapeutic intervention. | PubMed |
| Arthritis, Rheumatoid | Recent data on the role for angiogenesis in rheumatoid arthritis. | PubMed |
| Arthritis, Rheumatoid | Reduction of soluble adhesion molecules (sICAM-1, sVCAM-1, and sE-selectin) and vascular endothelial growth factor levels in serum of rheumatoid arthritis patients following multiple intravenous infusions of infliximab. | PubMed |
| Arthritis, Rheumatoid | Role of vascular endothelial growth factor in angiogenesis of rheumatoid arthritis. | PubMed |
| Arthritis, Rheumatoid | Serum concentrations of vascular endothelial growth factor in collagen diseases. | PubMed |
| Arthritis, Rheumatoid | Serum vascular endothelial growth factor in late rheumatoid arthritis. | PubMed |
| Arthritis, Rheumatoid | Signaling of vascular endothelial growth factor receptor-1 tyrosine kinase promotes rheumatoid arthritis through activation of monocytes/macrophages. | PubMed |
| Arthritis, Rheumatoid | Soluble adhesion molecules (ICAM-1, VCAM-1, and E-selectin) and vascular endothelial growth factor (VEGF) in patients with distinct variants of rheumatoid synovitis. | PubMed |
| Arthritis, Rheumatoid | Splice variants VEGF121 and VEGF165 of the angiogenic peptide vascular endothelial cell growth factor are expressed in the synovial tissue of patients with rheumatoid arthritis. | PubMed |
| Arthritis, Rheumatoid | Study of active controlled tocilizumab monotherapy for rheumatoid arthritis patients with an inadequate response to methotrexate (SATORI): significant reduction in disease activity and serum vascular endothelial growth factor by IL-6 receptor inhibition therapy. | PubMed |
| Arthritis, Rheumatoid | Subclinical gut inflammation in spondyloarthritis is associated with a pro-angiogenic intestinal mucosal phenotype. | PubMed |
| Arthritis, Rheumatoid | Synovial concentrations of the angiogenic peptides bFGF and VEGF do not discriminate rheumatoid arthritis from other forms of inflammatory arthritis. | PubMed |
| Arthritis, Rheumatoid | The anti-malaria agent artesunate inhibits expression of vascular endothelial growth factor and hypoxia-inducible factor-1alpha in human rheumatoid arthritis fibroblast-like synoviocyte. | PubMed |
| Arthritis, Rheumatoid | The Ets 1 transcription factor is upregulated during inflammatory angiogenesis in rheumatoid arthritis. | PubMed |
| Arthritis, Rheumatoid | The relation of serum vascular endothelial growth factor level with disease duration and activity in patients with rheumatoid arthritis. | PubMed |
| Arthritis, Rheumatoid | Vascular endothelial growth factor A and cardiovascular disease in rheumatoid arthritis patients. | PubMed |
| Arthritis, Rheumatoid | Vascular endothelial growth factor expression by activated synovial leukocytes in rheumatoid arthritis: critical involvement of the interaction with synovial fibroblasts. | PubMed |
| Arthritis, Rheumatoid | Vascular endothelial growth factor gene polymorphisms and rheumatoid arthritis. | PubMed |
| Arthritis, Rheumatoid | Vascular endothelial growth factor in patients with rheumatoid arthritis. | PubMed |
| Arthritis, Rheumatoid | Vascular endothelial growth factor induces protein kinase D-dependent production of proinflammatory cytokines in endothelial cells. | PubMed |
| Arthritis, Rheumatoid | Vascular endothelial growth factor levels in the serum and synovial fluid of patients with rheumatoid arthritis. | PubMed |
| Arthritis, Rheumatoid | Vascular endothelial growth factor. A cytokine modulating endothelial function in rheumatoid arthritis. | PubMed |
| Arthritis, Rheumatoid | Vascular endothelial growth factors C and D and their VEGFR-2 and 3 receptors in blood and lymphatic vessels in healthy and arthritic synovium. | PubMed |
| Arthritis, Rheumatoid | Vascular permeability factor/vascular endothelial growth factor: an important mediator of angiogenesis in malignancy and inflammation. | PubMed |
| Arthritis, Rheumatoid | [Effect of strengthening Pi and activating blood circulation therapy on serum levels of adrenocorticotrophic hormone and vascular endothelial growth factor in rheumatoid arthritis patients] | PubMed |
| Arthritis, Rheumatoid | [Effects of RNAi on cyclooxygenase-2 expression and biologic activity of human rheumatoid arthritis synovial fibroblasts] | PubMed |
| Arthritis, Rheumatoid | [Serum tumor necrosis factor alpha (TNF-alpha) concentration correlates with soluble adhesion molecules and vascular endothelial growth factor (VEGF) in rheumatoid arthritis] | PubMed |
| Aspergillosis | Invasive aspergillosis associated with bevacizumab, a vascular endothelial growth factor inhibitor. | PubMed |
| Asthma | A comparative study of two angiogenic factors: vascular endothelial growth factor and angiogenin in induced sputum from asthmatic children in acute attack. | PubMed |
| Asthma | A potent antiangiogenic factor, endostatin prevents the development of asthma in a murine model. | PubMed |
| Asthma | A prodrug of cysteine, L-2-oxothiazolidine-4-carboxylic acid, regulates vascular permeability by reducing vascular endothelial growth factor expression in asthma. | PubMed |
| Asthma | Abnormal histone methylation is responsible for increased vascular endothelial growth factor 165a secretion from airway smooth muscle cells in asthma. | PubMed |
| Asthma | Acute and chronic changes of vascular endothelial growth factor (VEGF) in induced sputum of toluene diisocyanate (TDI)-induced asthma patients. | PubMed |
| Asthma | Alveolar macrophage-derived VEGF contributes to allergic airway inflammation in a mouse asthma model. | PubMed |
| Asthma | Analysis of growth factors and inflammatory cytokines in exhaled breath condensate from asthmatic children. | PubMed |
| Asthma | Analysis of vascular endothelial growth factor levels in induced sputum samples from patients with cough variant asthma. | PubMed |
| Asthma | Angiogenesis: a potentially critical part of remodelling in chronic airway diseases? | PubMed |
| Asthma | Association of vascular endothelial growth factor polymorphisms with asthma in tunisian children. | PubMed |
| Asthma | Association of Vascular Endothelial Growth Factor polymorphisms with childhood asthma, lung function, and airways responsiveness. | PubMed |
| Asthma | Asthma treatment outcome in children is associated with vascular endothelial growth factor A (VEGFA) polymorphisms. | PubMed |
| Asthma | Azithromycin Attenuates Fibroblast Growth Factors Induced Vascular Endothelial Growth Factor Via p38(MAPK) Signaling in Human Airway Smooth Muscle Cells. | PubMed |
| Asthma | Budesonide/formoterol decreases expression of vascular endothelial growth factor (VEGF) and VEGF receptor 1 within airway remodelling in asthma. | PubMed |
| Asthma | Chlamydophila pneumoniae triggers release of CCL20 and vascular endothelial growth factor from human bronchial epithelial cells through enhanced intracellular oxidative stress and MAPK activation. | PubMed |
| Asthma | Circulating and exhaled vascular endothelial growth factor in asthmatic pregnancy. | PubMed |
| Asthma | Clinical significance of plasma and serum vascular endothelial growth factor in asthma. | PubMed |
| Asthma | Contribution of vascular endothelial growth factor to airway hyperresponsiveness and inflammation in a murine model of toluene diisocyanate-induced asthma. | PubMed |
| Asthma | Cough and asthma. | PubMed |
| Asthma | Effects of inhaled fluticasone on angiogenesis and vascular endothelial growth factor in asthma. | PubMed |
| Asthma | Effects of leukotriene receptor antagonists on vascular endothelial growth factor levels in asthma. | PubMed |
| Asthma | Expression and function of the vascular endothelial growth factor receptor FLT-1 in human eosinophils. | PubMed |
| Asthma | Gene expression of vascular endothelial growth factor and its receptors and angiogenesis in bronchial asthma. | PubMed |
| Asthma | High vascular endothelial growth factor levels in NZW mice do not correlate with collagen deposition in allergic asthma. | PubMed |
| Asthma | IL-9 Induces VEGF Secretion from Human Mast Cells and IL-9/IL-9 Receptor Genes Are Overexpressed in Atopic Dermatitis. | PubMed |
| Asthma | Impaired TNFalpha-induced VEGF expression in human airway smooth muscle cells from smokers with COPD: role of MAPkinases and histone acetylation--effect of dexamethasone. | PubMed |
| Asthma | Increased expression of tissue vascular endothelial growth factor and foetal liver kinase-1 receptor in seasonal allergic rhinitis and relevance to asthma component. | PubMed |
| Asthma | Increased synthesis of vascular endothelial growth factor in allergic airway inflammation in histidine decarboxylase knockout (HDC(-/-)) mice. | PubMed |
| Asthma | Increased vascular endothelial growth factor and receptors: relationship to angiogenesis in asthma. | PubMed |
| Asthma | Increased vascular permeability precedes cellular inflammation as asthma control deteriorates. | PubMed |
| Asthma | Inhibition of VEGF blocks TGF-beta1 production through a PI3K/Akt signalling pathway. | PubMed |
| Asthma | L-2-Oxothiazolidine-4-Carboxylic Acid or ?-Lipoic Acid Attenuates Airway Remodeling: Involvement of Nuclear Factor-?B (NF-?B), Nuclear Factor Erythroid 2p45-Related Factor-2 (Nrf2), and Hypoxia-Inducible Factor (HIF). | PubMed |
| Asthma | Markers of autoreactivity, coagulation and angiogenesis in patients with nonallergic asthma. | PubMed |
| Asthma | Microvascular theory of exercise-induced bronchoconstriction in asthma: potential implication of vascular endothelial growth factor. | PubMed |
| Asthma | Neovastat (AE-941) inhibits the airway inflammation via VEGF and HIF-2 alpha suppression. | PubMed |
| Asthma | Oncostatin M causes VEGF release from human airway smooth muscle: synergy with IL-1beta. | PubMed |
| Asthma | Phosphatase and tensin homolog deleted on chromosome 10 (PTEN) reduces vascular endothelial growth factor expression in allergen-induced airway inflammation. | PubMed |
| Asthma | Proangiogenic activity in bronchoalveolar lavage fluid from patients with asthma. | PubMed |
| Asthma | Recent advances in mechanisms and treatments of airway remodeling in asthma: a message from the bench side to the clinic. | PubMed |
| Asthma | Recombinant IGFBP-3 inhibits allergic lung inflammation, VEGF production, and vascular leak in a mouse model of asthma. | PubMed |
| Asthma | Relationship between neurokinin 2 receptor gene polymorphisms and serum vascular endothelial growth factor levels in patients with toluene diisocyanate-induced asthma. | PubMed |
| Asthma | Relationships of methacholine and adenosine monophosphate responsiveness with serum vascular endothelial growth factor in children with asthma. | PubMed |
| Asthma | Remodeling in asthma and chronic obstructive pulmonary disease. | PubMed |
| Asthma | Role of the extracellular signal-regulated kinase 1/2 signaling pathway in regulating the secretion of bronchial smooth muscle cells in a rat model of chronic asthma. | PubMed |
| Asthma | Silver nanoparticles modify VEGF signaling pathway and mucus hypersecretion in allergic airway inflammation. | PubMed |
| Asthma | Studies of vascular endothelial growth factor in asthma and chronic obstructive pulmonary disease. | PubMed |
| Asthma | TH2 Cytokine-enhanced and TGF-beta-enhanced vascular endothelial growth factor production by cultured human airway smooth muscle cells is attenuated by IFN-gamma and corticosteroids. | PubMed |
| Asthma | The indication and effectiveness of low-dose erythromycin therapy in pediatric patients with bronchial asthma. | PubMed |
| Asthma | Up-regulation of thrombin activity induced by vascular endothelial growth factor in asthmatic airways. | PubMed |
| Asthma | Vascular endothelial growth factor in patients with acute asthma. | PubMed |
| Asthma | Vascular endothelial growth factor induction by rhinovirus infection. | PubMed |
| Asthma | Vascular endothelial growth factor levels in induced sputum and emphysematous changes in smoking asthmatic patients. | PubMed |
| Asthma | Vascular endothelial growth factor modulates matrix metalloproteinase-9 expression in asthma. | PubMed |
| Asthma | Vascular endothelial growth factor overexpression in induced sputum of children with bronchial asthma. | PubMed |
| Asthma | Vascular endothelial growth factor up-regulation and bronchial wall remodelling in asthma. | PubMed |
| Asthma | Vascular remodeling is airway generation-specific in a primate model of chronic asthma. | PubMed |
| Asthma | Vascular remodelling and angiogenesis in asthma: morphological aspects and pharmacological modulation. | PubMed |
| Asthma | Vascular remodelling in asthma. | PubMed |
| Asthma | [Effects of bacterial lipopolysaccharide on serum IL-4, serum IL-8 and pulmonary VEGF expression in mice with asthma]. | PubMed |
| Asthma | [Modulation of Toll-like signal path of allergic asthma by CpG-ODNs from Bordetella pertussis]. | PubMed |
| Asthma | [Potential mechanisms of airway remodeling initiated by activated thrombin in asthma] | PubMed |
| Asthma | [The effect of a vascular endothelial growth factor receptor inhibitor on airway inflammation and airway remodeling in a murine model of asthma] | PubMed |
| Asthma | [Vascular endothelial growth factor - structure, function and role in airways inflammation and the clinical course of asthma] | PubMed |
| Astrocytoma | Analysis of interleukin (IL)-8 expression in human astrocytomas: Associations with IL-6, cyclooxygenase-2, vascular endothelial growth factor, and microvessel morphometry. | PubMed |
| Astrocytoma | Angiogenesis and its role in the behavior of astrocytic brain tumors. | PubMed |
| Astrocytoma | Antiangiogenic activity of BAI1 in vivo: implications for gene therapy of human glioblastomas. | PubMed |
| Astrocytoma | Blood-brain barrier breakdown in septic encephalopathy and brain tumours. | PubMed |
| Astrocytoma | Correlation of bFGF, FGFR-1 and VEGF expression with vascularity and malignancy of human astrocytomas. | PubMed |
| Astrocytoma | Cyclooxygenase-2 and inducible nitric oxide synthase expression in human astrocytic gliomas: correlation with angiogenesis and prognostic significance. | PubMed |
| Astrocytoma | Decrease of endogenous vascular endothelial growth factor may not affect glioma cell proliferation and invasion. | PubMed |
| Astrocytoma | Dynamic contrast-enhanced derived cerebral blood volume correlates better with leak correction than with no correction for vascular endothelial growth factor, microvascular density, and grading of astrocytoma. | PubMed |
| Astrocytoma | Expression and hypoxic regulation of angiopoietins in human astrocytomas. | PubMed |
| Astrocytoma | Expression and regulation of neuropilin-1 in human astrocytomas. | PubMed |
| Astrocytoma | Expression of angiopoietin-2 in human glioma cells and its role for angiogenesis. | PubMed |
| Astrocytoma | Expression of endothelial nitric oxide synthase and vascular endothelial growth factor in association with neovascularization in human primary astrocytoma. | PubMed |
| Astrocytoma | Expression of growth factors in brain tumors: correlation with tumor grade, recurrence and survival. | PubMed |
| Astrocytoma | EXPRESSION OF INTERLEUKIN-8 (IL-8) RECEPTOR CXCR2 AND SUPPRESSOR OF CYTOKINE SIGNALING-3 (SOCS-3) IN ASTROCYTIC TUMORS. | PubMed |
| Astrocytoma | Expression of KIT Receptor Tyrosine Kinase in Endothelial Cells of Juvenile Brain Tumors. | PubMed |
| Astrocytoma | Expression of nuclear factor-kappaB in human astrocytomas: relation to pI kappa Ba, vascular endothelial growth factor, Cox-2, microvascular characteristics, and survival. | PubMed |
| Astrocytoma | Expression of pERK and pAKT in human astrocytomas: correlation with IDH1-R132H presence, vascular endothelial growth factor, microvascular characteristics and clinical outcome. | PubMed |
| Astrocytoma | Expression of the angiogenic factor thymidine phosphorylase in human astrocytic tumors. | PubMed |
| Astrocytoma | Expression of vascular endothelial growth factor (VEGF) and its two receptors in diffusely infiltrating astrocytomas and relationship to proliferative activity of tumor cells. | PubMed |
| Astrocytoma | Expression of vascular endothelial growth factor and its receptors in pilocytic astrocytoma. | PubMed |
| Astrocytoma | Expression of vascular endothelial growth factor and its receptors in the anaplastic progression of astrocytoma, oligodendroglioma, and ependymoma. | PubMed |
| Astrocytoma | Expression patterns of the hypoxia-related genes osteopontin, CA9, erythropoietin, VEGF and HIF-1alpha in human glioma in vitro and in vivo. | PubMed |
| Astrocytoma | Growth inhibition of astrocytoma cells by farnesyl transferase inhibitors is mediated by a combination of anti-proliferative, pro-apoptotic and anti-angiogenic effects. | PubMed |
| Astrocytoma | Hypoxia-inducible factor 1alpha/vascular endothelial growth factor axis in astrocytomas. Associations with microvessel morphometry, proliferation and prognosis. | PubMed |
| Astrocytoma | Inhibition of growth of C6 glioma cells in vivo by expression of antisense vascular endothelial growth factor sequence. | PubMed |
| Astrocytoma | Malignant transformation of p53-deficient astrocytes is modulated by environmental cues in vitro. | PubMed |
| Astrocytoma | Normoxic and hypoxic regulation of vascular endothelial growth factor (VEGF) by astrocytoma cells is mediated by Ras. | PubMed |
| Astrocytoma | Oncostatin-M induction of vascular endothelial growth factor expression in astroglioma cells. | PubMed |
| Astrocytoma | Pathological and molecular progression of astrocytomas in a GFAP:12 V-Ha-Ras mouse astrocytoma model. | PubMed |
| Astrocytoma | Phosphatidylinositol 3'-kinase and MAPK/ERK kinase 1/2 differentially regulate expression of vascular endothelial growth factor in human malignant astrocytoma cells. | PubMed |
| Astrocytoma | Production and interferon-gamma-mediated regulation of complement component C2 and factors B and D by the astroglioma cell line U105-MG. | PubMed |
| Astrocytoma | Progesterone receptor and SRC-1 participate in the regulation of VEGF, EGFR and Cyclin D1 expression in human astrocytoma cell lines. | PubMed |
| Astrocytoma | PTEN protein expression correlates with PTEN gene molecular changes but not with VEGF expression in astrocytomas. | PubMed |
| Astrocytoma | Quantitation of angiogenesis and its correlation with vascular endothelial growth factor expression in astrocytic tumors. | PubMed |
| Astrocytoma | Ras activation in astrocytomas and neurofibromas. | PubMed |
| Astrocytoma | The effects of exogenous growth factors on matrix metalloproteinase secretion by human brain tumour cells. | PubMed |
| Astrocytoma | The expressions of carbonic anhydrase 9 and vascular endothelial growth factor in astrocytic tumors predict a poor prognosis. | PubMed |
| Astrocytoma | The importance of cell density in the interpretation of growth factor effects on collagenase IV activity release and extracellular matrix production from C6 astrocytoma cells. | PubMed |
| Astrocytoma | The prognostic significance of vascular endothelial growth factor (VEGF C-1) immunoexpression in oligodendroglioma. An analysis of 91 cases. | PubMed |
| Astrocytoma | Vascular endothelial growth factor (VEGF) in astrocytic gliomas--a prognostic factor? | PubMed |
| Astrocytoma | Vascular endothelial growth factor and basic fibroblast growth factor expression positively correlates with angiogenesis and peritumoural brain oedema in astrocytoma. | PubMed |
| Astrocytoma | Vascular endothelial growth factor expression and vascular density as prognostic markers of survival in patients with low-grade astrocytoma. | PubMed |
| Astrocytoma | Vascular endothelial growth factor in astroglioma stem cell biology and response to therapy. | PubMed |
| Astrocytoma | Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo. | PubMed |
| Astrocytoma | [A quantitative pathological study on angiogenesis, vascular endothelial growth factor and inducible nitric oxide synthase in astrocytomas] | PubMed |
| Astrocytoma | [Expression of vascular endothelial growth factor in brain astrocytoma and its clinical evaluation] | PubMed |
| Astrocytoma | [p53 and vascular endothelial growth factor expression in astrocytoma and their relation to angiogenesis] | PubMed |
| Ataxia Telangiectasia | Epigenetic inactivation of BCL6B, a novel functional tumour suppressor for gastric cancer, is associated with poor survival of gastric cancer. | PubMed |
| Atherosclerosis | Angiotensin II upregulates the expression of placental growth factor in human vascular endothelial cells and smooth muscle cells. | PubMed |
| Atherosclerosis | Atherosclerosis and angiogenesis. Its pathophysiological significance in humans as well as in an animal model induced by the gene transfer of vascular endothelial growth factor. | PubMed |
| Atherosclerosis | Atherosclerosis and the protective role played by different proteins in apolipoprotein E-deficient mice. | PubMed |
| Atherosclerosis | Basic fibrobrast growth factor induces the secretion of vascular endothelial growth factor by human aortic smooth muscle cells but not by endothelial cells. | PubMed |
| Atherosclerosis | Betaxolol stimulates eNOS production associated with LOX-1 and VEGF in Dahl salt-sensitive rats. | PubMed |
| Atherosclerosis | Both vascular endothelial growth factor and soluble Flt-1 are increased in type 2 diabetes but not in impaired fasting glucose. | PubMed |
| Atherosclerosis | Comparative effects of basic fibroblast growth factor and vascular endothelial growth factor on coronary collateral development and the arterial response to injury. | PubMed |
| Atherosclerosis | Complement components as uremic toxins and their potential role as mediators of microinflammation. | PubMed |
| Atherosclerosis | Cytokine-inducible growth factor gene expression in human umbilical endothelial cells. | PubMed |
| Atherosclerosis | Diabetes mellitus-associated atherosclerosis : mechanisms involved and potential for pharmacological invention. | PubMed |
| Atherosclerosis | Effects of PDGF-C and PDGF-D on monocyte migration and MMP-2 and MMP-9 expression. | PubMed |
| Atherosclerosis | Heritability for plasma VEGF concentration in the Stanislas family study. | PubMed |
| Atherosclerosis | High levels of oestrogen receptor-alpha in tumorigenesis: inhibition of cell growth and angiogenic factors. | PubMed |
| Atherosclerosis | HO-1 and VGEF gene expression in human arteries with advanced atherosclerosis. | PubMed |
| Atherosclerosis | Homocysteine induces vascular endothelial growth factor expression in differentiated THP-1 macrophages. | PubMed |
| Atherosclerosis | Identification of cis- and trans-Acting Genetic Variants Explaining Up to Half the Variation in Circulating Vascular Endothelial Growth Factor Levels. | PubMed |
| Atherosclerosis | Induction of high mobility group box 1 release from serotonin-stimulated human umbilical vein endothelial cells. | PubMed |
| Atherosclerosis | Induction of vascular endothelial growth factor in balloon-injured baboon arteries. A novel role for reactive oxygen species in atherosclerosis. | PubMed |
| Atherosclerosis | Inflammatory mediators and premature coronary atherosclerosis in rheumatoid arthritis. | PubMed |
| Atherosclerosis | Inhibitions of vascular endothelial growth factor expression and foam cell formation by EGb 761, a special extract of Ginkgo biloba, in oxidatively modified low-density lipoprotein-induced human THP-1 monocytes cells. | PubMed |
| Atherosclerosis | Intercellular adhesion molecule-1 and vascular endothelial growth factor expression kinetics in macrophage-derived foam cells. | PubMed |
| Atherosclerosis | Lipoprotein-associated phosphatidylethanol increases the plasma concentration of vascular endothelial growth factor. | PubMed |
| Atherosclerosis | Nicotine potentiates vascular endothelial growth factor expression in balloon-injured rabbit aortas. | PubMed |
| Atherosclerosis | Oxidised LDL decreases VEGFR-1 expression in human monocyte-derived macrophages. | PubMed |
| Atherosclerosis | Peroxynitrite increases VEGF expression in vascular endothelial cells via STAT3. | PubMed |
| Atherosclerosis | Phosphatidylethanol in high density lipoproteins increases the vascular endothelial growth factor in smooth muscle cells. | PubMed |
| Atherosclerosis | Phosphatidylethanol mediates its effects on the vascular endothelial growth factor via HDL receptor in endothelial cells. | PubMed |
| Atherosclerosis | Placenta growth factor is not required for exercise-induced angiogenesis. | PubMed |
| Atherosclerosis | Plasma vascular endothelial growth factor and its receptor Flt-1 in patients with hyperlipidemia and atherosclerosis and the effects of fluvastatin or fenofibrate. | PubMed |
| Atherosclerosis | Polymorphisms of the methylenetetrahydrofolate reductase, vascular endothelial growth factor, endothelial nitric oxide synthase, monocyte chemoattractant protein-1 and apolipoprotein E genes are not associated with carotid intima-media thickness. | PubMed |
| Atherosclerosis | Possible association between circulating vascular endothelial growth factor and oxidative stress markers in hemodialysis patients. | PubMed |
| Atherosclerosis | Possible new role of monocyte chemoattractant protein-1 in hemodialysis patients with cardiovascular disease. | PubMed |
| Atherosclerosis | Post-transcriptional regulation of VEGF expression by oxidised LDL in human macrophages. | PubMed |
| Atherosclerosis | Radiofrequency-enhanced vascular gene transduction and expression for intravascular MR imaging-guided therapy: feasibility study in pigs. | PubMed |
| Atherosclerosis | Reactive hyperemia and BOLD MRI demonstrate that VEGF inhibition, age, and atherosclerosis adversely affect functional recovery in a murine model of peripheral artery disease. | PubMed |
| Atherosclerosis | Reduction of atherosclerosis in cholesterol-fed rabbits and decrease of expressions of intracellular adhesion molecule-1 and vascular endothelial growth factor in foam cells by a water-soluble fraction of Polygonum multiflorum. | PubMed |
| Atherosclerosis | Reductions of circulating matrix metalloproteinase 2 and vascular endothelial growth factor levels after treatment with pegvisomant in subjects with acromegaly. | PubMed |
| Atherosclerosis | Serum level of vascular endothelial growth factor is decreased by hormone replacement therapy in postmenopausal women without hypercholesterolemia. | PubMed |
| Atherosclerosis | Serum VEGF--as a prognostic factor of atherosclerosis. | PubMed |
| Atherosclerosis | Signal transduction via vascular endothelial growth factor (VEGF) receptors and their roles in atherogenesis. | PubMed |
| Atherosclerosis | Significance of nitric oxide and peroxynitrite in permeability changes of the retinal microvascular endothelial cell monolayer induced by vascular endothelial growth factor. | PubMed |
| Atherosclerosis | The effects of growth hormone status on circulating levels of vascular growth factors. | PubMed |
| Atherosclerosis | Traditional and non traditional risk factors in accelerated atherosclerosis in systemic lupus erythematosus: role of vascular endothelial growth factor (VEGATS Study). | PubMed |
| Atherosclerosis | Variation in the vascular endothelial growth factor gene, carotid intima-media thickness and the risk of acute myocardial infarction. | PubMed |
| Atherosclerosis | Vascular endothelial growth factor (VEGF) expression in human coronary atherosclerotic lesions: possible pathophysiological significance of VEGF in progression of atherosclerosis. | PubMed |
| Atherosclerosis | Vascular endothelial growth factor and its inhibitors. | PubMed |
| Atherosclerosis | Vascular endothelial growth factor and its receptor, Flt-1, in the plasma of patients with coronary or peripheral atherosclerosis, or Type II diabetes. | PubMed |
| Atherosclerosis | Vascular endothelial growth factor increases the migration and proliferation of smooth muscle cells through the mediation of growth factors released by endothelial cells. | PubMed |
| Atherosclerosis | Vascular endothelial growth factor induces protein kinase D-dependent production of proinflammatory cytokines in endothelial cells. | PubMed |
| Atherosclerosis | Vascular endothelial growth factor polymorphisms are involved in the late vascular complications in Type II diabetic patients. | PubMed |
| Atherosclerosis | Vascular endothelial growth factor promotes cell-cycle transition from G0 to G1 phase in subcultured endothelial cells of diabetic rat thoracic aorta. | PubMed |
| Atherosclerosis | Vascular endothelial growth factor-D expression in human atherosclerotic lesions. | PubMed |
| Atherosclerosis | Vascular endothelial growth factor-D is overexpressed in human cardiac allograft vasculopathy and diabetic atherosclerosis and induces endothelial permeability to low-density lipoproteins in vitro. | PubMed |
| Atherosclerosis | Vascular endothelial growth factor: angiogenesis, atherogenesis or both? | PubMed |
| Atherosclerosis | VEGF and therapeutic opportunities in cardiovascular diseases. | PubMed |
| Atherosclerosis | VEGF protects against oxidized LDL toxicity to endothelial cells by an intracellular glutathione-dependent mechanism through the KDR receptor. | PubMed |
| Atherosclerosis | VEGF regulates FGF-2 and TGF-beta1 expression in injury endothelial cells and mediates smooth muscle cells proliferation and migration. | PubMed |
| Atherosclerosis | VEGF-A, VEGF-D, VEGF receptor-1, VEGF receptor-2, NF-kappaB, and RAGE in atherosclerotic lesions of diabetic Watanabe heritable hyperlipidemic rabbits. | PubMed |
| Atherosclerosis | Vitamins C and E downregulate vascular VEGF and VEGFR-2 expression in apolipoprotein-E-deficient mice. | PubMed |
| Atherosclerosis | Vitamins C and E prevent endothelial VEGF and VEGFR-2 overexpression induced by porcine hypercholesterolemic LDL. | PubMed |
| Atherosclerosis | [Role of anti-angiogenic factor chondromodulin-I for maintaining cardiac valvular function] | PubMed |
| Atherosclerosis | [What is new in the treatment of diabetes?--The importance of nephro- and cardioprotective management] | PubMed |
| Atrial Fibrillation | Increased intracardiac vascular endothelial growth factor levels in patients with paroxysmal, but not persistent atrial fibrillation. | PubMed |
| Atrial Fibrillation | Relationship of soluble CD40 ligand to vascular endothelial growth factor, angiopoietins, and tissue factor in atrial fibrillation: a link among platelet activation, angiogenesis, and thrombosis? | PubMed |
| Atrial Fibrillation | Serum levels of vascular endothelial growth factor and transforming growth factor-beta1 in patients with atrial fibrillation undergoing defibrillation therapy. | PubMed |
| Autoimmune Diseases | Vascular endothelial growth factor (VEGF) in autoimmune diseases. | PubMed |
| Azoospermia | Caspase-3 and VEGF immunopositivity in seminiferous tubule germ cells in cases of obstructive and non-obstructive azoospermia in smokers versus non-smokers. | PubMed |
| Bacteremia | Pre-existing renal disease promotes sepsis-induced acute kidney injury and worsens outcome. | PubMed |
| Bacterial Infections | Bacterial induction of pleural mesothelial monolayer barrier dysfunction. | PubMed |
| Bacterial Infections | Functional deficiency of complement factor D in a monozygous twin. | PubMed |
| Bacterial Infections | Serum hemolytic factor D values in children with steroid-responsive idiopathic nephrotic syndrome. | PubMed |
| Barrett Esophagus | Vascular endothelial growth factor and basic fibroblast growth factor expression in esophageal adenocarcinoma and Barrett esophagus. | PubMed |
| Bartonella Infections | Infectious angiogenesis: Bartonella bacilliformis infection results in endothelial production of angiopoetin-2 and epidermal production of vascular endothelial growth factor. | PubMed |
| Behcet Syndrome | Association of vascular endothelial growth factor gene polymorphisms with behcet disease in a Korean population. | PubMed |
| Behcet Syndrome | EFFECT OF INTRAVITREAL METHOTREXATE AND AQUEOUS HUMOR CYTOKINE LEVELS IN REFRACTORY RETINAL VASCULITIS IN BEHCET DISEASE. | PubMed |
| beta-Thalassemia | Correlation of vascular endothelial growth factor with the severity of thalassemia intermedia. | PubMed |
| Biliary Atresia | Genetic Variation in the Vascular Endothelial Growth Factor Gene is Associated With Biliary Atresia. | PubMed |
| Biliary Tract Neoplasms | Novel targeted approaches to treating biliary tract cancer: the dual epidermal growth factor receptor and ErbB-2 tyrosine kinase inhibitor NVP-AEE788 is more efficient than the epidermal growth factor receptor inhibitors gefitinib and erlotinib. | PubMed |
| Blast Crisis | Immunohistochemical detection of VEGF in the bone marrow of patients with chronic myeloid leukemia and correlation with the phase of disease. | PubMed |
| Blindness | A shift in the balance of vascular endothelial growth factor and connective tissue growth factor by bevacizumab causes the angiofibrotic switch in proliferative diabetic retinopathy. | PubMed |
| Blindness | An endothelin type a receptor antagonist reverses upregulated VEGF and icam-1 levels in streptozotocin-induced diabetic rat retina. | PubMed |
| Blindness | Association of genetic polymorphisms of vascular endothelial growth factor and risk for proliferative retinopathy of prematurity. | PubMed |
| Blindness | Clinical application of therapies targeting VEGF. | PubMed |
| Blindness | Effect of endothelin dual receptor antagonist on VEGF levels in streptozotocin-induced diabetic rat retina. | PubMed |
| Blindness | Inhibition of in vitro VEGF expression and choroidal neovascularization by synthetic dendrimer peptide mediated delivery of a sense oligonucleotide. | PubMed |
| Blindness | Inhibitory activity of bevacizumab to differentiation of retinoblastoma cells. | PubMed |
| Blindness | Regulation of tight junctions and loss of barrier function in pathophysiology. | PubMed |
| Blindness | RETHINKING STOP-ROP: IS IT WORTHWHILE TRYING TO MODULATE EXCESSIVE VEGF LEVELS IN PRETHRESHOLD ROP EYES BY SYSTEMIC INTERVENTION?: A Review of the Role of Oxygen, Light Adaptation State, and Anemia in Prethreshold ROP. | PubMed |
| Blindness | Somatostatin inhibits IGF-1 mediated induction of VEGF in human retinal pigment epithelial cells. | PubMed |
| Blindness | TCCR/WSX-1 is a novel angiogenic factor in age-related macular degeneration. | PubMed |
| Blindness | The angio-fibrotic switch of VEGF and CTGF in proliferative diabetic retinopathy. | PubMed |
| Blindness | [New drug treatment for age-related macular degeneration] | PubMed |
| Blister | Levels of mast-cell growth factors in plasma and in suction skin blister fluid in adults with mastocytosis: correlation with dermal mast-cell numbers and mast-cell tryptase. | PubMed |
| Blister | Severe generalized pustular psoriasis accompanied by bullae formation with increased serum vascular endothelial growth factor level. | PubMed |
| Blister | UV radiation induces the release of angiopoietin-2 from dermal microvascular endothelial cells. | PubMed |
| Bone Diseases | Changes in bone resorption and vascular endothelial growth factor after a single zoledronic acid infusion in cancer patients with bone metastases from solid tumours. | PubMed |
| Bone Diseases | Emerging role of bisphosphonates in the clinic--antitumor activity and prevention of metastasis to bone. | PubMed |
| Bone Diseases | Expression of human VEGF(121) cDNA in mouse bone marrow stromal cells. | PubMed |
| Bone Diseases | Relationship between serum levels of vascular endothelial growth factor, hepatocyte growth factor and matrix metalloproteinase-9 with biochemical markers of bone disease in multiple myeloma. | PubMed |
| Bone Resorption | Changes in bone resorption and vascular endothelial growth factor after a single zoledronic acid infusion in cancer patients with bone metastases from solid tumours. | PubMed |
| Bone Resorption | Estrogen regulates the production of VEGF for osteoclast formation and activity in op/op mice. | PubMed |
| Bone Resorption | Phase I and pharmacological study of the oral matrix metalloproteinase inhibitor, MMI270 (CGS27023A), in patients with advanced solid cancer. | PubMed |
| Bone Resorption | The combination of bortezomib, melphalan, dexamethasone and intermittent thalidomide is an effective regimen for relapsed/refractory myeloma and is associated with improvement of abnormal bone metabolism and angiogenesis. | PubMed |
| Bone Resorption | Vascular endothelial growth factor (VEGF) directly enhances osteoclastic bone resorption and survival of mature osteoclasts. | PubMed |
| Bone Resorption | Vascular endothelial growth factor acts as an osteolytic factor in breast cancer metastases to bone. | PubMed |
| Bone Resorption | Vascular endothelial growth factor can substitute for macrophage colony-stimulating factor in the support of osteoclastic bone resorption. | PubMed |
| Brain Diseases | Occludin phosphorylation and ubiquitination regulate tight junction trafficking and vascular endothelial growth factor-induced permeability. | PubMed |
| Brain Edema | Angiopoietin-2 interferes with anti-VEGFR2-induced vessel normalization and survival benefit in mice bearing gliomas. | PubMed |
| Brain Edema | Anti-vasopermeability effects of PEDF in retinal-renal disorders. | PubMed |
| Brain Edema | Antibody neutralization of vascular endothelial growth factor (VEGF) fails to attenuate vascular permeability and brain edema in experimental pneumococcal meningitis. | PubMed |
| Brain Edema | AQP-4 in peritumoral edematous tissue is correlated with the degree of glioma and with expression of VEGF and HIF-alpha. | PubMed |
| Brain Edema | Astrocytes co-express aquaporin-1, -4, and vascular endothelial growth factor in brain edema tissue associated with brain contusion. | PubMed |
| Brain Edema | Brain edema in meningiomas is associated with increased vascular endothelial growth factor expression. | PubMed |
| Brain Edema | Correlation of vascular endothelial growth factor messenger RNA expression with peritumoral vasogenic cerebral edema in meningiomas. | PubMed |
| Brain Edema | Edaravone inhibits the expression of vascular endothelial growth factor in human astrocytes exposed to hypoxia. | PubMed |
| Brain Edema | Effects of intraventricular infusion of vascular endothelial growth factor on cerebral blood flow, edema, and infarct volume. | PubMed |
| Brain Edema | Flt-1, but not Flk-1 mediates hyperpermeability through activation of the PI3-K/Akt pathway. | PubMed |
| Brain Edema | Greater free plasma VEGF and lower soluble VEGF receptor-1 in acute mountain sickness. | PubMed |
| Brain Edema | Intraventricular infusion of vascular endothelial growth factor promotes cerebral angiogenesis with minimal brain edema. | PubMed |
| Brain Edema | Mechanism of dexamethasone suppression of brain tumor-associated vascular permeability in rats. Involvement of the glucocorticoid receptor and vascular permeability factor. | PubMed |
| Brain Edema | No correlation between plasma levels of vascular endothelial growth factor or its soluble receptor and acute mountain sickness. | PubMed |
| Brain Edema | Peritumoral brain edema associated with meningioma: influence of vascular endothelial growth factor expression and vascular blood supply. | PubMed |
| Brain Edema | Protective effect of albumin on VEGF and brain edema in acute ischemia in rats. | PubMed |
| Brain Edema | Regulations of astrocytic functions by endothelins: roles in the pathophysiological responses of damaged brains. | PubMed |
| Brain Edema | The relationship between peritumoral brain edema and the expression of vascular endothelial growth factor and its receptors in intracranial meningiomas. | PubMed |
| Brain Edema | Vascular endothelial growth factor A protein level and gene expression in intracranial meningiomas with brain edema. | PubMed |
| Brain Edema | Vascular endothelial growth factor and blood-brain barrier disruption in tuberculous meningitis. | PubMed |
| Brain Edema | Vascular endothelial growth factor antagonist reduces brain edema formation and venous infarction. | PubMed |
| Brain Edema | Vascular endothelial growth factor in bacterial meningitis: detection in cerebrospinal fluid and localization in postmortem brain. | PubMed |
| Brain Edema | Vascular endothelial growth factor is associated with blood brain barrier dysfunction in eosinophilic meningitis caused by Angiostrongylus cantonensis infection. | PubMed |
| Brain Edema | [Correlation between vascular endothelial growth factor and peritumoural edema in meningiomas] | PubMed |
| Brain Edema | [Small interfering RNA (siRNA) targeting vascular endothelial growth factor inhibits vascular leakage in brain of rats exposed to high altitude] | PubMed |
| Brain Edema | [Vascular endothelial factor of meningomas and peritumoural vasogenic brain edema] | PubMed |
| Brain Infarction | Association between kinase insert domain-containing receptor gene polymorphisms and silent brain infarction: a Korean study. | PubMed |
| Brain Infarction | Postischemic gene transfer of soluble Flt-1 protects against brain ischemia with marked attenuation of blood-brain barrier permeability. | PubMed |
| Brain Infarction | Vascular protection and restorative therapy in ischemic stroke. | PubMed |
| Brain Injuries | Adeno-associated viral vector-mediated hypoxia-inducible vascular endothelial growth factor gene expression attenuates ischemic brain injury after focal cerebral ischemia in mice. | PubMed |
| Brain Injuries | Adenovirus-mediated brain-derived neurotrophic factor expression regulated by hypoxia response element protects brain from injury of transient middle cerebral artery occlusion in mice. | PubMed |
| Brain Injuries | Astrocytes co-express aquaporin-1, -4, and vascular endothelial growth factor in brain edema tissue associated with brain contusion. | PubMed |
| Brain Injuries | Differential expression of capillary VEGF isoforms following traumatic brain injury. | PubMed |
| Brain Injuries | Differential expression of vascular endothelial growth factor-A (VEGF-A) and VEGF-B after brain injury. | PubMed |
| Brain Injuries | Dynamic Changes of Vascular Endothelial Growth Factor and Angiopoietin-1 in Association With Circulating Endothelial Progenitor Cells After Severe Traumatic Brain Injury. | PubMed |
| Brain Injuries | Early neutrophilic expression of vascular endothelial growth factor after traumatic brain injury. | PubMed |
| Brain Injuries | Erythropoietin Mediates Neurobehavioral Recovery and Neurovascular Remodeling Following Traumatic Brain Injury in Rats by Increasing Expression of Vascular Endothelial Growth Factor. | PubMed |
| Brain Injuries | Exercise-induced overexpression of angiogenic factors and reduction of ischemia/reperfusion injury in stroke. | PubMed |
| Brain Injuries | Hippocampal Neurogenesis after Traumatic Brain Injury Is Mediated by Vascular Endothelial Growth Factor Receptor-2 and the Raf/MEK/ERK Cascade. | PubMed |
| Brain Injuries | Neuroprotective Effects of Vascular Endothelial Growth Factor Following Hypoxic Ischemic Brain Injury in Neonatal Rats. | PubMed |
| Brain Injuries | Neuroprotective effects of VEGF administration after focal cerebral ischemia/reperfusion: Dose response and time window. | PubMed |
| Brain Injuries | Neuroprotective Profile of Novel Src Kinase Inhibitors in Rodent Models of Cerebral Ischemia. | PubMed |
| Brain Injuries | Postacute ischemia vascular endothelial growth factor transfer by transferrin-targeted liposomes attenuates ischemic brain injury after experimental stroke in rats. | PubMed |
| Brain Injuries | Rapid, reversible modulation of blood-brain barrier P-glycoprotein transport activity by vascular endothelial growth factor. | PubMed |
| Brain Injuries | Release of VEGF and FGF in the extracellular space following severe subarachnoidal haemorrhage or traumatic head injury in humans. | PubMed |
| Brain Injuries | Role of vascular endothelial growth factor in blood-brain barrier breakdown and angiogenesis in brain trauma. | PubMed |
| Brain Injuries | Signaling pathways for early brain injury after subarachnoid hemorrhage. | PubMed |
| Brain Injuries | Subacute treatment with vascular endothelial growth factor after traumatic brain injury increases angiogenesis and gliogenesis. | PubMed |
| Brain Injuries | Vascular endothelial growth factor (vascular permeability factor) expression in injured rat brain. | PubMed |
| Brain Injuries | Vascular endothelial growth factor increases neurogenesis after traumatic brain injury. | PubMed |
| Brain Injuries | Vascular endothelial growth factor is increased in cerebrospinal fluid after traumatic brain injury in infants and children. | PubMed |
| Brain Injuries | Vascular endothelial growth factor is involved in mediating increased de novo hippocampal neurogenesis in response to traumatic brain injury. | PubMed |
| Brain Injuries | Vascular endothelial growth factor regulates focal adhesion assembly in human brain microvascular endothelial cells through activation of the focal adhesion kinase and related adhesion focal tyrosine kinase. | PubMed |
| Brain Injuries | VEGF increases permeability of the blood-brain barrier via a nitric oxide synthase/cGMP-dependent pathway. | PubMed |
| Brain Injuries | VEGF overexpression in the astroglial cells of rat brainstem following ozone exposure. | PubMed |
| Brain Injuries | Very early expression of vascular endothelial growth factor in brain oedema tissue associated with brain contusion. | PubMed |
| Brain Injury, Chronic | Huanglian-Jie-Du-Tang Extract Protects against Chronic Brain Injury after Focal Cerebral Ischemia via Hypoxia-Inducible-Factor-1?-Regulated Vascular Endothelial Growth Factor Signaling in Mice. | PubMed |
| Brain Ischemia | Activated microvessels express vascular endothelial growth factor and integrin alpha(v)beta3 during focal cerebral ischemia. | PubMed |
| Brain Ischemia | Adeno-associated viral vector-mediated hypoxia-inducible vascular endothelial growth factor gene expression attenuates ischemic brain injury after focal cerebral ischemia in mice. | PubMed |
| Brain Ischemia | Aggravation of hemorrhagic transformation by early intraarterial infusion of low-dose vascular endothelial growth factor after transient focal cerebral ischemia in rats. | PubMed |
| Brain Ischemia | Attenuation of edema and infarct volume following focal cerebral ischemia by early but not delayed administration of a novel small molecule KDR kinase inhibitor. | PubMed |
| Brain Ischemia | Combined treatment of vascular endothelial growth factor and human neural stem cells in experimental focal cerebral ischemia. | PubMed |
| Brain Ischemia | Effects of anti-VEGF antibody on blood-brain barrier disruption in focal cerebral ischemia. | PubMed |
| Brain Ischemia | Effects of VEGF and nitric oxide synthase inhibition on blood-brain barrier disruption in the ischemic and non-ischemic cerebral cortex. | PubMed |
| Brain Ischemia | Encapsulated vascular endothelial growth factor-secreting cell grafts have neuroprotective and angiogenic effects on focal cerebral ischemia. | PubMed |
| Brain Ischemia | Enhanced expression of vascular endothelial growth factor receptor-3 in the subventricular zone of stroke-lesioned rats. | PubMed |
| Brain Ischemia | Enhancement of expression of vascular endothelial growth factor after adeno-associated virus gene transfer is associated with improvement of brain ischemia injury in the gerbil. | PubMed |
| Brain Ischemia | Expression of angiopoietin-2 and vascular endothelial growth factor in mice cerebral cortex after permanent focal cerebral ischemia. | PubMed |
| Brain Ischemia | Expression of brain-specific angiogenesis inhibitor 2 (BAI2) in normal and ischemic brain: involvement of BAI2 in the ischemia-induced brain angiogenesis. | PubMed |
| Brain Ischemia | Expression of vascular endothelial growth factor (VEGF) and its receptors (Flt-1 and Flk-1) following permanent and transient occlusion of the middle cerebral artery in the rat. | PubMed |
| Brain Ischemia | Expression of VEGF and neural repair after alprostadil treatment in a rat model of sciatic nerve crush injury. | PubMed |
| Brain Ischemia | HIF-1 alpha and VEGF expression after transient global cerebral ischemia. | PubMed |
| Brain Ischemia | Huanglian-Jie-Du-Tang Extract Protects against Chronic Brain Injury after Focal Cerebral Ischemia via Hypoxia-Inducible-Factor-1?-Regulated Vascular Endothelial Growth Factor Signaling in Mice. | PubMed |
| Brain Ischemia | Human neural stem cells over-expressing VEGF provide neuroprotection, angiogenesis and functional recovery in mouse stroke model. | PubMed |
| Brain Ischemia | Hypoxia-induced vascular endothelial growth factor expression precedes neovascularization after cerebral ischemia. | PubMed |
| Brain Ischemia | Hypoxia-Inducible Factor 1-?-AA-Modified Bone Marrow Stem Cells Protect PC12 Cells from Hypoxia-Induced Apoptosis, Partially Through VEGF/PI3K/Akt/FoxO1 Pathway. | PubMed |
| Brain Ischemia | Implications of vascular endothelial growth factor, sFlt-1, and sTie-2 in plasma, serum and cerebrospinal fluid during cerebral ischemia in man. | PubMed |
| Brain Ischemia | Increased protein and mRNA expression of endostatin in the ischemic brain tissue of rabbits after middle cerebral artery occlusion. | PubMed |
| Brain Ischemia | Induction of vascular endothelial growth factor and hypoxia-inducible factor-1alpha by global ischemia in rat brain. | PubMed |
| Brain Ischemia | Induction of vascular endothelial growth factor receptor-3 expression in perivascular cells of the ischemic core following focal cerebral ischemia in rats. | PubMed |
| Brain Ischemia | Induction of vascular endothelial growth factor receptor-3 mRNA in glial cells following focal cerebral ischemia in rats. | PubMed |
| Brain Ischemia | Induction of vascular endothelial growth factor receptors and phosphatidylinositol 3'-kinase/Akt signaling by global cerebral ischemia in the rat. | PubMed |
| Brain Ischemia | Inhibition of VEGF signaling pathway attenuates hemorrhage after tPA treatment. | PubMed |
| Brain Ischemia | Intraventricular vascular endothelial growth factor antibody increases infarct volume following transient cerebral ischemia. | PubMed |
| Brain Ischemia | Nitric oxide enhances angiogenesis via the synthesis of vascular endothelial growth factor and cGMP after stroke in the rat. | PubMed |
| Brain Ischemia | Optimal dose of plasmid vascular endothelial growth factor for enhancement of angiogenesis in the rat brain ischemia model. | PubMed |
| Brain Ischemia | Retraction: Vascular endothelial growth factor in cerebral ischemia. | PubMed |
| Brain Ischemia | Transplantation of vascular endothelial growth factor-transfected neural stem cells into the rat brain provides neuroprotection after transient focal cerebral ischemia. | PubMed |
| Brain Ischemia | Vascular endothelial growth factor and angiopoietins in focal cerebral ischemia. | PubMed |
| Brain Ischemia | Vascular endothelial growth factor expression in transient focal cerebral ischemia in the rat. | PubMed |
| Brain Ischemia | Vascular endothelial growth factor gene expression in middle cerebral artery occlusion in the rat. | PubMed |
| Brain Ischemia | Vascular endothelial growth factor gene-transferred bone marrow stromal cells engineered with a herpes simplex virus type 1 vector can improve neurological deficits and reduce infarction volume in rat brain ischemia. | PubMed |
| Brain Ischemia | Vascular endothelial growth factor improves recovery of sensorimotor and cognitive deficits after focal cerebral ischemia in the rat. | PubMed |
| Brain Ischemia | Vascular endothelial growth factor in Alzheimer's disease and experimental cerebral ischemia. | PubMed |
| Brain Ischemia | Vascular endothelial growth factor in cerebral ischemia. | PubMed |
| Brain Ischemia | Vascular endothelial growth factor upregulation in transient global ischemia induced by cardiac arrest and resuscitation in rat brain. | PubMed |
| Brain Ischemia | VEGF promotes angiogenesis and functional recovery in stroke rats. | PubMed |
| Brain Ischemia | VEGF protects brain against focal ischemia without increasing blood--brain permeability when administered intracerebroventricularly. | PubMed |
| Brain Ischemia | [Effects of electroacupuncture combined with compound Salviae Miltiorrhizae tablet on the expressions of brain derived neurotrophic factor and vascular endothelial growth factor in hippocampus CA1 of chronic cerebral ischemia rats]. | PubMed |
| Brain Ischemia | [Expression and function of vascular endothelial growth factor and angiopoietins in rat brain after cerebral ischemia]. | PubMed |
| Brain Ischemia | [Recent advance in experimental study of cerebral ischemia treated by vascular endothelial growth factor] | PubMed |
| Brain Ischemia | [Recombinant AAV1 mediated vascular endothelial growth factor gene expression promotes angiogenesis and improves neural function: experiment with rats] | PubMed |
| Brain Neoplasms | Angiogenic factors in plasma of brain tumour patients. | PubMed |
| Brain Neoplasms | Antidepressant hyperforin up-regulates VEGF in CNS tumour cells. | PubMed |
| Brain Neoplasms | Antitumor activity of ZD6474 in a metastatic orthotopic brain tumor model. | PubMed |
| Brain Neoplasms | Autocrine regulation of glioblastoma cell cycle progression, viability and radioresistance through the VEGF-VEGFR2 (KDR) interplay. | PubMed |
| Brain Neoplasms | Bevacizumab and irinotecan in children with recurrent or refractory brain tumors: Toxicity and efficacy trends. | PubMed |
| Brain Neoplasms | Brain tumor tropism of transplanted human neural stem cells is induced by vascular endothelial growth factor. | PubMed |
| Brain Neoplasms | Changes in VEGF expression and in the vasculature during the growth of early-stage ethylnitrosourea-induced malignant astrocytomas in rats. | PubMed |
| Brain Neoplasms | Complex Oncogenic Signaling Networks Regulate Brain Tumor-Initiating Cells and Their Progenies: Pivotal Roles of Wild-Type EGFR, EGFRvIII Mutant and Hedgehog Cascades and Novel Multitargeted Therapies. | PubMed |
| Brain Neoplasms | Concentration of vascular endothelial growth factor in the serum and tumor tissue of brain tumor patients. | PubMed |
| Brain Neoplasms | Correlation of vascular endothelial growth factor messenger RNA expression with peritumoral vasogenic cerebral edema in meningiomas. | PubMed |
| Brain Neoplasms | Discontinuing bevacizumab in patients with glioblastoma: an ethical analysis. | PubMed |
| Brain Neoplasms | Edema Control by Cediranib, a Vascular Endothelial Growth Factor Receptor-Targeted Kinase Inhibitor, Prolongs Survival Despite Persistent Brain Tumor Growth in Mice. | PubMed |
| Brain Neoplasms | Epidermal growth factor receptor transcriptionally up-regulates vascular endothelial growth factor expression in human glioblastoma cells via a pathway involving phosphatidylinositol 3'-kinase and distinct from that induced by hypoxia. | PubMed |
| Brain Neoplasms | Evidence for telomerase involvement in the angiogenesis of astrocytic tumors: expression of human telomerase reverse transcriptase messenger RNA by vascular endothelial cells. | PubMed |
| Brain Neoplasms | Expression and distribution of vascular endothelial growth factor protein in human brain tumors. | PubMed |
| Brain Neoplasms | Expression and localization of placenta growth factor and PlGF receptors in human meningiomas. | PubMed |
| Brain Neoplasms | Expression and localization of VEGF-C and VEGFR-3 in glioblastomas and haemangioblastomas. | PubMed |
| Brain Neoplasms | Expression of growth factors in brain tumors: correlation with tumor grade, recurrence and survival. | PubMed |
| Brain Neoplasms | Expression of KIT Receptor Tyrosine Kinase in Endothelial Cells of Juvenile Brain Tumors. | PubMed |
| Brain Neoplasms | Expression of vascular endothelial growth factor and its possible relation with neovascularization in human brain tumors. | PubMed |
| Brain Neoplasms | Expression of vascular endothelial growth factor in human brain tumors. | PubMed |
| Brain Neoplasms | Expression of vascular endothelial growth factor in tumors and plasma from dogs with primary intracranial neoplasms. | PubMed |
| Brain Neoplasms | Expression of vascular endothelial growth-factor in the cyst fluid of human cerebral gliomas. | PubMed |
| Brain Neoplasms | Expression of VEGF and its receptor genes in intracranial schwannomas. | PubMed |
| Brain Neoplasms | Gene-linked shift in ganglioside distribution influences growth and vascularity in a mouse astrocytoma. | PubMed |
| Brain Neoplasms | Hypoxia and acidosis independently up-regulate vascular endothelial growth factor transcription in brain tumors in vivo. | PubMed |
| Brain Neoplasms | Induction of vascular endothelial growth factor by tumor necrosis factor alpha in human glioma cells. Possible roles of SP-1. | PubMed |
| Brain Neoplasms | Inhibition of growth of C6 glioma cells in vivo by expression of antisense vascular endothelial growth factor sequence. | PubMed |
| Brain Neoplasms | Intense focal expression of vascular endothelial growth-factor messenger-RNA in human intracranial neoplasms - association with regions of necrosis. | PubMed |
| Brain Neoplasms | Metastatic brain mass caused by slow-growing small-cell lung cancer: differential vascular endothelial growth factor expression in primary and metastatic tumor. | PubMed |
| Brain Neoplasms | Patients With Metastatic Breast Cancer Using Bevacizumab as a Treatment: Is There Still a Role for it? | PubMed |
| Brain Neoplasms | Pilot evaluation of cytokine levels in patients undergoing radiotherapy for brain tumor. | PubMed |
| Brain Neoplasms | Plasmalemmal vesicle associated protein-1 is a novel marker implicated in brain tumor angiogenesis. | PubMed |
| Brain Neoplasms | Platelet-derived growth factor (PDGF) autocrine signaling regulates survival and mitogenic pathways in glioblastoma cells: evidence that the novel PDGF-C and PDGF-D ligands may play a role in the development of brain tumors. | PubMed |
| Brain Neoplasms | Relationship between expression of vascular endothelial growth factor and intratumoral hemorrhage in human pituitary adenomas. | PubMed |
| Brain Neoplasms | The genesis of peritumoral vasogenic brain edema and tumor cysts: a hypothetical role for tumor-derived vascular permeability factor. | PubMed |
| Brain Neoplasms | Tumor growth modulation by sense and antisense vascular endothelial growth factor gene expression: effects on angiogenesis, vascular permeability, blood volume, blood flow, fluorodeoxyglucose uptake, and proliferation of human melanoma intracerebral xenografts. | PubMed |
| Brain Neoplasms | Vascular abnormalities in surgical specimens obtained from the resected focus of intractable epilepsy. | PubMed |
| Brain Neoplasms | Vascular endothelial growth factor (VEGF) is elevated in brain tumor cysts and correlates with tumor progression. | PubMed |
| Brain Neoplasms | Vascular endothelial growth factor expression correlates with tumour grade and vascularity in gliomas. | PubMed |
| Brain Neoplasms | Vascular endothelial growth factor expression, vascular volume, and, capillary permeability in human brain tumors. | PubMed |
| Brain Neoplasms | VEGF increases BMEC monolayer permeability by affecting occludin expression and tight junction assembly. | PubMed |
| Brain Neoplasms | VEGF inhibitors in the treatment of cerebral edema in patients with brain cancer. | PubMed |
| Brain Neoplasms | VEGF Trap induces antiglioma effect at different stages of disease. | PubMed |
| Brain Neoplasms | YB-1 dependent virotherapy in combination with temozolomide as a multimodal therapy approach to eradicate malignant glioma. | PubMed, PubMed |
| Breast Neoplasms | 17beta-estradiol inhibits forskolin-induced vascular endothelial growth factor promoter in MCF-7 breast adenocarcinoma cells. | PubMed |
| Breast Neoplasms | 99m-Tc-MDP-Scintimammography in the evaluation of breast masses or tumor angiogenesis. | PubMed |
| Breast Neoplasms | A common 936 C/T gene polymorphism of vascular endothelial growth factor is associated with decreased breast cancer risk. | PubMed |
| Breast Neoplasms | A comparison of serum and plasma levels of vascular endothelial growth factor during the menstrual cycle in healthy female volunteers. | PubMed |
| Breast Neoplasms | A general approach for receptor and antibody-targeted detection of native proteins utilizing split-luciferase reassembly. | PubMed |
| Breast Neoplasms | A multicenter phase II trial of ZD6474, a vascular endothelial growth factor receptor-2 and epidermal growth factor receptor tyrosine kinase inhibitor, in patients with previously treated metastatic breast cancer. | PubMed |
| Breast Neoplasms | A new impedimetric biosensor utilizing VEGF receptor-1 (Flt-1): early diagnosis of vascular endothelial growth factor in breast cancer. | PubMed |
| Breast Neoplasms | A phase I/II dose-escalation trial of bevacizumab in previously treated metastatic breast cancer. | PubMed |
| Breast Neoplasms | A phase II trial of erlotinib in combination with bevacizumab in patients with metastatic breast cancer. | PubMed |
| Breast Neoplasms | A physiologic imaging pilot study of breast cancer treated with AZD2171. | PubMed |
| Breast Neoplasms | A potential role for vascular endothelial growth factor-D as an autocrine growth factor for human breast carcinoma cells. | PubMed |
| Breast Neoplasms | A radicicol derivative, KF58333, inhibits expression of hypoxia-inducible factor-1alpha and vascular endothelial growth factor, angiogenesis and growth of human breast cancer xenografts. | PubMed |
| Breast Neoplasms | Adverse events risk associated with bevacizumab addition to breast cancer chemotherapy: a meta-analysis. | PubMed |
| Breast Neoplasms | AG-013736, a novel inhibitor of VEGF receptor tyrosine kinases, inhibits breast cancer growth and decreases vascular permeability as detected by dynamic contrast-enhanced magnetic resonance imaging. | PubMed |
| Breast Neoplasms | Alteration in platelet function in patients with early breast cancer. | PubMed |
| Breast Neoplasms | An open-label, phase 2 trial of RPI.4610 (angiozyme) in the treatment of metastatic breast cancer. | PubMed |
| Breast Neoplasms | Angiotensin II Type 1 Receptor (AT-1R) Expression Correlates with VEGF-A and VEGF-D Expression in Invasive Ductal Breast Cancer. | PubMed |
| Breast Neoplasms | Anti-angiogenesis effect of generation 4 polyamidoamine/vascular endothelial growth factor antisense oligodeoxynucleotide on breast cancer in vitro. | PubMed |
| Breast Neoplasms | Anti-angiogenic potential of a cancer chemopreventive flavonoid antioxidant, silymarin: inhibition of key attributes of vascular endothelial cells and angiogenic cytokine secretion by cancer epithelial cells. | PubMed |
| Breast Neoplasms | Anti-angiogenic potential of Gleditsia sinensis fruit extract. | PubMed |
| Breast Neoplasms | Antiangiogenic potential of the Mammalian target of rapamycin inhibitor temsirolimus. | PubMed |
| Breast Neoplasms | Antiangiogenic strategies, compounds, and early clinical results in breast cancer. | PubMed |
| Breast Neoplasms | Apigenin blocks induction of vascular endothelial growth factor mRNA and protein in progestin-treated human breast cancer cells. | PubMed |
| Breast Neoplasms | Association between HER-2/neu and vascular endothelial growth factor expression predicts clinical outcome in primary breast cancer patients. | PubMed |
| Breast Neoplasms | Association of a vascular endothelial growth factor gene 936 C/T polymorphism with breast cancer risk: a meta-analysis. | PubMed |
| Breast Neoplasms | Association of ARNT splice variants with estrogen receptor-negative breast cancer, poor induction of vascular endothelial growth factor under hypoxia, and poor prognosis. | PubMed |
| Breast Neoplasms | Association of the VEGF 936C>T Polymorphism with FDG Uptake, Clinical, Histopathological, and Metabolic Response in Patients with Adenocarcinomas of the Esophagogastric Junction. | PubMed |
| Breast Neoplasms | Association of vascular endothelial growth factor and vascular endothelial growth factor receptor-2 genetic polymorphisms with outcome in a trial of paclitaxel compared with paclitaxel plus bevacizumab in advanced breast cancer: ECOG 2100. | PubMed |
| Breast Neoplasms | Association of vascular endothelial growth factor expression with tumor angiogenesis and with early relapse in primary breast cancer. | PubMed |
| Breast Neoplasms | Autocrine vascular endothelial growth factor signalling in breast cancer. Evidence from cell lines and primary breast cancer cultures in vitro. | PubMed |
| Breast Neoplasms | Basic fibroblast growth factor and vascular endothelial growth factor serum levels in breast cancer patients and healthy women: useful as diagnostic tools? | PubMed |
| Breast Neoplasms | Bevacizumab for advanced breast cancer. | PubMed |
| Breast Neoplasms | Bevacizumab in combination with metronomic chemotherapy in patients with anthracycline- and taxane-refractory breast cancer. | PubMed |
| Breast Neoplasms | Bevacizumab in metastatic breast cancer: when may it be used? | PubMed |
| Breast Neoplasms | Bevacizumab in the treatment of metastatic breast cancer. | PubMed |
| Breast Neoplasms | Bevacizumab inhibits breast cancer-induced osteolysis, surrounding soft tissue metastasis, and angiogenesis in rats as visualized by VCT and MRI. | PubMed |
| Breast Neoplasms | Bevacizumab: an angiogenesis inhibitor for the treatment of solid malignancies. | PubMed |
| Breast Neoplasms | Bevacizumab: in first-line treatment of metastatic breast cancer. | PubMed |
| Breast Neoplasms | Biologic therapy of breast cancer: focus on co-inhibition of endocrine and angiogenesis pathways. | PubMed |
| Breast Neoplasms | Biological evidence for dual antiangiogenic-antiaromatase activity of the VEGFR inhibitor PTK787/ZK222584 in vivo. | PubMed |
| Breast Neoplasms | Biomarkers of disease: cerebrospinal fluid vascular endothelial growth factor (VEGF) and stromal cell derived factor (SDF)-1 levels in patients with neoplastic meningitis (NM) due to breast cancer, lung cancer and melanoma. | PubMed |
| Breast Neoplasms | Blocking ?v?3 integrin by a recombinant RGD disintegrin impairs VEGF signaling in endothelial cells. | PubMed |
| Breast Neoplasms | Breast cancer brain metastases. | PubMed |
| Breast Neoplasms | Breast cancer cell-derived fibroblast growth factor 2 and vascular endothelial growth factor are chemoattractants for bone marrow stromal stem cells. | PubMed |
| Breast Neoplasms | Breast cancer cells stimulate neutrophils to produce oncostatin M: potential implications for tumor progression. | PubMed |
| Breast Neoplasms | Broad antitumor activity in breast cancer xenografts by motesanib, a highly selective, oral inhibitor of vascular endothelial growth factor, platelet-derived growth factor, and Kit receptors. | PubMed |
| Breast Neoplasms | Cancer cell-derived interleukin 1alpha contributes to autocrine and paracrine induction of pro-metastatic genes in breast cancer. | PubMed |
| Breast Neoplasms | CD36-mediated activation of endothelial cell apoptosis by an N-terminal recombinant fragment of thrombospondin-2 inhibits breast cancer growth and metastasis in vivo. | PubMed |
| Breast Neoplasms | Changes in plasma vascular endothelial growth factor, angiopoietins, and their receptors following surgery for breast cancer. | PubMed |
| Breast Neoplasms | Changes in the circulating plasma levels of VEGF and VEGF-D after adjuvant chemotherapy in patients with breast cancer and 1 to 3 positive lymph nodes. | PubMed |
| Breast Neoplasms | Changes in vascular endothelial growth factor (VEGF) after chemoendocrine therapy in breast cancer. | PubMed |
| Breast Neoplasms | Chemically modified siRNA directed against the KDR gene inhibits the proliferation of breast cancer cells. | PubMed |
| Breast Neoplasms | Chemiluminometric determination of tissue polypeptide antigen (TPA), cancer antigen 15-3 (CA 15-3), carcinoembryonic antigen (CEA) in comparison with vascular endothelial growth factor (VEGF) in follow-up of breast cancer. | PubMed |
| Breast Neoplasms | Chemoprevention of breast cancer by targeting cyclooxygenase-2 and peroxisome proliferator-activated receptor-gamma (Review). | PubMed |
| Breast Neoplasms | Chemotherapy and angiogenesis in advanced cancer: vascular endothelial growth factor (VEGF) decline as predictor of disease control during taxol therapy in metastatic breast cancer. | PubMed |
| Breast Neoplasms | Circulating levels of angiogenic cytokines in advanced breast cancer patients with system chemotherapy and their potential value in monitoring disease course. | PubMed |
| Breast Neoplasms | Circulating levels of VEGF-A, VEGF-D and soluble VEGF-A receptor (sFIt-1) in human breast cancer. | PubMed |
| Breast Neoplasms | Clinical relevance of vascular endothelial growth factor and thymidine phosphorylase in patients with node-positive breast cancer treated with either adjuvant chemotherapy or hormone therapy. | PubMed |
| Breast Neoplasms | Clinical significance of determination of surrogate markers of angiogenesis in breast cancer. | PubMed |
| Breast Neoplasms | Clinicopathologic and prognostic characteristics of triple-negative breast cancer. | PubMed |
| Breast Neoplasms | Co-determination of the angiogenic factors thymidine phosphorylase and vascular endothelial growth factor in node-negative breast cancer: prognostic implications. | PubMed |
| Breast Neoplasms | Co-expression of ?9?1 integrin and VEGF-D confers lymphatic metastatic ability to a human breast cancer cell line MDA-MB-468LN. | PubMed |
| Breast Neoplasms | Co-expression of vascular endothelial growth factor (VEGF) and its receptors (flk-1 and flt-1) in hormone-induced mammary cancer in the Noble rat. | PubMed |
| Breast Neoplasms | Combinational Polymorphisms of Seven CXCL12-Related Genes Are Protective against Breast Cancer in Taiwan. | PubMed |
| Breast Neoplasms | Combined biological therapy of breast cancer using monoclonal antibodies directed against HER2/neu protein and vascular endothelial growth factor. | PubMed |
| Breast Neoplasms | Combined vascular endothelial growth factor and TP53 status predicts poor response to tamoxifen therapy in estrogen receptor-positive advanced breast cancer. | PubMed |
| Breast Neoplasms | Combining the Multitargeted Tyrosine Kinase Inhibitor Vandetanib with the Antiestrogen Fulvestrant Enhances Its Antitumor Effect in Non-small Cell Lung Cancer. | PubMed |
| Breast Neoplasms | Compounds in clinical Phase III and beyond. | PubMed |
| Breast Neoplasms | Contribution of vascular endothelial growth factor to the Nottingham prognostic index in node-negative breast cancer. | PubMed |
| Breast Neoplasms | Correlation and expression of p53, HER-2, vascular endothelial growth factor (VEGF), and e-cadherin in a high-risk breast-cancer population. | PubMed |
| Breast Neoplasms | Correlation between hepatocyte growth factor receptor and vascular endothelial growth factor-A in breast carcinoma. | PubMed |
| Breast Neoplasms | Correlation between serum vascular endothelial growth factor and endostatin levels in patients with breast cancer. | PubMed |
| Breast Neoplasms | Correlation of vascular endothelial growth factor content with recurrences, survival, and first relapse site in primary node-positive breast carcinoma after adjuvant treatment. | PubMed |
| Breast Neoplasms | Correspondence re: K. Heer et al., serum vascular endothelial growth factor in breast cancer: its relation with cancer type and estrogen receptor status. Clin. Cancer Res., 7: 3491-3494, 2001. | PubMed |
| Breast Neoplasms | Crosstalk between IGF signaling and steroid hormone receptors in breast cancer. | PubMed |
| Breast Neoplasms | Curcumin inhibits MPA-induced secretion of VEGF from T47-D human breast cancer cells. | PubMed |
| Breast Neoplasms | Curcumin suppresses breast tumor angiogenesis by abrogating osteopontin-induced VEGF expression. | PubMed |
| Breast Neoplasms | Current evidences on vascular endothelial growth factor polymorphisms and breast cancer susceptibility. | PubMed |
| Breast Neoplasms | CXCL7-Mediated Stimulation of Lymphangiogenic Factors VEGF-C, VEGF-D in Human Breast Cancer Cells. | PubMed |
| Breast Neoplasms | Cyclin I correlates with VEGFR-2 and cell proliferation in human epithelial ovarian cancer. | PubMed |
| Breast Neoplasms | Cytokine gene polymorphisms and breast cancer susceptibility and prognosis. | PubMed |
| Breast Neoplasms | Dauricine inhibits insulin-like growth factor-I-induced hypoxia inducible factor 1alpha protein accumulation and vascular endothelial growth factor expression in human breast cancer cells. | PubMed |
| Breast Neoplasms | Decreased production of vascular endothelial growth factor in adriamycin-resistant breast cancer cells. | PubMed |
| Breast Neoplasms | Degradation of HER2/neu by ANT2 shRNA suppresses migration and invasiveness of breast cancer cells. | PubMed |
| Breast Neoplasms | Different signalling pathways regulate VEGF and IL-8 expression in breast cancer: implications for therapy. | PubMed |
| Breast Neoplasms | Differential expression of vascular endothelial growth factor mRNA vs protein isoform expression in human breast cancer and relationship to eIF-4E. | PubMed |
| Breast Neoplasms | Differential stimulation of VEGF-C production by adhesion/growth-regulatory galectins and plant lectins in human breast cancer cells. | PubMed |
| Breast Neoplasms | Direct interaction between BRCA1 and the estrogen receptor regulates vascular endothelial growth factor (VEGF) transcription and secretion in breast cancer cells. | PubMed |
| Breast Neoplasms | Do serum angiogenic growth factors provide additional information to that of conventional markers in monitoring the course of metastatic breast cancer? | PubMed |
| Breast Neoplasms | Does vascular endothelial growth factor (VEGF) predict local relapse and survival in radiotherapy-treated node-negative breast cancer? | PubMed |
| Breast Neoplasms | Double-stranded RNA-binding protein regulates vascular endothelial growth factor mRNA stability, translation, and breast cancer angiogenesis. | PubMed |
| Breast Neoplasms | Early changes in the haemostatic and procoagulant systems after chemotherapy for breast cancer. | PubMed |
| Breast Neoplasms | Effect of 17 beta-estradiol, progesterone, synthetic progestins, tibolone, and tibolone metabolites on vascular endothelial growth factor mRNA in breast cancer cells. | PubMed |
| Breast Neoplasms | Effect of anesthetic technique on serum vascular endothelial growth factor C and transforming growth factor ? in women undergoing anesthesia and surgery for breast cancer. | PubMed |
| Breast Neoplasms | Effect of estrogen, tamoxifen and epidermal growth factor on the transcriptional regulation of vascular endothelial growth factor in breast cancer cells. | PubMed |
| Breast Neoplasms | Effect of tamoxifen on serum IL-18, vascular endothelial growth factor and nitric oxide activities in breast carcinoma patients. | PubMed |
| Breast Neoplasms | Effects of 17beta-estradiol, progesterone, synthetic progestins, tibolone, and raloxifene on vascular endothelial growth factor and Thrombospondin-1 messenger RNA in breast cancer cells. | PubMed |
| Breast Neoplasms | Effects of a Weight Loss Intervention on Body Mass, Fitness, and Inflammatory Biomarkers in Overweight or Obese Breast Cancer Survivors. | PubMed |
| Breast Neoplasms | Effects of brucine on vascular endothelial growth factor expression and microvessel density in a nude mouse model of bone metastasis due to breast cancer. | PubMed |
| Breast Neoplasms | Elevated serum levels of vascular endothelial growth factor are associated with tumor-associated macrophages in primary breast cancer. | PubMed |
| Breast Neoplasms | Emerging targeted therapies for breast cancer. | PubMed |
| Breast Neoplasms | Endothelin-1-, endothelin-A-, and endothelin-B-receptor expression is correlated with vascular endothelial growth factor expression and angiogenesis in breast cancer. | PubMed |
| Breast Neoplasms | Enhanced Expression of Rab27A Gene by Breast Cancer Cells Promoting Invasiveness and the Metastasis Potential by Secretion of Insulin-Like Growth Factor-II. | PubMed |
| Breast Neoplasms | Epithelial-mesenchymal transition in breast cancer lines is mediated through PDGF-D released by tissue-resident stem cells. | PubMed |
| Breast Neoplasms | ErbB2 increases vascular endothelial growth factor protein synthesis via activation of mammalian target of rapamycin/p70S6K leading to increased angiogenesis and spontaneous metastasis of human breast cancer cells. | PubMed |
| Breast Neoplasms | ErbB2 overexpression correlates with increased expression of vascular endothelial growth factors A, C, and D in human breast carcinoma. | PubMed |
| Breast Neoplasms | Estrogen regulation of vascular endothelial growth factor gene expression in ZR-75 breast cancer cells through interaction of estrogen receptor alpha and SP proteins. | PubMed |
| Breast Neoplasms | Estrogen regulation of VEGF in breast cancer in vitro and in vivo: the role of estrogen receptor {alpha} and c-Myc. | PubMed |
| Breast Neoplasms | Estrogen-related receptor ? expression and function are associated with vascular endothelial growth factor in human cervical cancer. | PubMed |
| Breast Neoplasms | Estrogen-related receptor alpha induces the expression of vascular endothelial growth factor in breast cancer cells. | PubMed |
| Breast Neoplasms | Eukaryotic initiation factor 4E (eIF4E) and angiogenesis: prognostic markers for breast cancer. | PubMed |
| Breast Neoplasms | Evaluation of cyclin-dependent kinase-like 1 expression in breast cancer tissues and its regulation in cancer cell growth. | PubMed |
| Breast Neoplasms | Evaluation of lymphangiogenic factors, vascular endothelial growth factor d and e-cadherin in distinguishing inflammatory from locally advanced breast cancer. | PubMed |
| Breast Neoplasms | Evaluation of prognostic value of VEGF-C and VEGF-D in breast cancer--10 years follow-up analysis. | PubMed |
| Breast Neoplasms | Evaluation of the correlation between colour power Doppler flow imaging and vascular endothelial growth factor in breast cancer. | PubMed |
| Breast Neoplasms | Evaluation of the prognostic role of vascular endothelial growth factor and microvessel density in stages I and II breast cancer patients. | PubMed |
| Breast Neoplasms | Evaluation of Vascular Endothelial Growth Factor as a Prognostic Marker for Local Relapse in Early-Stage Breast Cancer Patients Treated with Breast-Conserving Therapy. | PubMed |
| Breast Neoplasms | Evidence for the involvement of ET(B) receptors in ET-1-induced changes in blood flow to the rat breast tumor. | PubMed |
| Breast Neoplasms | Examination of the mechanisms of osteolysis in patients with metastatic breast cancer. | PubMed |
| Breast Neoplasms | Expression of breast cancer anti-estrogen resistance 1 in relation to vascular endothelial growth factor, p53, and prognosis in esophageal squamous cell cancer. | PubMed |
| Breast Neoplasms | Expression of Flt-1 and Flk-1 receptors for vascular endothelial growth factor on tumor cells as a new prognostic criterion for locally advanced breast cancer. | PubMed |
| Breast Neoplasms | Expression of growth factors, growth-inhibiting factors, and their receptors in invasive breast cancer. II: Correlations with proliferation and angiogenesis. | PubMed |
| Breast Neoplasms | Expression of vascular endothelial growth factor (VEGF) family members in breast cancer. | PubMed |
| Breast Neoplasms | Expression of vascular endothelial growth factor and proliferation marker MIB1 are influenced by neoadjuvant chemotherapy in locally advanced breast cancer. | PubMed |
| Breast Neoplasms | Expression of vascular endothelial growth factor and vascular endothelial growth factor receptors 1 and 2 in invasive breast carcinoma: prognostic significance and relationship with markers for aggressiveness. | PubMed |
| Breast Neoplasms | Expression of vascular endothelial growth factor D is associated with hypoxia inducible factor (HIF-1alpha) and the HIF-1alpha target gene DEC1, but not lymph node metastasis in primary human breast carcinomas. | PubMed |
| Breast Neoplasms | Expression of vascular endothelial growth factor, its receptor, and other angiogenic factors in human breast cancer. | PubMed |
| Breast Neoplasms | Expression of VEGFR-1 (Flt-1) in breast cancer is associated with VEGF expression and with node-negative tumour stage. | PubMed |
| Breast Neoplasms | Expression profile of IL-8 and growth factors in breast cancer cells and adipose-derived stem cells (ASCs) isolated from breast carcinoma. | PubMed |
| Breast Neoplasms | Extracellular matrix metalloproteinase inducer stimulates tumor angiogenesis by elevating vascular endothelial cell growth factor and matrix metalloproteinases. | PubMed |
| Breast Neoplasms | Five polymorphisms of vascular endothelial growth factor (VEGF) and risk of breast cancer: A meta-analysis involving 16,703 individuals. | PubMed |
| Breast Neoplasms | Flaxseed and its lignans inhibit estradiol-induced growth, angiogenesis, and secretion of vascular endothelial growth factor in human breast cancer xenografts in vivo. | PubMed |
| Breast Neoplasms | Flaxseed inhibits metastasis and decreases extracellular vascular endothelial growth factor in human breast cancer xenografts. | PubMed |
| Breast Neoplasms | Flt-4-positive vessel density correlates with vascular endothelial growth factor-d expression, nodal status, and prognosis in breast cancer. | PubMed |
| Breast Neoplasms | FOXO3a represses VEGF expression through FOXM1-dependent and -independent mechanisms in breast cancer. | PubMed |
| Breast Neoplasms | Genetic polymorphisms in the vascular endothelial growth factor gene and breast cancer risk. The Austrian 'tumor of breast tissue: incidence, genetics, and environmental risk factors' study. | PubMed |
| Breast Neoplasms | Green tea catechins inhibit angiogenesis through suppression of STAT3 activation. | PubMed |
| Breast Neoplasms | Green tea inhibits vascular endothelial growth factor (VEGF) induction in human breast cancer cells. | PubMed |
| Breast Neoplasms | HER2 is unlikely to be involved in directly regulating angiogenesis in human breast cancer. | PubMed |
| Breast Neoplasms | Heterogeneity in the angiogenic response of a BT474 human breast cancer to a novel vascular endothelial growth factor-receptor tyrosine kinase inhibitor: assessment by voxel analysis of dynamic contrast-enhanced MRI. | PubMed |
| Breast Neoplasms | High basic fibroblast growth factor levels in nipple aspirate fluid are correlated with breast cancer. | PubMed |
| Breast Neoplasms | High levels of vascular endothelial growth factor and its receptors (VEGFR-1, VEGFR-2, neuropilin-1) are associated with worse outcome in breast cancer. | PubMed |
| Breast Neoplasms | High tumor levels of vascular endothelial growth factor predict poor response to systemic therapy in advanced breast cancer. | PubMed |
| Breast Neoplasms | Higher plasma vascular endothelial growth factor levels correlate with menopause, overexpression of p53, and recurrence of breast cancer. | PubMed |
| Breast Neoplasms | Hormonal regulation of VEGF in orthotopic MCF7 human breast cancer. | PubMed |
| Breast Neoplasms | HTERT mRNA expression correlates with matrix metalloproteinase-1 and vascular endothelial growth factor expression in human breast cancer: a correlative study using RT-PCR. | PubMed |
| Breast Neoplasms | Hypoxia and estrogen receptor profile influence the responsiveness of human breast cancer cells to estradiol and antiestrogens. | PubMed |
| Breast Neoplasms | Hypoxia-inducible factor-1alpha and vascular endothelial growth factor expression in circulating tumor cells of breast cancer patients. | PubMed |
| Breast Neoplasms | Hypoxia-inducible factor-2alpha correlates to distant recurrence and poor outcome in invasive breast cancer. | PubMed |
| Breast Neoplasms | Immunohistochemical expression of vascular endothelial growth factor and its correlation with tumor grade in breast ductal carcinoma. | PubMed |
| Breast Neoplasms | Immunohistochemical measurement of tumor vascular endothelial growth factor in breast cancer. A more reliable predictor of tumor stage than microvessel density or serum vascular endothelial growth factor. | PubMed |
| Breast Neoplasms | In vitro regulation of vascular endothelial growth factor by estrogens and antiestrogens in estrogen-receptor positive breast cancer. | PubMed |
| Breast Neoplasms | In vitro study of HIF-1 activation and VEGF release by bFGF in the T47D breast cancer cell line under normoxic conditions: involvement of PI-3K/Akt and MEK1/ERK pathways. | PubMed |
| Breast Neoplasms | In vivo measurement of tumor estradiol and vascular endothelial growth factor in breast cancer patients. | PubMed |
| Breast Neoplasms | Increased angiogenesis and lymphangiogenesis in inflammatory versus noninflammatory breast cancer by real-time reverse transcriptase-PCR gene expression quantification. | PubMed |
| Breast Neoplasms | Increased expression of CYP4Z1 promotes tumor angiogenesis and growth in human breast cancer. | PubMed |
| Breast Neoplasms | Increased expression of Rab25 in breast cancer correlates with lymphatic metastasis. | PubMed |
| Breast Neoplasms | Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis. | PubMed |
| Breast Neoplasms | Induction of vascular endothelial growth factor by peptidyl-prolyl isomerase Pin1 in breast cancer cells. | PubMed |
| Breast Neoplasms | Inhibition of progesterone-induced VEGF production in human breast cancer cells by the pure antiestrogen ICI 182,780. | PubMed |
| Breast Neoplasms | Inhibition of the stress response to breast cancer surgery by regional anesthesia and analgesia does not affect vascular endothelial growth factor and prostaglandin E2. | PubMed |
| Breast Neoplasms | Inhibition of vascular endothelial growth factor reduces angiogenesis and modulates immune cell infiltration of orthotopic breast cancer xenografts. | PubMed |
| Breast Neoplasms | Interleukin 7 upregulates vascular endothelial growth factor D in breast cancer cells and induces lymphangiogenesis in vivo. | PubMed |
| Breast Neoplasms | JNK/AP-1 pathway is involved in tumor necrosis factor-alpha induced expression of vascular endothelial growth factor in MCF7 cells. | PubMed |
| Breast Neoplasms | Leptin pro-angiogenic signature in breast cancer is linked to IL-1 signalling. | PubMed |
| Breast Neoplasms | Leptin signaling in breast cancer: an overview. | PubMed |
| Breast Neoplasms | LGALS3BP, lectin galactoside-binding soluble 3 binding protein, induces vascular endothelial growth factor in human breast cancer cells and promotes angiogenesis. | PubMed |
| Breast Neoplasms | Ligand- and cell-specific effects of signal transduction pathway inhibitors on progestin-induced vascular endothelial growth factor levels in human breast cancer cells. | PubMed |
| Breast Neoplasms | Lipocalin 2 is a novel regulator of angiogenesis in human breast cancer. | PubMed |
| Breast Neoplasms | Low-dose oral methotrexate and cyclophosphamide in metastatic breast cancer: antitumor activity and correlation with vascular endothelial growth factor levels. | PubMed |
| Breast Neoplasms | Mammary fibroblasts may influence breast tumor angiogenesis via hypoxia-induced vascular endothelial growth factor up-regulation and protein expression. | PubMed |
| Breast Neoplasms | Measurement of serum vascular endothelial growth factor in breast cancer patients. | PubMed |
| Breast Neoplasms | Mesenchymal stem cell-derived interleukin-6 and vascular endothelial growth factor promote breast cancer cell migration. | PubMed |
| Breast Neoplasms | Metabolism and disposition of [14C]BMS-690514, an ErbB/vascular endothelial growth factor receptor inhibitor, after oral administration to humans. | PubMed |
| Breast Neoplasms | Metastatic breast cancer: an updating. | PubMed |
| Breast Neoplasms | Metronomic low-dose oral cyclophosphamide and methotrexate plus or minus thalidomide in metastatic breast cancer: antitumor activity and biological effects. | PubMed |
| Breast Neoplasms | MicroRNAs regulate tumor angiogenesis modulated by endothelial progenitor cells. | PubMed |
| Breast Neoplasms | Migration-promoting role of VEGF-C and VEGF-C binding receptors in human breast cancer cells. | PubMed |
| Breast Neoplasms | miR-20b modulates VEGF expression by targeting HIF-1 alpha and STAT3 in MCF-7 breast cancer cells. | PubMed |
| Breast Neoplasms | miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis. | PubMed |
| Breast Neoplasms | Modulation of gene expression in human central nervous system tumors under methionine deprivation-induced stress. | PubMed |
| Breast Neoplasms | Molecular targeted therapies for breast cancer treatment. | PubMed |
| Breast Neoplasms | Molecular-targeted antitumor agents. 15. Neolamellarins from the marine sponge Dendrilla nigra inhibit hypoxia-inducible factor-1 activation and secreted vascular endothelial growth factor production in breast tumor cells. | PubMed |
| Breast Neoplasms | Monoclonal antibody therapy of non-Hodgkin's lymphoma: the Rituximab story. | PubMed |
| Breast Neoplasms | Motesanib, or open-label bevacizumab, in combination with paclitaxel, as first-line treatment for HER2-negative locally recurrent or metastatic breast cancer: a phase 2, randomised, double-blind, placebo-controlled study. | PubMed |
| Breast Neoplasms | Mycophenolic acid induces adipocyte-like differentiation and reversal of malignancy of breast cancer cells partly through PPAR?. | PubMed |
| Breast Neoplasms | Neoadjuvant chemotherapy and bevacizumab for HER2-negative breast cancer. | PubMed |
| Breast Neoplasms | New targeted therapies in breast cancer. | PubMed |
| Breast Neoplasms | Non-angiogenic functions of VEGF in breast cancer. | PubMed |
| Breast Neoplasms | Oral administration of pyrrolidine dithiocarbamate (PDTC) inhibits VEGF expression, tumor angiogenesis and growth of breast cancer in female mice. | PubMed |
| Breast Neoplasms | Osteopontin promotes vascular endothelial growth factor-dependent breast tumor growth and angiogenesis via autocrine and paracrine mechanisms. | PubMed |
| Breast Neoplasms | Over expression of vascular endothelial growth factor in correlation to Ki-67, grade, and stage of breast cancer. | PubMed |
| Breast Neoplasms | Overexpression of c-erbB-2 is related to a higher expression of vascular endothelial growth factor (VEGF) and constitutes an independent prognostic factor in primary node-positive breast cancer after adjuvant systemic treatment. | PubMed |
| Breast Neoplasms | Overexpression of vascular endothelial growth factor 189 in breast cancer cells leads to delayed tumor uptake with dilated intratumoral vessels. | PubMed |
| Breast Neoplasms | Overexpression of vascular endothelial growth factor by MCF-7 breast cancer cells promotes estrogen-independent tumor growth in vivo. | PubMed |
| Breast Neoplasms | p16 Modulates VEGF Expression via Its Interaction With HIF-1alpha in Breast Cancer Cells. | PubMed |
| Breast Neoplasms | p53, HER2 and tumor cell apoptosis correlate with clinical outcome after neoadjuvant bevacizumab plus chemotherapy in breast cancer. | PubMed |
| Breast Neoplasms | Paclitaxel (Taxol): an inhibitor of angiogenesis in a highly vascularized transgenic breast cancer. | PubMed |
| Breast Neoplasms | Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer. | PubMed |
| Breast Neoplasms | PAF produced by human breast cancer cells promotes migration and proliferation of tumor cells and neo-angiogenesis. | PubMed |
| Breast Neoplasms | Patients With Metastatic Breast Cancer Using Bevacizumab as a Treatment: Is There Still a Role for it? | PubMed |
| Breast Neoplasms | PDGF-D improves drug delivery and efficacy via vascular normalization, but promotes lymphatic metastasis by activating CXCR4 in breast cancer. | PubMed |
| Breast Neoplasms | Peritumoral lymphangiogenesis induced by vascular endothelial growth factor C and D promotes lymph node metastasis in breast cancer patients. | PubMed |
| Breast Neoplasms | Pharmacodynamic behavior of liposomal antisense oligonucleotides targeting Her-2/neu and vascular endothelial growth factor in an ascitic MDA435/LCC6 human breast cancer model. | PubMed |
| Breast Neoplasms | Pharmacogenetics in breast cancer: focus on hormone therapy, taxanes, trastuzumab and bevacizumab. | PubMed |
| Breast Neoplasms | Pharmacological and endogenous progestins induce vascular endothelial growth factor expression in human breast cancer cells. | PubMed |
| Breast Neoplasms | Phase I/II trial of metronomic chemotherapy with daily dalteparin and cyclophosphamide, twice-weekly methotrexate, and daily prednisone as therapy for metastatic breast cancer using vascular endothelial growth factor and soluble vascular endothelial growth factor receptor levels as markers of response. | PubMed |
| Breast Neoplasms | PI3K/Akt and MAPK/ERK1/2 signaling pathways are involved in IGF-1-induced VEGF-C upregulation in breast cancer. | PubMed |
| Breast Neoplasms | Plasma fibrin D-dimer levels correlate with tumour volume, progression rate and survival in patients with metastatic breast cancer. | PubMed |
| Breast Neoplasms | Plasma levels of vascular endothelial growth factor (VEGF) and its receptor, Flt-1, in haematological cancers: a comparison with breast cancer. | PubMed |
| Breast Neoplasms | Plasma vascular endothelial growth factor is useful in assessing progression of breast cancer post surgery and during adjuvant treatment. | PubMed |
| Breast Neoplasms | Platelet release of Vascular Endothelial Growth Factor (VEGF) in patients undergoing chemotherapy for breast cancer. | PubMed |
| Breast Neoplasms | Platelet-derived growth factor-D contributes to aggressiveness of breast cancer cells by up-regulating Notch and NF-kappaB signaling pathways. | PubMed |
| Breast Neoplasms | Polymorphisms in the KDR and POSTN genes: association with breast cancer susceptibility and prognosis. | PubMed |
| Breast Neoplasms | Polymorphisms in the vascular endothelial growth factor gene and breast cancer in the Cancer Prevention Study II cohort. | PubMed |
| Breast Neoplasms | Predictors of inflammation in response to anthracycline-based chemotherapy for breast cancer. | PubMed |
| Breast Neoplasms | Preliminary studies on the anti-angiogenic potential of pomegranate fractions in vitro and in vivo. | PubMed |
| Breast Neoplasms | Preoperative assessment of tumor angiogenesis by vascular endothelial growth factor mRNA expression in homogenate samples of breast carcinoma: fine-needle aspirates vs. resection samples. | PubMed |
| Breast Neoplasms | Prevalence of vascular-endothelial growth factor, matrix metalloproteinases and tissue inhibitors of metalloproteinases in primary breast cancer. | PubMed |
| Breast Neoplasms | Progestin regulation of vascular endothelial growth factor in human breast cancer cells. | PubMed |
| Breast Neoplasms | Progestin-dependent induction of vascular endothelial growth factor in human breast cancer cells: preferential regulation by progesterone receptor B. | PubMed |
| Breast Neoplasms | Prognostic analysis of tumour angiogenesis, determined by microvessel density and expression of vascular endothelial growth factor, in high-risk primary breast cancer patients treated with high-dose chemotherapy. | PubMed |
| Breast Neoplasms | Prognostic correlation of basic fibroblast growth factor and vascular endothelial growth factor in 1307 primary breast cancers. | PubMed |
| Breast Neoplasms | Prognostic impact of placenta growth factor and vascular endothelial growth factor A in patients with breast cancer. | PubMed |
| Breast Neoplasms | Prognostic significance of vascular endothelial growth factor D in breast carcinoma with long-term follow-up. | PubMed |
| Breast Neoplasms | Prognostic significance of vascular endothelial growth factor protein in node-negative breast carcinoma. | PubMed |
| Breast Neoplasms | Prognostic value of serum levels of interleukin 6 and of serum and plasma levels of vascular endothelial growth factor in hormone-refractory metastatic breast cancer patients. | PubMed |
| Breast Neoplasms | Prognostic value of serum vascular endothelial growth factor in Egyptian females with metastatic triple negative breast cancer. | PubMed |
| Breast Neoplasms | Prognostic value of vascular endothelial growth factor in breast cancer. | PubMed |
| Breast Neoplasms | Proliferation of endothelial and tumor epithelial cells by progestin-induced vascular endothelial growth factor from human breast cancer cells: paracrine and autocrine effects. | PubMed |
| Breast Neoplasms | Prolonged disease control after myeloablative chemotherapy, autologous transplantation and immunotherapy in high-risk early breast cancer. | PubMed |
| Breast Neoplasms | Promising molecular targeted therapies in breast cancer. | PubMed |
| Breast Neoplasms | Protease-activated receptor-2 regulates vascular endothelial growth factor expression in MDA-MB-231 cells via MAPK pathways. | PubMed |
| Breast Neoplasms | Protein chip based miniaturized assay for the simultaneous quantitative monitoring of cancer biomarkers in tissue extracts. | PubMed |
| Breast Neoplasms | Quantitation of vascular endothelial growth factor mRNA levels in human breast tumors and metastatic lymph nodes. | PubMed |
| Breast Neoplasms | Quantitative analysis of vascular endothelial growth factor in primary breast cancer. | PubMed |
| Breast Neoplasms | Race to report: are vascular endothelial growth factor genetic polymorphisms associated with outcome in advanced breast cancer patients treated with Paclitaxel plus bevacizumab? | PubMed |
| Breast Neoplasms | Raised plasma endostatin levels correlate inversely with breast cancer angiogenesis. | PubMed |
| Breast Neoplasms | Randomized phase III trial of capecitabine compared with bevacizumab plus capecitabine in patients with previously treated metastatic breast cancer. | PubMed |
| Breast Neoplasms | Rcl is a novel ETV1/ER81 target gene upregulated in breast tumors. | PubMed |
| Breast Neoplasms | Real-time PCR of CD146 mRNA in peripheral blood enables the relative quantification of circulating endothelial cells and is an indicator of angiogenesis. | PubMed |
| Breast Neoplasms | Receptor activator of NF-kappaB ligand enhances breast cancer-induced osteolytic lesions through upregulation of extracellular matrix metalloproteinase inducer/CD147. | PubMed |
| Breast Neoplasms | Recombination of CXCR4, VEGF, and MMP-9 predicting lymph node metastasis in human breast cancer. | PubMed |
| Breast Neoplasms | Regenerative Therapy and Cancer: In Vitro and In Vivo Studies of the Interaction Between Adipose-Derived Stem Cells and Breast Cancer Cells from Clinical Isolates. | PubMed |
| Breast Neoplasms | Regulation of thrombospondin-1 by natural and synthetic progestins in human breast cancer cells. | PubMed |
| Breast Neoplasms | Regulation of transcription of hypoxia-inducible factor-1? (HIF-1?) by heat shock factors HSF2 and HSF4. | PubMed |
| Breast Neoplasms | Relation of serum vascular endothelial growth factor as an angiogenesis biomarker with nitric oxide & urokinase-type plasminogen activator in breast cancer patients. | PubMed |
| Breast Neoplasms | Relationship between cyclooxygenase-2 and human epidermal growth factor receptor 2 in vascular endothelial growth factor C up-regulation and lymphangiogenesis in human breast cancer. | PubMed |
| Breast Neoplasms | Relationship of hypoxia-inducible factor (HIF)-1alpha and HIF-2alpha expression to vascular endothelial growth factor induction and hypoxia survival in human breast cancer cell lines. | PubMed |
| Breast Neoplasms | Revaluation of the association between vascular endothelial growth factor gene 936 C/T polymorphism and breast cancer risk. | PubMed |
| Breast Neoplasms | RNA interference-directed silencing of VPAC1 receptor inhibits VIP effects on both EGFR and HER2 transactivation and VEGF secretion in human breast cancer cells. | PubMed |
| Breast Neoplasms | Role of placenta growth factor in malignancy and evidence that an antagonistic PlGF/Flt-1 peptide inhibits the growth and metastasis of human breast cancer xenografts. | PubMed |
| Breast Neoplasms | Role of vascular endothelial growth factor during breast cancer. | PubMed |
| Breast Neoplasms | Role of vascular endothelial growth factor in the stimulation of cellular invasion and signaling of breast cancer cells. | PubMed |
| Breast Neoplasms | Role of vascular endothelial growth factor-C and -D mRNA in breast cancer. | PubMed |
| Breast Neoplasms | Selective and effective killing of angiogenic vascular endothelial cells and cancer cells by targeting tissue factor using a factor VII-targeted photodynamic therapy for breast cancer. | PubMed |
| Breast Neoplasms | Semaphorin 3B (SEMA3B) induces apoptosis in lung and breast cancer, whereas VEGF165 antagonizes this effect. | PubMed |
| Breast Neoplasms | Serum cytokine levels of interleukin-1beta, -6, -8, tumour necrosis factor-alpha and vascular endothelial growth factor in breast cancer patients treated with tamoxifen and supplemented with co-enzyme Q(10), riboflavin and niacin. | PubMed |
| Breast Neoplasms | Serum interleukin 6, plasma VEGF, serum VEGF, and VEGF platelet load in breast cancer patients. | PubMed |
| Breast Neoplasms | Serum leptin, prolactin and vascular endothelial growth factor (VEGF) levels in patients with breast cancer. | PubMed |
| Breast Neoplasms | Serum soluble tumour necrosis factor receptor type I concentrations independently predict prognosis in patients with breast cancer. | PubMed |
| Breast Neoplasms | Serum vascular endothelial growth factor (VEGF) levels correlate with tumor VEGF and p53 overexpression in endocrine positive primary breast cancer. | PubMed |
| Breast Neoplasms | Serum vascular endothelial growth factor in breast cancer. | PubMed |
| Breast Neoplasms | Serum vascular endothelial growth factor in breast cancer: its relation with cancer type and estrogen receptor status. | PubMed |
| Breast Neoplasms | Serum Vascular Endothelial Growth Factors A, C and D in Human Breast Tumors. | PubMed |
| Breast Neoplasms | Sesamin Inhibits Macrophage-Induced Vascular Endothelial Growth Factor and Matrix Metalloproteinase-9 Expression and Proangiogenic Activity in Breast Cancer Cells. | PubMed |
| Breast Neoplasms | Sex-steroid regulation of vascular endothelial growth factor in breast cancer. | PubMed |
| Breast Neoplasms | Shorter survival-times following adjuvant endocrine therapy in oestrogen- and progesterone-receptor positive breast cancer overexpressing HER2 and/or with an increased expression of vascular endothelial growth factor. | PubMed |
| Breast Neoplasms | Significance of aeg-1 expression in correlation with vegf, microvessel density and clinicopathological characteristics in triple-negative breast cancer. | PubMed |
| Breast Neoplasms | Significance of AEG-1 expression in correlation with VEGF, microvessel density and clinicopathological characteristics in triple-negative breast cancer. | PubMed |
| Breast Neoplasms | Significance of macrophage chemoattractant protein-1 in macrophage recruitment, angiogenesis, and survival in human breast cancer. | PubMed |
| Breast Neoplasms | Significance of serum vascular endothelial growth factor, insulin-like growth factor-I levels and nitric oxide activity in breast cancer patients. | PubMed |
| Breast Neoplasms | Significance of vascular endothelial growth factor (VEGF)/soluble VEGF receptor-1 relationship in breast cancer. | PubMed |
| Breast Neoplasms | Significance of vascular endothelial growth factor, interleukin-18 and nitric oxide in patients with breast cancer: correlation with carbohydrate antigen 15.3. | PubMed |
| Breast Neoplasms | Significantly higher levels of vascular endothelial growth factor (VEGF) and shorter survival times for patients with primary operable triple-negative breast cancer. | PubMed |
| Breast Neoplasms | Silencing of osteopontin promotes the radiosensitivity of breast cancer cells by reducing the expression of hypoxia inducible factor 1 and vascular endothelial growth factor. | PubMed |
| Breast Neoplasms | Size optimization of synthetic graft copolymers for in vivo angiogenesis imaging. | PubMed |
| Breast Neoplasms | Sorafenib in combination with ionizing radiation has a greater anti-tumour activity in a breast cancer model. | PubMed |
| Breast Neoplasms | Study of COX-2, Ki67, and p53 expression to predict effectiveness of 5-flurouracil, epirubicin and cyclophosphamide with celecoxib treatment in breast cancer patients. | PubMed |
| Breast Neoplasms | Study on relationship between angiogenesis and micrometastases of peripheral blood in breast cancer. | PubMed |
| Breast Neoplasms | Survivin expression in breast cancer predicts clinical outcome and is associated with HER2, VEGF, urokinase plasminogen activator and PAI-1. | PubMed |
| Breast Neoplasms | Systemic effects of surgery: quantitative analysis of circulating basic fibroblast growth factor (bFGF), Vascular endothelial growth factor (VEGF) and transforming growth factor beta (TGF-beta) in patients with breast cancer who underwent limited or extended surgery. | PubMed |
| Breast Neoplasms | Tamoxifen and aromatase inhibitors differentially affect vascular endothelial growth factor and endostatin levels in women with breast cancer. | PubMed |
| Breast Neoplasms | Tamoxifen and flaxseed alter angiogenesis regulators in normal human breast tissue in vivo. | PubMed |
| Breast Neoplasms | Tamoxifen inhibits secretion of vascular endothelial growth factor in breast cancer in vivo. | PubMed |
| Breast Neoplasms | Targeting angiogenesis with antibodies for the treatment of cancer. | PubMed |
| Breast Neoplasms | Targeting COX-2 and EP4 to control tumor growth, angiogenesis, lymphangiogenesis and metastasis to the lungs and lymph nodes in a breast cancer model. | PubMed |
| Breast Neoplasms | The 936C>T polymorphism of the gene for vascular endothelial growth factor is associated with 18F-fluorodeoxyglucose uptake. | PubMed |
| Breast Neoplasms | The association between vascular endothelial growth factor expression in invasive breast cancer and survival varies with intrinsic subtypes and use of adjuvant systemic therapy: results from the Nurses' Health Study. | PubMed |
| Breast Neoplasms | The correlation between immunohistochemically-detected markers of angiogenesis and serum vascular endothelial growth factor in patients with breast cancer. | PubMed |
| Breast Neoplasms | The Determination of VEGF and MVD, among Patients with Primary Breast Cancer. | PubMed |
| Breast Neoplasms | The effect of cancer procoagulant on expression of metastatic and angiogenic markers in breast cancer and embryonic stem cell lines. | PubMed |
| Breast Neoplasms | The effect of menopause and hysterectomy on systemic vascular endothelial growth factor in women undergoing surgery for breast cancer. | PubMed |
| Breast Neoplasms | The effect of vascular endothelial growth factor C expression in tumor-associated macrophages on lymphangiogenesis and lymphatic metastasis in breast cancer. | PubMed |
| Breast Neoplasms | The effects of neoadjuvant anastrozole and tamoxifen on circulating vascular endothelial growth factor and soluble vascular endothelial growth factor receptor 1 in breast cancer. | PubMed |
| Breast Neoplasms | The effects of standard anthracycline-based chemotherapy on soluble ICAM-1 and vascular endothelial growth factor levels in breast cancer. | PubMed |
| Breast Neoplasms | The expanding role of bevacizumab in the treatment of human epidermal growth factor receptor 2-negative breast cancer. | PubMed |
| Breast Neoplasms | The expression of ER beta protein correlates with vascular endothelial growth factor and its prognostic significance in human breast cancer. | PubMed |
| Breast Neoplasms | The expression of vascular endothelial growth factor correlates with mutant p53 and poor prognosis in human breast cancer. | PubMed |
| Breast Neoplasms | The mechanisms on apoptosis by inhibiting VEGF expression in human breast cancer cells. | PubMed |
| Breast Neoplasms | The mRNA expression of cyclo-oxygenase-2 (COX-2) and vascular endothelial growth factor (VEGF) in human breast cancer. | PubMed |
| Breast Neoplasms | The mRNA-destabilizing protein tristetraprolin is suppressed in many cancers, altering tumorigenic phenotypes and patient prognosis. | PubMed |
| Breast Neoplasms | The pharmacological pathways of GnRH mediating the inhibition of mammary tumours: implications in humans and domestic animals. | PubMed |
| Breast Neoplasms | The potential of anti-vascular endothelial growth factor therapy in metastatic breast cancer: clinical experience with anti-angiogenic agents, focusing on bevacizumab. | PubMed |
| Breast Neoplasms | The prognostic value of vascular endothelial growth factor in 574 node-negative breast cancer patients who did not receive adjuvant systemic therapy. | PubMed |
| Breast Neoplasms | The prognostic value of vascular endothelial growth factor, urokinase plasminogen activator and plasminogen activator inhibitor-1 in node-negative breast cancer. | PubMed |
| Breast Neoplasms | The prolyl hydroxylase enzymes are positively associated with hypoxia-inducible factor-1? and vascular endothelial growth factor in human breast cancer and alter in response to primary systemic treatment with epirubicin and tamoxifen. | PubMed |
| Breast Neoplasms | The relationship of human wound vascular endothelial growth factor (VEGF) after breast cancer surgery to circulating VEGF and angiogenesis. | PubMed |
| Breast Neoplasms | The role of ?III-tubulin in non-small cell lung cancer patients treated by taxane-based chemotherapy. | PubMed |
| Breast Neoplasms | The role of antiangiogenetic agents in the treatment of breast cancer. | PubMed |
| Breast Neoplasms | The role of proto-oncogene Fra-1 in remodeling the tumor microenvironment in support of breast tumor cell invasion and progression. | PubMed |
| Breast Neoplasms | The role of the hemostatic system in tumor growth, metastasis, and angiogenesis: tissue factor is a bifunctional molecule capable of inducing both fibrin deposition and angiogenesis in cancer. | PubMed |
| Breast Neoplasms | The role of vascular endothelial growth factor and its receptor Flk-1/KDR in promoting tumour angiogenesis in feline and canine mammary carcinomas: a preliminary study of autocrine and paracrine loops. | PubMed |
| Breast Neoplasms | The Vascular Endothelial Growth Factor Receptor Inhibitor PTK787/ZK222584 Inhibits Aromatase. | PubMed |
| Breast Neoplasms | Thrombospondin-1 expression in relation to p53 status and VEGF expression in human breast cancers. | PubMed |
| Breast Neoplasms | Transcriptional deregulation of VEGF, FGF2, TGF-beta1, 2, 3 and cognate receptors in breast tumorigenesis. | PubMed |
| Breast Neoplasms | Transcriptional regulation of vascular endothelial growth factor by estradiol and tamoxifen in breast cancer cells: a complex interplay between estrogen receptors alpha and beta. | PubMed |
| Breast Neoplasms | Transforming growth factor-beta in osteolytic breast cancer bone metastases. | PubMed |
| Breast Neoplasms | Treatment of premenopausal women with early breast cancer: old challenges and new opportunities. | PubMed |
| Breast Neoplasms | Tumor angiogenesis in breast cancer: its importance as a prognostic indicator and the association with vascular endothelial growth factor expression. | PubMed |
| Breast Neoplasms | Tumor vascular permeability to a nanoprobe correlates to tumor-specific expression levels of angiogenic markers. | PubMed |
| Breast Neoplasms | Tumor-derived VEGF-C, but not VEGF-D, promotes sentinel lymph node lymphangiogenesis prior to metastasis in breast cancer patients. | PubMed |
| Breast Neoplasms | Tumor-specific expression of vascular endothelial growth factor receptor 2 but not vascular endothelial growth factor or human epidermal growth factor receptor 2 is associated with impaired response to adjuvant tamoxifen in premenopausal breast cancer. | PubMed |
| Breast Neoplasms | Tumor-specific VEGF-A and VEGFR2 in postmenopausal breast cancer patients with long-term follow-up. Implication of a link between VEGF pathway and tamoxifen response. | PubMed |
| Breast Neoplasms | Type 1 TNF receptor forms a complex with and uses Jak2 and c-Src to selectively engage signaling pathways that regulate transcription factor activity. | PubMed |
| Breast Neoplasms | Up-regulation of vascular endothelial growth factor C in breast cancer cells by heregulin-beta 1. A critical role of p38/nuclear factor-kappa B signaling pathway. | PubMed |
| Breast Neoplasms | Up-regulation of vascular endothelial growth factor in breast cancer cells by the heregulin-beta1-activated p38 signaling pathway enhances endothelial cell migration. | PubMed |
| Breast Neoplasms | Vascular endothelial growth factor (VEGF) and other common tissue prognostic indicators in breast cancer: a case-control study. | PubMed |
| Breast Neoplasms | Vascular endothelial growth factor (VEGF) in breast cancer: comparison of plasma, serum, and tissue VEGF and microvessel density and effects of tamoxifen. | PubMed |
| Breast Neoplasms | Vascular endothelial growth factor (VEGF) in human breast cancer: correlation with disease-free survival. | PubMed |
| Breast Neoplasms | Vascular endothelial growth factor (VEGF) levels and mutation of the BRCA1 gene in breast cancer patients. | PubMed |
| Breast Neoplasms | Vascular endothelial growth factor A (VEGF-A) mRNA expression levels decrease after menopause in normal breast tissue but not in breast cancer lesions. | PubMed |
| Breast Neoplasms | Vascular endothelial growth factor activity after switching of bisphosphonate treatment for metastatic breast cancer. | PubMed |
| Breast Neoplasms | Vascular endothelial growth factor acts as an osteolytic factor in breast cancer metastases to bone. | PubMed |
| Breast Neoplasms | Vascular endothelial growth factor and bevacitumab in breast cancer. | PubMed |
| Breast Neoplasms | Vascular endothelial growth factor and breast cancer risk. | PubMed |
| Breast Neoplasms | Vascular endothelial growth factor and its relationships with endogenous inhibitors in a breast cancer microenvironment manipulated by hormonal therapy: a hypothetical consideration. | PubMed |
| Breast Neoplasms | Vascular endothelial growth factor and platelet-derived endothelial cell growth factor are frequently coexpressed in highly vascularized human breast cancer. | PubMed |
| Breast Neoplasms | Vascular endothelial growth factor and platelet-derived growth factor are potential angiogenic and metastatic factors in human breast cancer. | PubMed |
| Breast Neoplasms | Vascular endothelial growth factor and prognosis in patients with node-negative breast cancer. | PubMed |
| Breast Neoplasms | Vascular endothelial growth factor enhances cancer cell adhesion to microvascular endothelium in vivo. | PubMed |
| Breast Neoplasms | Vascular endothelial growth factor expression promotes the growth of breast cancer brain metastases in nude mice. | PubMed |
| Breast Neoplasms | Vascular endothelial growth factor gene 936 C/T polymorphism in breast cancer patients. | PubMed |
| Breast Neoplasms | Vascular endothelial growth factor gene expression in the human breast cancer cell line MX-1 is controlled by O2 availability in vitro and in vivo. | PubMed |
| Breast Neoplasms | Vascular endothelial growth factor in breast cancer: biologic and therapeutic aspects. | PubMed |
| Breast Neoplasms | Vascular endothelial growth factor in node-positive breast cancer patients treated with adjuvant tamoxifen. | PubMed |
| Breast Neoplasms | Vascular endothelial growth factor in predicting outcome in breast cancer. | PubMed |
| Breast Neoplasms | Vascular endothelial growth factor in premenopausal women--indicator of the best time for breast cancer surgery? | PubMed |
| Breast Neoplasms | Vascular endothelial growth factor in the serum of breast cancer patients. | PubMed |
| Breast Neoplasms | Vascular endothelial growth factor in tumor tissue and blood serum from patients with breast cancer. | PubMed |
| Breast Neoplasms | Vascular endothelial growth factor independently predicts the efficacy of postoperative radiotherapy in node-negative breast cancer patients. | PubMed |
| Breast Neoplasms | Vascular endothelial growth factor induces proliferation of breast cancer cells and inhibits the anti-proliferative activity of anti-hormones. | PubMed |
| Breast Neoplasms | Vascular endothelial growth factor is a strong predictor of early distant recurrences in a prospective study of premenopausal women with lymph-node negative breast cancer. | PubMed |
| Breast Neoplasms | Vascular endothelial growth factor is a target gene for estrogen receptor and contributes to breast cancer progression. | PubMed |
| Breast Neoplasms | Vascular endothelial growth factor is an autocrine survival factor for breast tumour cells under hypoxia. | PubMed |
| Breast Neoplasms | Vascular endothelial growth factor levels do not predict efficacy of systemic adjuvant treatment as assessed in 1127 breast cancer patients. | PubMed |
| Breast Neoplasms | Vascular endothelial growth factor levels in relation to oxidative damage and antioxidant status in patients with breast cancer. | PubMed |
| Breast Neoplasms | Vascular endothelial growth factor mediates intracrine survival in human breast carcinoma cells through internally expressed VEGFR1/FLT1. | PubMed |
| Breast Neoplasms | Vascular endothelial growth factor modulates the transendothelial migration of MDA-MB-231 breast cancer cells through regulation of brain microvascular endothelial cell permeability. | PubMed |
| Breast Neoplasms | Vascular endothelial growth factor mRNA levels quantified by reverse transcription-polymerase chain reaction in microdissected breast carcinoma tissues are correlated with histological type and grade of both invasive and intraductal components. | PubMed |
| Breast Neoplasms | Vascular endothelial growth factor polymorphisms in relation to breast cancer development and prognosis. | PubMed |
| Breast Neoplasms | Vascular endothelial growth factor receptor-2 expression is down-regulated by 17beta-estradiol in MCF-7 breast cancer cells by estrogen receptor alpha/Sp proteins. | PubMed |
| Breast Neoplasms | Vascular endothelial growth factor receptor-2 expression is induced by 17beta-estradiol in ZR-75 breast cancer cells by estrogen receptor alpha/Sp proteins. | PubMed |
| Breast Neoplasms | Vascular endothelial growth factor receptor-2 in breast cancer. | PubMed |
| Breast Neoplasms | Vascular endothelial growth factor receptor-3 and focal adhesion kinase bind and suppress apoptosis in breast cancer cells. | PubMed |
| Breast Neoplasms | Vascular endothelial growth factor receptor-3 promotes breast cancer cell proliferation, motility and survival in vitro and tumor formation in vivo. | PubMed |
| Breast Neoplasms | Vascular endothelial growth factor reduces tamoxifen efficacy and promotes metastatic colonization and desmoplasia in breast tumors. | PubMed |
| Breast Neoplasms | Vascular endothelial growth factor secreted by activated stroma enhances angiogenesis and hormone-independent growth of estrogen receptor-positive breast cancer. | PubMed |
| Breast Neoplasms | Vascular endothelial growth factor targeted therapy in the perioperative setting: implications for patient care. | PubMed |
| Breast Neoplasms | Vascular endothelial growth factor-C and vascular endothelial growth factor-d messenger RNA expression in breast cancer: association with lymph node metastasis. | PubMed |
| Breast Neoplasms | Vascular endothelial growth factors are differentially regulated by steroid hormones and antiestrogens in breast cancer cells. | PubMed |
| Breast Neoplasms | Vasoactive intestinal peptide (VIP) increases vascular endothelial growth factor (VEGF) expression and secretion in human breast cancer cells. | PubMed |
| Breast Neoplasms | VEGF Expression is Associated with Negative Estrogen Receptor Status in Patients with Breast Cancer. | PubMed |
| Breast Neoplasms | VEGF-D and HIF-1alpha in breast cancer. | PubMed |
| Breast Neoplasms | VEGF-D in Association With VEGFR-3 Promotes Nodal Metastasis in Human Invasive Lobular Breast Cancer. | PubMed |
| Breast Neoplasms | Visfatin stimulates proliferation of MCF-7 human breast cancer cells. | PubMed |
| Breast Neoplasms | WITHDRAWN: Significance of serum vascular endothelial growth factor, insulin-like growth factor-I levels and nitric oxide activity in breast cancer patients. | PubMed |
| Breast Neoplasms | Xenoestrogens modulate vascular endothelial growth factor secretion in breast cancer cells through an estrogen receptor-dependent mechanism. | PubMed |
| Breast Neoplasms | Zoledronic acid-related angiogenesis modifications and survival in advanced breast cancer patients. | PubMed |
| Breast Neoplasms | Zoledronic-acid-induced circulating level modifications of angiogenic factors, metalloproteinases and proinflammatory cytokines in metastatic breast cancer patients. | PubMed |
| Breast Neoplasms | [Change and clinic significance of serum VEGF level before and after breast cancer patients treated] | PubMed |
| Breast Neoplasms | [Chemopreventive effect of celecoxib against DMBA-induced breast cancer and its mechanism] | PubMed |
| Breast Neoplasms | [Effect and mechanism of apigenin on VEGF expression in human breast cancer cells] | PubMed |
| Breast Neoplasms | [Effect of different estrogen receptor subtypes on vascular endothelial growth factor protein expression in human breast cancer samples] | PubMed |
| Breast Neoplasms | [Effect of siRNA transfection targeting VEGF gene on proliferation and apoptosis of human breast cancer cells] | PubMed |
| Breast Neoplasms | [Evaluation of angiogenesis in the tumorigenesis and progression of breast cancer] | PubMed |
| Breast Neoplasms | [Expression correlation of Ki67 to P53,VEGF,and C-erbB-2 genes in breast cancer and their clinical significances] | PubMed |
| Breast Neoplasms | [Expression of angiogenesis-related factors in invasive breast cancer and its clinical significance] | PubMed |
| Breast Neoplasms | [Expression of MMP-9 and VEGF in breast cancer: correlation with other prognostic indicators] | PubMed |
| Breast Neoplasms | [Expression of vascular endothelial growth factor A and C in human breast cancer and their significance] | PubMed |
| Breast Neoplasms | [Expression of vascular endothelial growth factor and its receptor Flk-1/KDR in benign and malignant breast neoplasms] | PubMed |
| Breast Neoplasms | [Expression of vascular endothelial growth factor C in human breast cancer cell lines MCF-7 and MCF-7/Adr] | PubMed |
| Breast Neoplasms | [Expressions of vascular endothelial growth factor and nm23-H1 gene and their relation to the prognosis of breast cancer in young women.] | PubMed |
| Breast Neoplasms | [HIF-1alpha expression and relationship involving tumor cell proliferation and angiogenesis in human breast carcinoma] | PubMed |
| Breast Neoplasms | [Inhibitation of tumor angiogenesis, growth and metastasis by blocking VEGF paracrine pathway] | PubMed |
| Breast Neoplasms | [Lymphangiogenes and location of tumor lymphatic vessels induced by VEGF-C in primary breast carcer] | PubMed |
| Breast Neoplasms | [mRNA expression of CK19 and CEA in peripheral blood of patients with breast cancer detected by real-time quantitative PCR] | PubMed |
| Breast Neoplasms | [Relationship between LKB1 gene and invasion-related factors of breast cancer cells] | PubMed |
| Breast Neoplasms | [Relevance of tumor angiogenesis in occurrence and development of breast cancer] | PubMed |
| Breast Neoplasms | [Role of matrix metalloproteinase (MMP)-2 and -9 and vascular endothelial growth factor C in lymph node metastasis of breast cancer.] | PubMed |
| Breast Neoplasms | [Role of RhoA in hypoxia-induced breast cancer cell VEGF secretion and proliferation, migration and tube formation of HUVECs]. | PubMed |
| Breast Neoplasms | [Role of short haipin RNA targeting vascular endothelial growth factor-C on biological characteristics of human breast cancer cell MCF-7] | PubMed |
| Breast Neoplasms | [Significance of microvascular density and vascular endothelial growth factor in breast cancer] | PubMed |
| Breast Neoplasms | [The prognostic value of vascular endothelial growth factor in breast cancer] | PubMed |
| Breast Neoplasms | [The relationship between lymphatic metastasis and serum vascular endothelial growth factor C and cyclooxygenase 2 expression in breast cancer] | PubMed |
| Breast Neoplasms | [Vascular endothelial growth factor (VEGF)-D in association with VEGF receptor-3 in lymphatic metastasis of breast cancer] | PubMed |
| Breast Neoplasms | [Vascular endothelial growth factor and two types of its receptors in breast cancer] | PubMed |
| Bronchiolitis | Critical Role of VEGF-C/VEGFR-3 Signaling in Innate and Adaptive Immune Responses in Experimental Obliterative Bronchiolitis. | PubMed |
| Bronchiolitis | Dual role of vascular endothelial growth factor in experimental obliterative bronchiolitis. | PubMed |
| Bronchiolitis | Role of vascular endothelial growth factor (VEGF) and its receptors in experimental obliterative bronchiolitis. | PubMed |
| Bronchiolitis | Vascular endothelial growth factor plays a major role in development of experimental obliterative bronchiolitis. | PubMed |
| Bronchitis | Cigarette smoke and ?,?-unsaturated aldehydes elicit VEGF release through the p38 MAPK pathway in human airway smooth muscle cells and lung fibroblasts. | PubMed |
| Bronchitis | Vascular endothelial growth factor: an angiogenic factor reflecting airway inflammation in healthy smokers and in patients with bronchitis type of chronic obstructive pulmonary disease? | PubMed |
| Bronchopulmonary Dysplasia | Alterations of the Thioredoxin System by Hyperoxia: Implications for Alveolar Development. | PubMed |
| Bronchopulmonary Dysplasia | Bronchopulmonary dysplasia and early prophylactic inhaled nitric oxide in preterm infants: current concepts and future research strategies in animal models. | PubMed |
| Bronchopulmonary Dysplasia | Disrupted pulmonary vasculature and decreased vascular endothelial growth factor, Flt-1, and TIE-2 in human infants dying with bronchopulmonary dysplasia. | PubMed |
| Bronchopulmonary Dysplasia | Genetic risk factors of bronchopulmonary dysplasia. | PubMed |
| Bronchopulmonary Dysplasia | Placental growth factor and vascular endothelial growth factor receptor-2 in human lung development. | PubMed |
| Bronchopulmonary Dysplasia | [Dynamic changes in vascular endothelial growth factor and endothelial nitric oxide synthase in lungs of premature rats after hyperoxia exposure] | PubMed |
| Bronchopulmonary Dysplasia | [Effects of prolonged exposure of high concentration of oxygen on expression of vascular endothelial growth factor and its receptors in neonatal rat lungs] | PubMed |
| Bursitis | Expression of vascular endothelial growth factor and angiogenesis in the diabetic frozen shoulder. | PubMed |
| Calcinosis | The differential expression of VEGF, VEGFR-2, and GLUT-1 proteins in disease subtypes of systemic sclerosis. | PubMed |
| Capillary Leak Syndrome | Plasma vascular endothelial growth factor level is a predictor of the severity of postoperative capillary leak syndrome in neonates undergoing cardiopulmonary bypass. | PubMed |
| Capillary Leak Syndrome | Synchronized changes in serum vascular endothelial growth factor during the clinical course of chronic systemic capillary leak syndrome. | PubMed |
| Capillary Leak Syndrome | Vascular endothelial growth factor in systemic capillary leak syndrome. | PubMed |
| Capillary Leak Syndrome | [Effect of fluid resuscitation on capillary permeability and vascular endothelial growth factor in dogs with septic shock] | PubMed |
| Carcinoid Tumor | Development and characterization of a novel in vivo model of carcinoid syndrome. | PubMed |
| Carcinoid Tumor | GHRH antagonist inhibits focal adhesion kinase (FAK) and decreases expression of vascular endothelial growth factor (VEGF) in human lung cancer cells in vitro. | PubMed |
| Carcinoid Tumor | Hypoxia stimulates CXCR4 signalling in ileal carcinoids. | PubMed |
| Carcinoid Tumor | mTOR inhibition, a potential novel approach for bronchial carcinoids. | PubMed |
| Carcinoid Tumor | Novel anticancer agents in clinical trials for well-differentiated neuroendocrine tumors. | PubMed |
| Carcinoid Tumor | Systemic therapy for advanced carcinoid tumors: where do we go from here? | PubMed |
| Carcinoid Tumor | Targeting vascular endothelial growth factor in advanced carcinoid tumor: a random assignment phase II study of depot octreotide with bevacizumab and pegylated interferon alpha-2b. | PubMed |
| Carcinoma | 1alpha,25-Dihydroxyvitamin D3 regulates the expression of Id1 and Id2 genes and the angiogenic phenotype of human colon carcinoma cells. | PubMed |
| Carcinoma | 3D dynamic contrast-enhanced MRI of rectal carcinoma at 3T: correlation with microvascular density and vascular endothelial growth factor markers of tumor angiogenesis. | PubMed |
| Carcinoma | 4-Hydroxy estradiol but not 2-hydroxy estradiol induces expression of hypoxia-inducible factor 1alpha and vascular endothelial growth factor A through phosphatidylinositol 3-kinase/Akt/FRAP pathway in OVCAR-3 and A2780-CP70 human ovarian carcinoma cells. | PubMed |
| Carcinoma | A comparison of antiangiogenic therapies for the prevention of liver metastases. | PubMed |
| Carcinoma | A fusion protein containing murine vascular endothelial growth factor and tissue factor induces thrombogenesis and suppression of tumor growth in a colon carcinoma model. | PubMed |
| Carcinoma | A high vascular count and overexpression of vascular endothelial growth factor are associated with unfavourable prognosis in operated small cell lung carcinoma. | PubMed |
| Carcinoma | A Novel LMP1 Antibody Synergizes with Mitomycin C to Inhibit Nasopharyngeal Carcinoma Growth in Vivo Through Inducing Apoptosis and Downregulating Vascular Endothelial Growth Factor. | PubMed |
| Carcinoma | A Novel Strategy for Advanced Pancreatic Cancer - Progression of Molecular Targeting Therapy. | PubMed |
| Carcinoma | A phase II study of subcutaneous low-dose interleukin-2 plus erythropoietin in metastatic renal cell carcinoma progressing on interleukin-2 alone. | PubMed |
| Carcinoma | A phase II study of sunitinib in recurrent and/or metastatic adenoid cystic carcinoma (ACC) of the salivary glands: current progress and challenges in evaluating molecularly targeted agents in ACC. | PubMed |
| Carcinoma | A potential role for vascular endothelial growth factor-D as an autocrine growth factor for human breast carcinoma cells. | PubMed |
| Carcinoma | A randomized trial of bevacizumab, an anti-vascular endothelial growth factor antibody, for metastatic renal cancer. | PubMed |
| Carcinoma | A review of molecular pathological markers in vulvar carcinoma: lack of application in clinical practice. | PubMed |
| Carcinoma | A second major native von Hippel-Lindau gene product, initiated from an internal translation start site, functions as a tumor suppressor. | PubMed |
| Carcinoma | Aberrant expression of EphA3 in gastric carcinoma: correlation with tumor angiogenesis and survival. | PubMed |
| Carcinoma | Activation of invasiveness of cervical carcinoma cells by angiotensin II. | PubMed |
| Carcinoma | Activation of the RAS/RAF/ERK signaling pathway contributes to resistance to sunitinib in thyroid carcinoma cell lines. | PubMed |
| Carcinoma | Activity of SU11248, a multitargeted inhibitor of vascular endothelial growth factor receptor and platelet-derived growth factor receptor, in patients with metastatic renal cell carcinoma. | PubMed |
| Carcinoma | Advances in the research on lymphangiogenesis in carcinoma tissues (Review). | PubMed |
| Carcinoma | Alpha-fetoprotein-producing lung carcinoma: report of three cases. | PubMed |
| Carcinoma | Alteration of the vascular endothelial growth factor and angiopoietins-1 and -2 pathways in transitional cell carcinomas of the urinary bladder associated with tumor progression. | PubMed |
| Carcinoma | An evaluation of the prognostic significance of vascular endothelial growth factor in node positive primary breast carcinoma. | PubMed |
| Carcinoma | An in vitro tumor model: analysis of angiogenic factor expression after chemotherapy. | PubMed |
| Carcinoma | An international expanded-access programme of everolimus: Addressing safety and efficacy in patients with metastatic renal cell carcinoma who progress after initial vascular endothelial growth factor receptor-tyrosine kinase inhibitor therapy. | PubMed |
| Carcinoma | Analysis of p53 and vascular endothelial growth factor expression in human gallbladder carcinoma for the determination of tumor vascularity. | PubMed |
| Carcinoma | Angiogenesis and angiogenic inhibitors in renal cell carcinoma. | PubMed |
| Carcinoma | Angiogenesis and Expression of Vascular Endothelial Growth Factor, Tumour Necrosis Factor-? and Hypoxia Inducible Factor-1? in Canine Renal Cell Carcinoma. | PubMed |
| Carcinoma | Angiogenesis and lymphangiogenesis in thyroid proliferative lesions: relationship to type and tumour behaviour. | PubMed |
| Carcinoma | Angiogenesis and VEGF expression in pre-invasive lesions of the human breast. | PubMed |
| Carcinoma | Angiogenesis correlates with vascular endothelial growth factor expression but not with Ki-ras oncogene activation in non-small cell lung carcinoma. | PubMed |
| Carcinoma | Angiogenesis gene expression profiling in xenograft models to study cellular interactions. | PubMed |
| Carcinoma | Angiogenesis in ovarian clear cell carcinoma and its relation to endometriosis. | PubMed |
| Carcinoma | Angiogenesis in renal cell carcinoma: Evaluation of microvessel density, vascular endothelial growth factor and matrix metalloproteinases. | PubMed |
| Carcinoma | Angiogenic factors in squamous cell carcinoma of the oral cavity: do they have prognostic relevance? | PubMed |
| Carcinoma | Angiogenic factors: vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (b-FGF) are not necessarily elevated in patients with advanced renal cell carcinoma. | PubMed |
| Carcinoma | Angiogenic growth factors and their receptors in non-small cell lung carcinomas and their relationships to drug response in vitro. | PubMed |
| Carcinoma | Angiogenic growth factors in preinvasive breast disease. | PubMed |
| Carcinoma | Angiogenic growth factors in tissue homogenates of HNSCC: expression pattern, prognostic relevance, and interrelationships. | PubMed |
| Carcinoma | Angiogenic potential of prostate carcinoma cells overexpressing bcl-2. | PubMed |
| Carcinoma | Angiogenic switch occurs during the precancerous stage of human esophageal squamous cell carcinoma. | PubMed |
| Carcinoma | Angiogenically active vascular endothelial growth factor is over-expressed in malignant human and rat prostate carcinoma cells. | PubMed |
| Carcinoma | Angiopoietin-2 inhibits the growth of tongue carcinoma without affecting expression of vascular endothelial growth factor. | PubMed |
| Carcinoma | Angiostatin expression in ovarian cancer. | PubMed |
| Carcinoma | Anti-angiogenesis therapy in pancreatic carcinoma. | PubMed |
| Carcinoma | Antiangiogenic and antitumor activity of a novel vascular endothelial growth factor receptor-2 tyrosine kinase inhibitor ZD6474 in a metastatic human pancreatic tumor model. | PubMed |
| Carcinoma | Antiangiogenic therapy of head and neck squamous cell carcinoma by vascular endothelial growth factor antisense therapy. | PubMed |
| Carcinoma | Antiangiogenic treatment enhances photodynamic therapy responsiveness in a mouse mammary carcinoma. | PubMed |
| Carcinoma | Antisense inhibition of vascular endothelial growth factor in human head and neck squamous cell carcinoma. | PubMed |
| Carcinoma | Antitumor effect of novel HSP90 inhibitor NVP-AUY922 against oral squamous cell carcinoma. | PubMed |
| Carcinoma | Antitumor effect on human gastric cancer and induction of apoptosis by vascular endothelial growth factor neutralizing antibody. | PubMed |
| Carcinoma | Antitumor effects of a combination of interferon-alpha and sorafenib on human renal carcinoma cell lines. | PubMed |
| Carcinoma | Antivascular therapy for orthotopic human ovarian carcinoma through blockade of the vascular endothelial growth factor and epidermal growth factor receptors. | PubMed |
| Carcinoma | Are angiogenic factors, cytokines, and soluble adhesion molecules prognostic factors in patients with renal cell carcinoma? | PubMed |
| Carcinoma | Ascochlorin inhibits growth factor-induced HIF-1? activation and tumor-angiogenesis through the suppression of EGFR/ERK/p70S6K signaling pathway in human cervical carcinoma cells. | PubMed |
| Carcinoma | Assessment of biomarkers for clinical diagnosis of papillary thyroid carcinoma with distant metastasis. | PubMed |
| Carcinoma | Assessment of c-erbB2 and vascular endothelial growth factor mRNA expression in fine-needle aspirates from early breast carcinomas: pre-operative determination of malignant potential. | PubMed |
| Carcinoma | Assessment of vascular remodeling under antiangiogenic therapy using DCE-MRI and vessel size imaging. | PubMed |
| Carcinoma | Association of preoperative radiation effect with tumor angiogenesis and vascular endothelial growth factor in oral squamous cell carcinoma. | PubMed |
| Carcinoma | Association of vascular endothelial growth factor and mast cells with angiogenesis in laryngeal squamous cell carcinoma. | PubMed |
| Carcinoma | Association of vascular endothelial growth factor expression with angiogenesis and lymph node metastasis in nasopharyngeal carcinoma. | PubMed |
| Carcinoma | Association of vascular endothelial growth factor expression with intratumoral microvessel density and tumour cell proliferation in human epidermoid lung carcinoma. | PubMed |
| Carcinoma | Association of vascular endothelial growth factor expression with tumor cell proliferation in ovarian carcinoma. | PubMed |
| Carcinoma | Association of VEGF and VEGFR2 single nucleotide polymorphisms with hypertension and clinical outcome in metastatic clear cell renal cell carcinoma patients treated with sunitinib. | PubMed |
| Carcinoma | Association of VEGF genetic polymorphisms with prostate carcinoma risk and clinical outcome. | PubMed |
| Carcinoma | Association of VEGF-A genetic polymorphisms with cancer risk and survival in advanced-stage oral squamous cell carcinoma patients. | PubMed |
| Carcinoma | Associations of single nucleotide polymorphisms in the vascular endothelial growth factor gene with the characteristics and prognosis of renal cell carcinomas. | PubMed |
| Carcinoma | Atorvastatin reduces vascular endothelial growth factor (VEGF) expression in human non-small cell lung carcinomas (NSCLCs) via inhibition of reactive oxygen species (ROS) production. | PubMed |
| Carcinoma | Autocrine signaling in carcinoma: VEGF and the alpha6beta4 integrin. | PubMed |
| Carcinoma | Avoiding bevacizumab related gastrointestinal toxicity for recurrent ovarian cancer by careful patient screening. | PubMed |
| Carcinoma | bcl-2 induction of urokinase plasminogen activator receptor expression in human cancer cells through Sp1 activation: involvement of ERK1/ERK2 activity. | PubMed |
| Carcinoma | Bcl-2 overexpression and hypoxia synergistically act to modulate vascular endothelial growth factor expression and in vivo angiogenesis in a breast carcinoma line. | PubMed |
| Carcinoma | Bcl2 and p53 regulate vascular endothelial growth factor (VEGF)-mediated angiogenesis in non-small cell lung carcinoma. | PubMed |
| Carcinoma | Beta2-microglobulin promotes the growth of human renal cell carcinoma through the activation of the protein kinase A, cyclic AMP-responsive element-binding protein, and vascular endothelial growth factor axis. | PubMed |
| Carcinoma | Bevacizumab enhances the therapeutic efficacy of Irinotecan against human head and neck squamous cell carcinoma xenografts. | PubMed |
| Carcinoma | Bevacizumab plus interferon alfa compared with interferon alfa monotherapy in patients with metastatic renal cell carcinoma: CALGB 90206. | PubMed |
| Carcinoma | Bevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma: a randomised, double-blind phase III trial. | PubMed |
| Carcinoma | Bevacizumab plus microtubule targeting agents in heavily pre-treated ovarian cancer patients: a retrospective study. | PubMed |
| Carcinoma | Bevacizumab: an angiogenesis inhibitor for the treatment of solid malignancies. | PubMed |
| Carcinoma | Bevacizumab: in first-line treatment of metastatic breast cancer. | PubMed |
| Carcinoma | Biologic implications of the expression of vascular endothelial growth factor subtypes in ovarian carcinoma. | PubMed |
| Carcinoma | Biological aspects and binding strategies of vascular endothelial growth factor in renal cell carcinoma. | PubMed |
| Carcinoma | Biological markers and prognosis in recurrent oral cancer after salvage surgery. | PubMed |
| Carcinoma | Biology and clinical development of vascular endothelial growth factor-targeted therapy in renal cell carcinoma. | PubMed |
| Carcinoma | Blockade of vascular endothelial growth factor receptor and epidermal growth factor receptor signaling for therapy of metastatic human pancreatic cancer. | PubMed |
| Carcinoma | Blockage of the vascular endothelial growth factor stress response increases the antitumor effects of ionizing radiation. | PubMed |
| Carcinoma | Blocking platelet-derived growth factor-D/platelet-derived growth factor receptor beta signaling inhibits human renal cell carcinoma progression in an orthotopic mouse model. | PubMed |
| Carcinoma | Blood flow indices by Doppler ultrasonography vary with neoadjuvant chemotherapy but are not related to plasma VEGF levels in locally advanced breast cancer. | PubMed |
| Carcinoma | c-MET expression level in primary colon cancer: a predictor of tumor invasion and lymph node metastases. | PubMed |
| Carcinoma | Cancer gene therapy with iCaspase-9 transcriptionally targeted to tumor endothelial cells. | PubMed |
| Carcinoma | Carbonic anhydrase IX and pathological features as predictors of outcome in patients with metastatic clear-cell renal cell carcinoma receiving vascular endothelial growth factor-targeted therapy. | PubMed |
| Carcinoma | Carcinoma ex pleomorphic adenoma of the salivary glands: distinct clinicopathologic features and immunoprofiles between subgroups according to cellular differentiation. | PubMed |
| Carcinoma | Carcinoma of the parotid gland: developing prognostic indices. | PubMed |
| Carcinoma | Cathepsin S Controls Angiogenesis and Tumor Growth via Matrix-derived Angiogenic Factors. | PubMed |
| Carcinoma | CCK-2/gastrin receptor signaling pathway is significant for gemcitabine-induced gene expression of VEGF in pancreatic carcinoma cells. | PubMed |
| Carcinoma | CD133 expression is correlated with lymph node metastasis and vascular endothelial growth factor-C expression in pancreatic cancer. | PubMed |
| Carcinoma | CD147 and VEGF expression in advanced renal cell carcinoma and their prognostic value. | PubMed |
| Carcinoma | CD40 is overexpressed by HPV16/18-E6 positive cervical carcinoma and correlated with clinical parameters and vascular density. | PubMed |
| Carcinoma | Cepharanthine inhibits angiogenesis and tumorigenicity of human oral squamous cell carcinoma cells by suppressing expression of vascular endothelial growth factor and interleukin-8. | PubMed |
| Carcinoma | Cessation of vascular endothelial growth factor-targeted therapy in patients with metastatic renal cell carcinoma: Feasibility and Clinical Outcome. | PubMed |
| Carcinoma | Chitosan/short hairpin RNA complexes for vascular endothelial growth factor suppression invasive breast carcinoma. | PubMed |
| Carcinoma | Circulating and imaging markers for angiogenesis. | PubMed |
| Carcinoma | Circulating levels of vascular endothelial growth factor in patients with oral squamous cell carcinoma. | PubMed |
| Carcinoma | Circulating plasma vascular endothelial growth factor in mice bearing human ovarian carcinoma xenograft correlates with tumor progression and response to therapy. | PubMed |
| Carcinoma | Circulating vascular endothelial growth factor correlates with systemic thrombin generation in patients with pancreatic carcinoma. | PubMed |
| Carcinoma | Clinical activity of sorafenib and sunitinib in renal cell carcinoma refractory to previous vascular endothelial growth factor-targeted therapy: two case reports. | PubMed |
| Carcinoma | Clinical and molecular prognostic factors in renal cell carcinoma: what we know so far. | PubMed |
| Carcinoma | Clinical effect and future considerations for molecularly-targeted therapy in renal cell carcinoma. | PubMed |
| Carcinoma | Clinical factors associated with outcome in patients with metastatic clear-cell renal cell carcinoma treated with vascular endothelial growth factor-targeted therapy. | PubMed |
| Carcinoma | Clinical importance of vascular endothelial growth factor (VEGF) for papillary thyroid carcinomas. | PubMed |
| Carcinoma | Clinical prognostic values of vascular endothelial growth factor, microvessel density,and p53 expression in esophageal carcinomas. | PubMed |
| Carcinoma | Clinical response to therapy targeted at vascular endothelial growth factor in metastatic renal cell carcinoma: impact of patient characteristics and Von Hippel-Lindau gene status. | PubMed |
| Carcinoma | Clinical significance of serum CA-125 and soluble tumor necrosis factor receptor type I in cervical adenocarcinoma patients. | PubMed |
| Carcinoma | Clinical significance of serum levels of vascular endothelial growth factor and its receptor in biliary disease and carcinoma. | PubMed |
| Carcinoma | Clinical significance of serum vascular endothelial growth factor in esophageal squamous cell carcinoma. | PubMed |
| Carcinoma | Clinical significance of urinary vascular endothelial growth factor and microvessel density in patients with renal cell carcinoma. | PubMed |
| Carcinoma | Clinical significance of vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 in patients with nonsmall cell lung carcinoma. | PubMed |
| Carcinoma | Clinical significance of vascular endothelial growth factor expression in patients with carcinoma of the mouth floor and tongue. | PubMed |
| Carcinoma | Clinicopathologic significance of hypoxia-inducible factor 1alpha overexpression in gastric carcinomas. | PubMed |
| Carcinoma | Clinicopathologic study of neovascularization and VEGF expression in superficial esophageal carcinoma. | PubMed |
| Carcinoma | Clinicopathologic study of vascular endothelial growth factor, thrombospondin-1, and microvessel density assessed by CD34 in patients with stage III ovarian carcinoma. | PubMed |
| Carcinoma | Clinicopathological and prognostic significance of vascular endothelial growth factors (VEGF)-C and -D and VEGF receptor 3 in invasive breast carcinoma. | PubMed |
| Carcinoma | Clinicopathological significance of vascular endothelial growth factor (VEGF)-C in human esophageal squamous cell carcinomas. | PubMed |
| Carcinoma | Close correlation between CXCR4 and VEGF expression and their prognostic implications in nasopharyngeal carcinoma. | PubMed |
| Carcinoma | Co-expression of vascular endothelial growth factor C (VEGF-C) and c-erbB2 in human breast carcinoma. | PubMed |
| Carcinoma | Coexpression of heparanase, basic fibroblast growth factor and vascular endothelial growth factor in human esophageal carcinomas. | PubMed |
| Carcinoma | Coexpression of hypoxia-inducible factors 1alpha and 2alpha, carbonic anhydrase IX, and vascular endothelial growth factor in nasopharyngeal carcinoma and relationship to survival. | PubMed |
| Carcinoma | Coexpression of proangiogenic factors IL-8 and VEGF by human head and neck squamous cell carcinoma involves coactivation by MEK-MAPK and IKK-NF-kappaB signal pathways. | PubMed |
| Carcinoma | Coexpression of vascular endothelial growth factor and p53 protein in squamous cell carcinoma of the esophagus. | PubMed |
| Carcinoma | Coexpression of VEGF and bFGF in human epidermoid lung carcinoma is associated with increased vessel density. | PubMed |
| Carcinoma | Combination of pigment epithelium-derived factor with radiotherapy enhances the antitumor effects on nasopharyngeal carcinoma by downregulating vascular endothelial growth factor expression and angiogenesis. | PubMed |
| Carcinoma | Combination therapy of imatinib mesylate and interferon-alpha demonstrates minimal activity and significant toxicity in metastatic renal cell carcinoma: results of a single- institution phase II trial. | PubMed |
| Carcinoma | Combined analysis of vascular endothelial growth factor and platelet-derived endothelial cell growth factor expression in gastric carcinoma. | PubMed |
| Carcinoma | Combined assay of CYFRA21-1, telomerase and vascular endothelial growth factor in the detection of bladder transitional cell carcinoma. | PubMed |
| Carcinoma | Combined effects of soluble vascular endothelial growth factor receptor FLT-1 gene therapy and cisplatin chemotherapy in human tongue carcinoma xenografts. | PubMed |
| Carcinoma | Combined ionizing radiation and sKDR gene delivery for treatment of prostate carcinomas. | PubMed |
| Carcinoma | Comparative analysis of COX-2, vascular endothelial growth factor and microvessel density in human renal cell carcinomas. | PubMed |
| Carcinoma | Comparative analysis of hepatocellular carcinoma in men and dogs. | PubMed |
| Carcinoma | Comparative efficacy of vascular endothelial growth factor (VEGF) tyrosine kinase inhibitor (TKI) and mammalian target of rapamycin (mTOR) inhibitor as second-line therapy in patients with metastatic renal cell carcinoma after the failure of first-line VEGF TKI. | PubMed |
| Carcinoma | Comparative study of human colonic tumor-derived endothelial cells (HCTEC) and normal colonic microvascular endothelial cells (HCMEC): Hypoxia-induced sVEGFR-1 and sVEGFR-2 levels. | PubMed |
| Carcinoma | Comparison of the prognosis indication of VEGFR-1 and VEGFR-2 and Tie2 receptor expression in breast carcinoma. | PubMed |
| Carcinoma | Competing autocrine pathways involving alternative neuropilin-1 ligands regulate chemotaxis of carcinoma cells. | PubMed |
| Carcinoma | Concomitant inhibition of epidermal growth factor and vascular endothelial growth factor receptor tyrosine kinases reduces growth and metastasis of human salivary adenoid cystic carcinoma in an orthotopic nude mouse model. | PubMed |
| Carcinoma | Constitutive upregulation of hypoxia-inducible factor-1alpha mRNA occurring in highly metastatic lung carcinoma cells leads to vascular endothelial growth factor overexpression upon hypoxic exposure. | PubMed |
| Carcinoma | Cooperative stimulation of vascular endothelial growth factor expression by hypoxia and reactive oxygen species: the effect of targeting vascular endothelial growth factor and oxidative stress in an orthotopic xenograft model of bladder carcinoma. | PubMed |
| Carcinoma | Coordinated expression of integrin subunits, matrix metalloproteinases (MMP), angiogenic genes and Ets transcription factors in advanced-stage ovarian carcinoma: a possible activation pathway? | PubMed |
| Carcinoma | Correlation between expression of S100A4 and VEGF-C, and lymph node metastasis and prognosis in gastric carcinoma. | PubMed |
| Carcinoma | Correlation between expression of vascular endothelial growth factor and tumor vascularity, and patient outcome in human gastric carcinoma. | PubMed |
| Carcinoma | Correlation between serum levels of interleukin-6 and vascular endothelial growth factor in gastric carcinoma. | PubMed |
| Carcinoma | Correlation between tumor vascularity, vascular endothelial growth factor production by tumor cells, serum vascular endothelial growth factor levels, and serum angiogenic activity in patients with breast carcinoma. | PubMed |
| Carcinoma | Correlation between vascular endothelial growth factor C expression and lymph node metastasis in T1 carcinoma of the colon and rectum. | PubMed |
| Carcinoma | Correlation between vascular endothelial growth factor C expression and prognosis in patients with esophageal squamous cell carcinomas after Ivor-Lewis esophagectomy. | PubMed |
| Carcinoma | Correlation between vascular endothelial growth factor, angiogenesis, and tumor-associated macrophages in invasive ductal breast carcinoma. | PubMed |
| Carcinoma | Correlation between vascular endothelial growth factor-C expression and invasion phenotype in cervical carcinomas. | PubMed |
| Carcinoma | Correlation between VEGF expression and angiogenesis in breast carcinoma. | PubMed |
| Carcinoma | Correlation of cyclooxygenase-2 pathway and VEGF expression in head and neck squamous cell carcinoma. | PubMed |
| Carcinoma | Correlation of epidermal growth factor receptor expression with tumor microdensity vessels and with vascular endothelial growth factor expression in ovarian carcinoma. | PubMed |
| Carcinoma | Correlation of expression of cyclooxygenase-2, vascular endothelial growth factor, and peroxisome proliferator-activated receptor delta with head and neck squamous cell carcinoma. | PubMed |
| Carcinoma | Correlation of integrin beta3 mRNA and vascular endothelial growth factor protein expression profiles with the clinicopathological features and prognosis of gastric carcinoma. | PubMed |
| Carcinoma | Correlation of matrix metalloproteinase suppressor genes RECK, VEGF, and CD105 with angiogenesis and biological behavior in esophageal squamous cell carcinoma. | PubMed |
| Carcinoma | Correlation of serum levels of vascular endothelial growth factor with TNM staging, histopathologic grading, and surgical therapy for oral squamous cell carcinoma. | PubMed |
| Carcinoma | Correlation of vascular endothelial growth factor content with recurrences, survival, and first relapse site in primary node-positive breast carcinoma after adjuvant treatment. | PubMed |
| Carcinoma | Correlation of vascular endothelial growth factor expression to overall survival in feline invasive mammary carcinomas. | PubMed |
| Carcinoma | Correlation of vascular endothelial growth factor-D expression and VEGFR-3-positive vessel density with lymph node metastasis in gastric carcinoma. | PubMed |
| Carcinoma | COX-2 expression in ampullary carcinoma: correlation with angiogenesis process and clinicopathological variables. | PubMed |
| Carcinoma | Cyclooxygenase-2 expression in an adenoid cystic carcinoma of the uterine cervix. | PubMed |
| Carcinoma | Cyclooxygenase-2 increases hypoxia-inducible factor-1 and vascular endothelial growth factor to promote angiogenesis in gastric carcinoma. | PubMed |
| Carcinoma | Cyclooxygenase-2 promotes angiogenesis by increasing vascular endothelial growth factor and predicts prognosis in gallbladder carcinoma. | PubMed |
| Carcinoma | Cyclooxygenase-2 upregulates vascular endothelial growth factor expression and angiogenesis in human gastric carcinoma. | PubMed |
| Carcinoma | Cyclooxygenase-2/prostaglandin E(2) pathway mediates icariside II induced apoptosis in human PC-3 prostate cancer cells. | PubMed |
| Carcinoma | Cyr61 promotes breast tumorigenesis and cancer progression. | PubMed |
| Carcinoma | Cyr61/CCN1 and CTGF/CCN2 mediate the proangiogenic activity of VHL-mutant renal carcinoma cells. | PubMed |
| Carcinoma | Cytokines in pancreatic carcinoma: correlation with phenotypic characteristics and prognosis. | PubMed |
| Carcinoma | Decorin Antagonizes the Angiogenic Network: CONCURRENT INHIBITION OF MET, HYPOXIA INDUCIBLE FACTOR 1?, VASCULAR ENDOTHELIAL GROWTH FACTOR A, AND INDUCTION OF THROMBOSPONDIN-1 AND TIMP3. | PubMed |
| Carcinoma | Decreased lung carcinoma cell functions on select polymer nanometer surface features. | PubMed |
| Carcinoma | Description of 2 angiogenic phenotypes in clear cell renal cell carcinoma. | PubMed |
| Carcinoma | Different isoform patterns for vascular endothelial growth factor between clear cell and papillary renal cell carcinoma. | PubMed |
| Carcinoma | Different vascular endothelial growth factor (VEGF), VEGF-receptor 1 and -2 mRNA expression profiles between clear cell and papillary renal cell carcinoma. | PubMed |
| Carcinoma | Differential effects between cyclooxygenase-2 inhibitors and siRNA on vascular endothelial growth factor production in head and neck squamous cell carcinoma cell lines. | PubMed |
| Carcinoma | Differential effects of vascular endothelial growth factor receptor-2 inhibitor ZD6474 on circulating endothelial progenitors and mature circulating endothelial cells: implications for use as a surrogate marker of antiangiogenic activity. | PubMed |
| Carcinoma | Differential expression of vascular endothelial growth factor165b in transitional cell carcinoma of the bladder. | PubMed |
| Carcinoma | Down-regulation of vascular endothelial growth factor in a human colon carcinoma cell line transfected with an antisense expression vector specific for c-src. | PubMed |
| Carcinoma | Down-regulation of vascular endothelial growth factor in human colon carcinoma cell lines by antisense transfection decreases endothelial cell proliferation. | PubMed |
| Carcinoma | Down-regulation of vascular endothelial growth factor in renal cell carcinoma cells by glucocorticoids. | PubMed |
| Carcinoma | Dual role of VEGF family members in the pathogenesis of head and neck cancer (HNSCC): possible link between angiogenesis and immune tolerance. | PubMed |
| Carcinoma | Ductal carcinoma in situ of the breast with osteoclast-like giant cells. | PubMed |
| Carcinoma | Early nuclear alterations and immunohistochemical expression of Ki-67, Erb-B2, vascular endothelial growth factor (VEGF), transforming growth factor (TGF-beta1) and integrine-linked kinase (ILK) two days after tamoxifen in breast carcinoma. | PubMed |
| Carcinoma | Editorial Comment on: Associations of single nucleotide polymorphisms in the vascular endothelial growth factor gene with the characteristics and prognosis of renal cell carcinomas. | PubMed |
| Carcinoma | Effect of cis-diammine dichloroplatinum on vascular endothelial growth factor expression in uterine cervical carcinoma. | PubMed |
| Carcinoma | Effect of duration of fixation on quantitative reverse transcription polymerase chain reaction analyses. | PubMed |
| Carcinoma | Effect of endothelial PAS domain protein 1 and hypoxia inducible factor 1alpha on vascular endothelial growth factor expression in human pancreatic carcinoma. | PubMed |
| Carcinoma | Effect of hypericin-mediated photodynamic therapy on the expression of vascular endothelial growth factor in human nasopharyngeal carcinoma. | PubMed |
| Carcinoma | Effect of Kang'ai Injection on serum level of soluble interleukin-2 receptor and vascular endothelial growth factor in patients with esophageal carcinoma during radiotherapy. | PubMed |
| Carcinoma | Effect of mitomycin C on concentrations of vascular endothelial growth factor and its receptors in bladder cancer cells and in bladders of rats intravesically instilled with mitomycin C. | PubMed |
| Carcinoma | Effect of neoadjuvant chemoradiotherapy on angiogenesis in oesophageal cancer. | PubMed |
| Carcinoma | Effect of non-anticoagulant N-desulfated heparin on expression of vascular endothelial growth factor, angiogenesis and metastasis of orthotopic implantation of human gastric carcinoma. | PubMed |
| Carcinoma | Effect of raloxifene on vascular endothelial growth factor expression in breast carcinomas of postmenopausal women. | PubMed |
| Carcinoma | Effect of tamoxifen on serum IL-18, vascular endothelial growth factor and nitric oxide activities in breast carcinoma patients. | PubMed |
| Carcinoma | Effects of an antibody to vascular endothelial growth factor receptor-2 on survival, tumor vascularity, and apoptosis in a murine model of colon carcinomatosis. | PubMed |
| Carcinoma | Effects of endostatin on expression of vascular endothelial growth factor and its receptors and neovascularization in colonic carcinoma implanted in nude mice. | PubMed |
| Carcinoma | Effects of meloxicam on vascular endothelial growth factor and angiopoietin-2 expression in colon carcinoma cell line HT-29. | PubMed |
| Carcinoma | Effects of pharmacologic antagonists of epidermal growth factor receptor, PI3K and MEK signal kinases on NF-kappaB and AP-1 activation and IL-8 and VEGF expression in human head and neck squamous cell carcinoma lines. | PubMed |
| Carcinoma | Effects of PTK787/ZK222584, a tyrosine kinase inhibitor, on the growth of a poorly differentiated thyroid carcinoma: an animal study. | PubMed |
| Carcinoma | Effects of the cyclooxygenase inhibitor, piroxicam, on tumor response, apoptosis, and angiogenesis in a canine model of human invasive urinary bladder cancer. | PubMed |
| Carcinoma | Efficacy and safety of pazopanib in patients with metastatic renal cell carcinoma. | PubMed |
| Carcinoma | Efficacy and safety of sunitinib in the treatment of metastatic renal cell carcinoma. | PubMed |
| Carcinoma | El-Gazzar R, Macluskey M, Williams H, Ogden GR. Vascularity and expression of vascular endothelial growth factor in oral squamous cell carcinoma, resection margins, and nodal metastases. Br J Oral Maxillofac Surg 2006;44:193-7 [Epub 2005, August 10]. | PubMed |
| Carcinoma | Elevated levels of the angiogenic cytokines basic fibroblast growth factor and vascular endothelial growth factor in sera of cancer patients. | PubMed |
| Carcinoma | Elevated perioperative serum vascular endothelial growth factor levels in patients with colon carcinoma. | PubMed, PubMed |
| Carcinoma | Elevated serum vascular endothelial growth factor and decreased survival in advanced laryngeal carcinoma. | PubMed |
| Carcinoma | Elevation of serum vascular endothelial growth factor in male patients with metastatic nasopharyngeal carcinoma. | PubMed |
| Carcinoma | Elevation of vascular endothelial growth factor in Indonesian advanced stage nasopharyngeal carcinoma. | PubMed |
| Carcinoma | Endoglin (CD105) expression in angiogenesis of colon cancer: analysis using tissue microarrays and comparison with other endothelial markers. | PubMed |
| Carcinoma | Endometriosis-associated ovarian carcinoma: differential expression of vascular endothelial growth factor and estrogen/progesterone receptors. | PubMed |
| Carcinoma | Endostatin gene transfer in murine lung carcinoma cells induces vascular endothelial growth factor secretion resulting in up-regulation of in vivo tumorigenecity. | PubMed |
| Carcinoma | Endostatin inhibits VEGF-induced endothelial cell migration and tumor growth independently of zinc binding. | PubMed |
| Carcinoma | Endothelial cell death, angiogenesis, and microvascular function after castration in an androgen-dependent tumor: role of vascular endothelial growth factor. | PubMed |
| Carcinoma | Endothelin-1 induces vascular endothelial growth factor by increasing hypoxia-inducible factor-1alpha in ovarian carcinoma cells. | PubMed |
| Carcinoma | Endothelin-1-, endothelin-A-, and endothelin-B-receptor expression is correlated with vascular endothelial growth factor expression and angiogenesis in breast cancer. | PubMed |
| Carcinoma | Endothelin-1-induced prostaglandin E2-EP2, EP4 signaling regulates vascular endothelial growth factor production and ovarian carcinoma cell invasion. | PubMed |
| Carcinoma | Enhanced expression of Tie2, its ligand angiopoietin-1, vascular endothelial growth factor, and CD31 in human non-small cell lung carcinomas. | PubMed |
| Carcinoma | Enzyme-digested Fucoidan Extracts Derived from Seaweed Mozuku of Cladosiphon novae-caledoniae kylin Inhibit Invasion and Angiogenesis of Tumor Cells. | PubMed |
| Carcinoma | Epidermal growth factor receptor (EGFR) and vascular endothelial growth factor (VEGF) negatively affect overall survival in carcinoma of the cervix treated with radiotherapy. | PubMed |
| Carcinoma | Epigallocatechin-3-gallate decreases VEGF production in head and neck and breast carcinoma cells by inhibiting EGFR-related pathways of signal transduction. | PubMed |
| Carcinoma | Epigenetic regulation of vascular endothelial growth factor a dynamic expression in transitional cell carcinoma. | PubMed |
| Carcinoma | ErbB2 overexpression correlates with increased expression of vascular endothelial growth factors A, C, and D in human breast carcinoma. | PubMed |
| Carcinoma | Ets-1 messenger RNA expression is a novel marker of poor survival in ovarian carcinoma. | PubMed |
| Carcinoma | Ets-1 mRNA expression in effusions of serous ovarian carcinoma patients is a marker of poor outcome. | PubMed |
| Carcinoma | Evaluation of hypoxia-inducible factor 1alpha overexpression as a predictor of tumour recurrence and progression in superficial urothelial bladder carcinoma. | PubMed |
| Carcinoma | Evaluation of peri-operative peripheral and renal venous levels of pro- and anti-angiogenic factors and their relevance in patients with renal cell carcinoma. | PubMed |
| Carcinoma | Evaluation of plasma and tissue S100A4 protein and mRNA levels as potential markers of metastasis and prognosis in clear cell renal cell carcinoma. | PubMed |
| Carcinoma | Evaluation of serum vascular endothelial growth factor (VEGF) and microvessel density (MVD) as prognostic indicators in carcinoma breast. | PubMed |
| Carcinoma | Evaluation of the vascular endothelial growth factor (VEGF)-C role in urothelial carcinomas of the bladder. | PubMed |
| Carcinoma | Evaluation of tissue and serum VEGF in patients with head and neck carcinoma. | PubMed |
| Carcinoma | Everolimus in metastatic renal cell carcinoma patients intolerant to previous VEGFr-TKI therapy: a RECORD-1 subgroup analysis. | PubMed |
| Carcinoma | Everolimus in metastatic renal cell carcinoma: Subgroup analysis of patients with 1 or 2 previous vascular endothelial growth factor receptor-tyrosine kinase inhibitor therapies enrolled in the phase III RECORD-1 study. | PubMed |
| Carcinoma | Everolimus. | PubMed |
| Carcinoma | Exploring the peritoneal surface malignancy phenotype-a pilot immunohistochemical study of human pseudomyxoma peritonei and derived animal models. | PubMed |
| Carcinoma | Expression and biological relationship of vascular endothelial growth factor-a and matrix metalloproteinase-9 in gastric carcinoma. | PubMed |
| Carcinoma | Expression and clinical significance of hepaCAM and VEGF in urothelial carcinoma. | PubMed |
| Carcinoma | Expression and correlation of CD44v6, vascular endothelial growth factor, matrix metalloproteinase-2, and matrix metalloproteinase-9 in Krukenberg tumor. | PubMed |
| Carcinoma | Expression and role of vascular endothelial growth factor in liver regeneration after partial hepatectomy in rats. | PubMed |
| Carcinoma | Expression level of vascular endothelial growth factor receptor-2 in radical nephrectomy specimens as a prognostic predictor in patients with metastatic renal cell carcinoma treated with sunitinib. | PubMed |
| Carcinoma | Expression levels of vascular endothelial growth factor, matrix metalloproteinases 2 and 9 and tissue inhibitor of metalloproteinases 1 and 2 in the plasma of patients with ovarian carcinoma. | PubMed |
| Carcinoma | Expression of angiogenesis-related genes in ovarian carcinoma--a clinicopathologic study. | PubMed |
| Carcinoma | Expression of angiogenic chemokines in ovarian clear cell carcinoma. | PubMed |
| Carcinoma | Expression of angiogenic factors and apoptotic factors in leiomyosarcoma and leiomyoma. | PubMed |
| Carcinoma | Expression of angiogenic factors, basic fibroblast growth factor and vascular endothelial growth factor, in human biliary tract carcinoma cell lines. | PubMed |
| Carcinoma | Expression of angiostatic platelet factor-4var/CXCL4L1 counterbalances angiogenic impulses of vascular endothelial growth factor, interleukin-8/CXCL8, and stromal cell-derived factor 1/CXCL12 in esophageal and colorectal cancer. | PubMed |
| Carcinoma | Expression of basic fibroblast growth factor, vascular endothelial growth factor, and thrombospondin-1 related to microvessel density in nonaggressive and aggressive basal cell carcinomas. | PubMed |
| Carcinoma | Expression of cyclooxygenase-2 in advanced stage ovarian serous carcinoma: correlation with tumor cell proliferation, apoptosis, angiogenesis, and survival. | PubMed |
| Carcinoma | Expression of cyclooxygenase-2 in primary and remnant gastric carcinoma: comparing it with p53 accumulation, Helicobacter pylori infection, and vascular endothelial growth factor expression. | PubMed |
| Carcinoma | Expression of cyclooxygenase-2, vascular endothelial growth factor and matrix metalloproteinase-2 in patients with primary laryngeal carcinoma: a tissue microarray study. | PubMed |
| Carcinoma | Expression of endocrine gland-derived vascular endothelial growth factor in ovarian carcinoma. | PubMed |
| Carcinoma | Expression of endothelial nitric oxide synthase and vascular endothelial growth factor in oral squamous cell carcinoma: its correlation with angiogenesis and disease progression. | PubMed |
| Carcinoma | Expression of Ets-1 in human clear cell renal cell carcinomas: implications for angiogenesis. | PubMed |
| Carcinoma | Expression of growth factors, growth inhibiting factors, and their receptors in invasive breast cancer. I: An inventory in search of autocrine and paracrine loops. | PubMed |
| Carcinoma | Expression of hypoxia-inducible factor (HIF)-1alpha and vascular endothelial growth factor (VEGF)-D as outcome predictors in resected esophageal squamous cell carcinoma. | PubMed |
| Carcinoma | Expression of hypoxia-inducible factor (HIF)-1alpha is associated with vascular endothelial growth factor expression and tumour angiogenesis in human oesophageal squamous cell carcinoma. | PubMed |
| Carcinoma | Expression of hypoxia-inducible factor (HIF-1alpha), VEGF-C and VEGF-D in non-invasive and invasive breast ductal carcinomas. | PubMed |
| Carcinoma | Expression of hypoxia-inducible factor-1alpha in esophageal squamous cell carcinoma. | PubMed |
| Carcinoma | Expression of inducible nitric oxide synthase is significantly correlated with expression of vascular endothelial growth factor and dendritic cell infiltration in patients with advanced gastric carcinoma. | PubMed |
| Carcinoma | Expression of interleukin-8, heme oxygenase-1 and vascular endothelial growth factor in DLD-1 colon carcinoma cells exposed to pyrrolidine dithiocarbamate. | PubMed |
| Carcinoma | Expression of liver-type fatty-acid-binding protein, fatty acid synthase and vascular endothelial growth factor in human lung carcinoma. | PubMed |
| Carcinoma | Expression of Livin and vascular endothelial growth factor in different clinical stages of human esophageal carcinoma. | PubMed |
| Carcinoma | Expression of matrix metalloproteinase-9 mRNA and vascular endothelial growth factor protein in gastric carcinoma and its relationship to its pathological features and prognosis. | PubMed |
| Carcinoma | Expression of p53 oncoprotein increases intratumoral microvessel formation in human salivary gland carcinomas. | PubMed |
| Carcinoma | Expression of p53 protein in esophageal squamous cell carcinoma: relation to hypoxia-inducible factor-1alpha, angiogenesis and apoptosis. | PubMed |
| Carcinoma | Expression of PC cell-derived growth factor and vascular endothelial growth factor in esophageal squamous cell carcinoma and their clinicopathologic significance. | PubMed |
| Carcinoma | Expression of proinflammatory and proangiogenic cytokines in patients with head and neck cancer. | PubMed |
| Carcinoma | Expression of semaphorins, vascular endothelial growth factor, and their common receptor neuropilins and alleic loss of semaphorin locus in epithelial ovarian neoplasms: increased ratio of vascular endothelial growth factor to semaphorin is a poor prognostic factor in ovarian carcinomas. | PubMed |
| Carcinoma | Expression of the pro-angiogenic factors vascular endothelial growth factor and interleukin-8/CXCL8 by human breast carcinomas is responsive to nutrient deprivation and endoplasmic reticulum stress. | PubMed |
| Carcinoma | Expression of the vascular endothelial growth factor receptor-2/Flk-1 in breast carcinomas: correlation with proliferation. | PubMed |
| Carcinoma | Expression of the von Hippel-Lindau Tumor Suppressor Gene in Nonneoplastic and Neoplastic Lesions of the Thyroid. | PubMed |
| Carcinoma | Expression of Tumor-Derived Vascular Endothelial Growth Factor and Its Receptors Is Associated With Outcome in Early Squamous Cell Carcinoma of the Lung. | PubMed |
| Carcinoma | Expression of vascular endothelial growth factor (VEGF) and association with microvessel density in small-cell and non-small-cell lung carcinomas. | PubMed |
| Carcinoma | Expression of vascular endothelial growth factor (VEGF) and its receptors (Flt-1 and Flk-1) in esophageal squamous cell carcinoma. | PubMed |
| Carcinoma | Expression of vascular endothelial growth factor (VEGF) and its receptors in thyroid carcinomas of follicular origin: a potential autocrine loop. | PubMed |
| Carcinoma | Expression of vascular endothelial growth factor (VEGF) and its two receptors (VEGF-R1-Flt1 and VEGF-R2-Flk1/KDR) in non-small cell lung carcinomas (NSCLCs): correlation with angiogenesis and survival. | PubMed |
| Carcinoma | Expression of vascular endothelial growth factor (VEGF) in normal oral mucosa, oral dysplasia and oral squamous cell carcinoma. | PubMed |
| Carcinoma | Expression of vascular endothelial growth factor (VEGF)-C and -D in gastric carcinoma. | PubMed |
| Carcinoma | Expression of vascular endothelial growth factor (VEGF)-C and VEGF-D in early gastric carcinoma: correlation with clinicopathological parameters. | PubMed |
| Carcinoma | Expression of vascular endothelial growth factor (VEGF)-C in preoperative biopsy specimens and metastatic foci of regional lymph nodes in submucosal gastric carcinoma. | PubMed |
| Carcinoma | Expression of vascular endothelial growth factor (VEGF)-D and its receptor, VEGF receptor 3, as a prognostic factor in endometrial carcinoma. | PubMed |
| Carcinoma | Expression of vascular endothelial growth factor A, B, C, and D in oral squamous cell carcinoma. | PubMed |
| Carcinoma | Expression of vascular endothelial growth factor and angiogenesis in gastrointestinal stromal tumor of the stomach. | PubMed |
| Carcinoma | Expression of vascular endothelial growth factor and basic fibroblast growth factor receptors in lung cancer. | PubMed |
| Carcinoma | Expression of vascular endothelial growth factor and cyclooxygenase-2 in laryngeal squamous cell carcinoma and its significance. | PubMed |
| Carcinoma | Expression of vascular endothelial growth factor and E26 transformation-specific-1 in breast carcinoma. | PubMed |
| Carcinoma | Expression of vascular endothelial growth factor and its receptors flt and KDR in ovarian carcinoma. | PubMed |
| Carcinoma | Expression of vascular endothelial growth factor and its receptors KDR and Flt-1 in gastric cancer cells. | PubMed |
| Carcinoma | Expression of vascular endothelial growth factor and its role in oncogenesis of human gastric carcinoma. | PubMed |
| Carcinoma | Expression of vascular endothelial growth factor and p53 in pancreatic carcinomas. | PubMed |
| Carcinoma | Expression of vascular endothelial growth factor and prognosis of oral squamous cell carcinoma. | PubMed |
| Carcinoma | Expression of vascular endothelial growth factor and receptor flk-1 in colon cancer liver metastases. | PubMed |
| Carcinoma | Expression of vascular endothelial growth factor and vascular endothelial growth factor receptors 1 and 2 in invasive breast carcinoma: prognostic significance and relationship with markers for aggressiveness. | PubMed |
| Carcinoma | Expression of vascular endothelial growth factor as a prognostic factor in node-positive squamous cell carcinoma in the thoracic esophagus: long-term follow-up study. | PubMed |
| Carcinoma | Expression of vascular endothelial growth factor by macrophages is up-regulated in poorly vascularized areas of breast carcinomas. | PubMed |
| Carcinoma | Expression of vascular endothelial growth factor by photodynamic therapy with mono-L-aspartyl chlorin e6 (NPe6) in oral squamous cell carcinoma. | PubMed |
| Carcinoma | Expression of vascular endothelial growth factor C and chemokine receptor CCR7 in gastric carcinoma and their values in predicting lymph node metastasis. | PubMed |
| Carcinoma | Expression of vascular endothelial growth factor C and D (VEGF-C and -D) is an important risk factor for lymphatic metastasis in undifferentiated early gastric carcinoma. | PubMed |
| Carcinoma | Expression of vascular endothelial growth factor C correlates with a poor prognosis based on analysis of prognostic factors in patients with cervical carcinomas. | PubMed |
| Carcinoma | Expression of vascular endothelial growth factor C correlates with lymphatic vessel density and prognosis in human gastroesophageal junction carcinoma. | PubMed |
| Carcinoma | Expression of vascular endothelial growth factor correlates with hematogenous recurrence in gastric carcinoma. | PubMed |
| Carcinoma | Expression of vascular endothelial growth factor D is associated with hypoxia inducible factor (HIF-1alpha) and the HIF-1alpha target gene DEC1, but not lymph node metastasis in primary human breast carcinomas. | PubMed |
| Carcinoma | Expression of vascular endothelial growth factor D is associated with lymph node metastasis in human colorectal carcinoma. | PubMed |
| Carcinoma | Expression of vascular endothelial growth factor family members in head and neck squamous cell carcinoma correlates with lymph node metastasis. | PubMed |
| Carcinoma | Expression of vascular endothelial growth factor gene and its receptor (flt-1) gene in urinary bladder cancer. | PubMed |
| Carcinoma | Expression of vascular endothelial growth factor in basal cell carcinoma and cutaneous squamous cell carcinoma of the head and neck. | PubMed |
| Carcinoma | Expression of vascular endothelial growth factor in basal cell tumours and in squamous cell carcinomas of canine skin. | PubMed |
| Carcinoma | Expression of Vascular Endothelial Growth Factor in Canine Inflammatory and Non-inflammatory Mammary Carcinoma. | PubMed |
| Carcinoma | Expression of vascular endothelial growth factor in human gallbladder lesions. | PubMed |
| Carcinoma | Expression of vascular endothelial growth factor in human gastric carcinomas. | PubMed |
| Carcinoma | Expression of vascular endothelial growth factor in human oral squamous cell carcinoma: its association with tumour progression and p53 gene status. | PubMed |
| Carcinoma | Expression of vascular endothelial growth factor in renal cell carcinoma and the relation to angiogenesis and p53 protein expression. | PubMed |
| Carcinoma | Expression of vascular endothelial growth factor in renal cell carcinoma is correlated with cancer advancement. | PubMed |
| Carcinoma | Expression of vascular endothelial growth factor in renal cell carcinomas. | PubMed |
| Carcinoma | Expression of vascular endothelial growth factor in salivary gland carcinomas and its relation to p53, Ki-67 and prognosis. | PubMed |
| Carcinoma | Expression of vascular endothelial growth factor in salivary gland carcinomas correlates with lymph node metastasis. | PubMed |
| Carcinoma | Expression of vascular endothelial growth factor in thoracic sarcomas. | PubMed |
| Carcinoma | Expression of vascular endothelial growth factor induces an invasive phenotype in human squamous cell carcinomas. | PubMed |
| Carcinoma | Expression of vascular endothelial growth factor is significantly associated with progression and prognosis of oral squamous cell carcinomas in Taiwan. | PubMed |
| Carcinoma | Expression of vascular endothelial growth factor mRNA in non-small-cell lung carcinomas. | PubMed |
| Carcinoma | Expression of vascular endothelial growth factor protein in human renal cell carcinoma. | PubMed, PubMed |
| Carcinoma | Expression of vascular endothelial growth factor receptor-2 in Merkel cell carcinoma. | PubMed |
| Carcinoma | Expression of vascular endothelial growth factor receptor-3 by lymphatic endothelial cells is associated with lymph node metastasis in prostate cancer. | PubMed |
| Carcinoma | Expression of vascular endothelial growth factor receptors on tumor cells in head and neck squamous cell carcinoma. | PubMed |
| Carcinoma | Expression of vascular endothelial growth factor, its receptor, and other angiogenic factors in human breast cancer. | PubMed |
| Carcinoma | Expression of vascular endothelial growth factor, receptor KDR and p53 protein in transitional cell carcinoma of the bladder. | PubMed |
| Carcinoma | Expression of vascular endothelial growth factors A and C in human pancreatic cancer. | PubMed |
| Carcinoma | Expression of VEGF in Urinary Bladder Transitional Cell Carcinoma in an Iraqi Population Subjected to Depleted Uranium: An Immunohistochemical Study. | PubMed |
| Carcinoma | Expression of VEGF, HGF, IL-6, IL-8, MMP-9, Telomerase in Peripheral Blood of Patients with Head and Neck Squamous Cell Carcinoma. | PubMed |
| Carcinoma | Expression of VEGF-A/C, VEGF-R2, PDGF-alpha/beta, c-kit, EGFR, Her-2/Neu, Mcl-1 and Bmi-1 in Merkel cell carcinoma. | PubMed |
| Carcinoma | Expression of VEGF-C and VEGF-D at the invasive edge correlates with lymph node metastasis and prognosis of patients with colorectal carcinoma. | PubMed |
| Carcinoma | Expression pattern of vascular endothelial growth factor isoform is closely correlated with tumour stage and vascularisation in renal cell carcinoma. | PubMed |
| Carcinoma | Expressional evaluation of vascular endothelial growth factor (VEGF) protein in urinary bladder carcinoma patients exposed to cigarette smoke. | PubMed |
| Carcinoma | Expressions of nuclear factor kappaB, inducible nitric oxide synthase, and vascular endothelial growth factor in adenoid cystic carcinoma of salivary glands: correlations with the angiogenesis and clinical outcome. | PubMed |
| Carcinoma | Expressions of thymidine phosphorylase (dThdPase) and vascular endothelial growth factor on angiogenesis in intestinal-type gastric carcinoma. | PubMed |
| Carcinoma | Extracellular signal-regulated kinase activation is required for up-regulation of vascular endothelial growth factor by serum starvation in human colon carcinoma cells. | PubMed |
| Carcinoma | Frequent overexpression of vascular endothelial growth factor gene in human renal cell carcinoma. | PubMed |
| Carcinoma | From gene delivery to gene silencing: plasmid DNA-transfecting cationic lipid 1,3-dimyristoylamidopropane-2-[bis(2-dimethylaminoethane)] carbamate efficiently promotes small interfering RNA-induced RNA interference. | PubMed |
| Carcinoma | Functional vascular endothelial growth factor -2578 C/A polymorphism in relation to nasopharyngeal carcinoma risk and tumor progression. | PubMed |
| Carcinoma | Generation of a syngeneic mouse model to study the effects of vascular endothelial growth factor in ovarian carcinoma. | PubMed |
| Carcinoma | Genome-wide expression analysis using microarray identified complex signaling pathways modulated by hypoxia in nasopharyngeal carcinoma. | PubMed |
| Carcinoma | Glucose deprivation increases mRNA stability of vascular endothelial growth factor through activation of AMP-activated protein kinase in DU145 prostate carcinoma. | PubMed |
| Carcinoma | Gonadotropin-regulated lymphangiogenesis in ovarian cancer is mediated by LEDGF-induced expression of VEGF-C. | PubMed |
| Carcinoma | Helicobacter pylori infection influences expression of genes related to angiogenesis and invasion in human gastric carcinoma cells. | PubMed |
| Carcinoma | Heme oxygenase-1 promotes angiogenesis in urothelial carcinoma of the urinary bladder. | PubMed |
| Carcinoma | Heparin octasaccharides inhibit angiogenesis in vivo. | PubMed |
| Carcinoma | Hepatocyte growth factor-stimulated renal tubular mitogenesis: effects on expression of c-myc, c-fos, c-met, VEGF and the VHL tumour-suppressor and related genes. | PubMed |
| Carcinoma | Hepatocyte growth factor/scatter factor differentially regulates expression of proangiogenic factors through Egr-1 in head and neck squamous cell carcinoma. | PubMed |
| Carcinoma | Hepatocyte growth factor/scatter factor-induced activation of MEK and PI3K signal pathways contributes to expression of proangiogenic cytokines interleukin-8 and vascular endothelial growth factor in head and neck squamous cell carcinoma. | PubMed |
| Carcinoma | High dose intermittent sorafenib shows improved efficacy over conventional continuous dose in renal cell carcinoma. | PubMed |
| Carcinoma | High expression of CD105 as a prognostic predictor of early tongue cancer. | PubMed |
| Carcinoma | Histochemical study of vascular endothelial growth factor in squamous cell carcinoma of the esophagus. | PubMed |
| Carcinoma | Histopathological analysis of angiogenic factors in renal cell carcinoma. | PubMed |
| Carcinoma | Host A(2B) adenosine receptors promote carcinoma growth. | PubMed |
| Carcinoma | Human head and neck squamous cell carcinoma cells are both targets and effectors for the angiogenic cytokine, VEGF. | PubMed |
| Carcinoma | Human oral squamous cell carcinoma cell lines promote angiogenesis via expression of vascular endothelial growth factor and upregulation of KDR/flk-1 expression in endothelial cells. | PubMed |
| Carcinoma | Hypertension as a potential biomarker of efficacy in patients with gastrointestinal stromal tumor treated with sunitinib. | PubMed |
| Carcinoma | Hypertension management in patients with renal cell cancer treated with anti-angiogenic agents. | PubMed |
| Carcinoma | Hypothyroidism in patients with metastatic renal cell carcinoma treated with sunitinib. | PubMed |
| Carcinoma | Hypoxia and vascular endothelial growth factor expression in human squamous cell carcinomas using pimonidazole as a hypoxia marker. | PubMed |
| Carcinoma | Hypoxia correlates with angiogenesis in cervical cancers. | PubMed |
| Carcinoma | Hypoxia inducible factor-1 alpha and vascular endothelial growth factor in biopsies of small cell lung carcinoma. | PubMed |
| Carcinoma | Hypoxia Inducible Factor-1alpha and Vascular Endothelial Growth Factor Expression are Associated with a Poor Prognosis in Patients with Nasopharyngeal Carcinoma Receiving Radiotherapy with Carbogen and Nicotinamide. | PubMed |
| Carcinoma | Hypoxia inducible factor-1alpha correlates with vascular endothelial growth factor A and C indicating worse prognosis in clear cell renal cell carcinoma. | PubMed |
| Carcinoma | Hypoxia regulation of expression and angiogenic effects of vasoactive intestinal peptide (VIP) and VIP receptors in LNCaP prostate cancer cells. | PubMed |
| Carcinoma | Hypoxia-induced activation of p38 mitogen-activated protein kinase and phosphatidylinositol 3'-kinase signaling pathways contributes to expression of interleukin 8 in human ovarian carcinoma cells. | PubMed |
| Carcinoma | Hypoxia-induced angiogenesis of cultured human salivary gland carcinoma cells enhances vascular endothelial growth factor production and basic fibroblast growth factor release. | PubMed |
| Carcinoma | Hypoxia-induced epithelial VEGF-C/VEGFR-3 upregulation in carcinoma cell lines. | PubMed |
| Carcinoma | Hypoxia-induced tumor angiogenic pathway in head and neck cancer: an in vivo study. | PubMed |
| Carcinoma | Hypoxia-induced vascular endothelial growth factor transcription and protection from apoptosis are dependent on alpha6beta1 integrin in breast carcinoma cells. | PubMed |
| Carcinoma | IGF-1 induced vascular endothelial growth factor secretion in head and neck squamous cell carcinoma. | PubMed |
| Carcinoma | Imaging of highly malignant osteosarcoma with iodine-123-vascular endothelial growth factor. | PubMed |
| Carcinoma | Immunohistochemical expression of hypoxia inducible factor-1alpha and its downstream molecules in sarcomatoid renal cell carcinoma. | PubMed |
| Carcinoma | Immunohistochemical expression of vascular endothelial growth factor (VEGF) does not correlate with microvessel density in renal cell carcinoma. | PubMed |
| Carcinoma | Immunohistochemical expression of vascular endothelial growth factor (VEGF) in intestinal type gastric carcinoma. | PubMed |
| Carcinoma | Immunohistochemical expression of vascular endothelial growth factor and its correlation with tumor grade in breast ductal carcinoma. | PubMed |
| Carcinoma | Immunohistochemical expression of vascular endothelial growth factor and vascular endothelial growth factor receptor associated with tumor cell proliferation in canine cutaneous squamous cell carcinomas and trichoepitheliomas. | PubMed |
| Carcinoma | Immunohistochemical expression of vascular endothelial growth factor correlates with positive surgical margins and recurrence in T1 and T2 squamous cell carcinoma (SCC) of the lower lip. | PubMed |
| Carcinoma | Immunohistochemical study of VEGF expression in oral squamous cell carcinomas: correlation with the mTOR-HIF-1? pathway. | PubMed |
| Carcinoma | Immunolocalization of VEGF, VEGF receptors, EGF-R and Ki-67 in leiomyoma, cellular leiomyoma and leiomyosarcoma. | PubMed |
| Carcinoma | Implication of vascular endothelial growth factor and p53 status for angiogenesis in noninvasive colorectal carcinoma. | PubMed |
| Carcinoma | In oesophageal squamous cell carcinoma vascular endothelial growth factor is associated with p53 mutation, advanced stage and poor prognosis. | PubMed |
| Carcinoma | Inactivation of the PTEN gene protein product is associated with the invasiveness and metastasis, but not angiogenesis, of breast cancer. | PubMed |
| Carcinoma | Increased expression of vascular endothelial growth factor in human hepatocellular carcinoma. | PubMed |
| Carcinoma | Increased hemoglobin associated with VEGF inhibitors in advanced renal cell carcinoma. | PubMed |
| Carcinoma | Increased serum levels of vascular endothelial growth factor in patients with renal cell carcinoma. | PubMed |
| Carcinoma | Independent expression of serum vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF) in patients with carcinoma and sarcoma. | PubMed |
| Carcinoma | Indirect treatment comparison of bevacizumab + interferon-?-2a vs tyrosine kinase inhibitors in first-line metastatic renal cell carcinoma therapy. | PubMed |
| Carcinoma | Inducible nitric oxide synthase expression in various laryngeal lesions in relation to carcinogenesis, angiogenesis, and patients' prognosis. | PubMed |
| Carcinoma | Induction by carbon-ion irradiation of the expression of vascular endothelial growth factor in lung carcinoma cells. | PubMed |
| Carcinoma | Induction of cyclooxygenase-2 by Epstein-Barr virus latent membrane protein 1 is involved in vascular endothelial growth factor production in nasopharyngeal carcinoma cells. | PubMed |
| Carcinoma | Induction of vascular endothelial growth factor receptor-3 expression on tumor microvasculature as a new progression marker in human cutaneous melanoma. | PubMed |
| Carcinoma | Influence of angiogenetic factors and matrix metalloproteinases upon tumour progression in non-small-cell lung cancer. | PubMed |
| Carcinoma | Inhibition of activator protein 1 activation, vascular endothelial growth factor, and cyclooxygenase-2 expression by 15-deoxy-Delta12,14-prostaglandin J2 in colon carcinoma cells: evidence for a redox-sensitive peroxisome proliferator-activated receptor-gamma-independent mechanism. | PubMed |
| Carcinoma | Inhibition of breast carcinoma and trophoblast cell invasiveness by vascular endothelial growth factor. | PubMed |
| Carcinoma | Inhibition of growth and metastasis of human pancreatic cancer growing in nude mice by PTK 787/ZK222584, an inhibitor of the vascular endothelial growth factor receptor tyrosine kinases. | PubMed |
| Carcinoma | Inhibition of growth and metastasis of ovarian carcinoma by administering a drug capable of interfering with vascular endothelial growth factor activity. | PubMed |
| Carcinoma | Inhibition of renal cell carcinoma angiogenesis and growth by antisense oligonucleotides targeting vascular endothelial growth factor. | PubMed |
| Carcinoma | Inhibition of Src kinase activity by Ad-mda7 suppresses vascular endothelial growth factor expression in prostate carcinoma cells. | PubMed |
| Carcinoma | Inhibition of the mammary carcinoma angiogenic switch in C3(1)/SV40 transgenic mice by a mutated form of human endostatin. | PubMed |
| Carcinoma | Inhibition of the renin-angiotensin system downregulates tissue factor and vascular endothelial growth factor in human breast carcinoma cells. | PubMed |
| Carcinoma | Inhibition of the VEGF expression and cell growth in hepatocellular carcinoma by blocking HIF-1alpha and Smad3 binding site in VEGF promoter. | PubMed |
| Carcinoma | Inhibition of VEGF mRNA by 2'-O,4'-C-ethylene-bridged nucleic acids (ENA) antisense oligonucleotides and their influence on off-target gene expressions. | PubMed |
| Carcinoma | Inhibition of VEGF-dependent multistage carcinogenesis by soluble EphA receptors. | PubMed |
| Carcinoma | Inhibitory effect on expression of angiogenic factors by antiangiogenic agents in renal cell carcinoma. | PubMed |
| Carcinoma | Insulin-like growth factor binding protein-3 suppresses vascular endothelial growth factor expression and tumor angiogenesis in head and neck squamous cell carcinoma. | PubMed |
| Carcinoma | Integrin (alpha 6 beta 4) regulation of eIF-4E activity and VEGF translation: a survival mechanism for carcinoma cells. | PubMed |
| Carcinoma | Interleukin 8 and vascular endothelial growth factor -- prognostic factors in human gastric carcinomas? | PubMed |
| Carcinoma | Interleukin-6 and vascular endothelial growth factor release by renal cell carcinoma cells impedes lymphocyte-dendritic cell cross-talk. | PubMed |
| Carcinoma | Interleukin-6 increases vascular endothelial growth factor and angiogenesis in gastric carcinoma. | PubMed |
| Carcinoma | Interleukin-6, interleukin-10, and vascular endothelial growth factor in metastatic renal cell carcinoma: prognostic value of interleukin-6--from the Groupe Francais d'Immunotherapie. | PubMed |
| Carcinoma | Interleukin-8 and vascular endothelial growth factor mRNA and protein levels are down-regulated in ovarian carcinoma cells in serous effusions. | PubMed |
| Carcinoma | Interrelationships between microvessel density, expression of VEGF and resistance to doxorubicin of non-small lung cell carcinoma. | PubMed |
| Carcinoma | Intracellular siRNA delivery system using polyelectrolyte complex micelles prepared from VEGF siRNA-PEG conjugate and cationic fusogenic peptide. | PubMed |
| Carcinoma | Intratumoral c-Met expression is associated with vascular endothelial growth factor C expression, lymphangiogenesis, and lymph node metastasis in oral squamous cell carcinoma: implications for use as a prognostic marker. | PubMed |
| Carcinoma | Intratumoral lymphangiogenesis of esophageal squamous cell carcinoma and relationship with regulatory factors and prognosis. | PubMed |
| Carcinoma | Intratumoral lymphatics and lymphatic vessel invasion detected by d2-40 are essential for lymph node metastasis in bladder transitional cell carcinoma. | PubMed |
| Carcinoma | Intratumoral neovascularization and growth pattern in early gastric carcinoma. | PubMed |
| Carcinoma | Inverse regulation of vascular endothelial growth factor and VHL tumor suppressor gene in sporadic renal cell carcinomas is correlated with vascular growth: an in vivo study on 29 tumors. | PubMed |
| Carcinoma | Involvement of BH4 domain of bcl-2 in the regulation of HIF-1-mediated VEGF expression in hypoxic tumor cells. | PubMed |
| Carcinoma | Involvement of inactive GSK3beta overexpression in tumorigenesis and progression of gastric carcinomas. | PubMed |
| Carcinoma | Irradiation-induced regulation of plasminogen activator inhibitor type-1 and vascular endothelial growth factor in six human squamous cell carcinoma lines of the head and neck. | PubMed |
| Carcinoma | JAK2/STAT3 signaling pathway activation mediates tumor angiogenesis by upregulation of VEGF and bFGF in non-small-cell lung cancer. | PubMed |
| Carcinoma | Kallikrein-binding protein inhibits growth of gastric carcinoma by reducing vascular endothelial growth factor production and angiogenesis. | PubMed |
| Carcinoma | Kidney injury during VEGF inhibitor therapy. | PubMed |
| Carcinoma | Kinase inhibitors in the treatment of renal cell carcinoma. | PubMed |
| Carcinoma | Levels and patterns of expression of hypoxia-inducible factor-1?, vascular endothelial growth factor, glucose transporter-1 and CD105 in adenoid cystic carcinomas with high-grade transformation. | PubMed |
| Carcinoma | Linomide blocks angiogenesis by breast carcinoma vascular endothelial growth factor transfectants. | PubMed |
| Carcinoma | Liposomal honokiol inhibits VEGF-D-induced lymphangiogenesis and metastasis in xenograft tumor model. | PubMed |
| Carcinoma | Loss of expression of TIMP3 in clear cell renal cell carcinoma. | PubMed |
| Carcinoma | Loss of ovarian function promotes angiogenesis in human ovarian carcinoma. | PubMed |
| Carcinoma | Loss of p16INK4a expression is associated with vascular endothelial growth factor expression in squamous cell carcinoma of the esophagus. | PubMed |
| Carcinoma | Lymphangiogenesis in human gynaecological cancers. | PubMed |
| Carcinoma | Lymphangiogenesis in kidney cancer: expression of VEGF-C, VEGF-D and VEGFR-3 in clear cell and papillary renal cell carcinoma. | PubMed |
| Carcinoma | Lymphangiogenesis induced by VEGF-C and VEGF-D promotes metastasis and a poor outcome in breast carcinoma: a retrospective study of 61 cases. | PubMed |
| Carcinoma | Lymphatic dissemination of tumour cells and the formation of micrometastases. | PubMed |
| Carcinoma | Lymphatic vessel density as a predictor of lymph node metastasis and its relationship with prognosis in urothelial carcinoma of the bladder. | PubMed |
| Carcinoma | Lymphatic Vessels and High Endothelial Venules are Increased in the Sentinel Lymph Nodes of Patients with Oral Squamous Cell Carcinoma Before the Arrival of Tumor Cells. | PubMed |
| Carcinoma | Lymphatic vessels and related factors in adenoid cystic carcinoma of the salivary gland. | PubMed |
| Carcinoma | Mammary carcinoma cells over-expressing tissue inhibitor of metalloproteinases-1 show enhanced vascular endothelial growth factor expression. | PubMed |
| Carcinoma | Management of side effects associated with sunitinib therapy for patients with renal cell carcinoma. | PubMed |
| Carcinoma | Manganese (II) induces chemical hypoxia by inhibiting HIF-prolyl hydroxylase: implication in manganese-induced pulmonary inflammation. | PubMed |
| Carcinoma | Manganese (II) induces chemical hypoxia by inhibiting HIF-prolyl hydroxylase: Implication in manganese-induced pulmonary inflammation. | PubMed |
| Carcinoma | Markedly increased amounts of messenger RNAs for vascular endothelial growth factor and placenta growth factor in renal cell carcinoma associated with angiogenesis. | PubMed |
| Carcinoma | Maspin expression in renal cell carcinoma and its correlation with clinicopathologic parameters. | PubMed |
| Carcinoma | Mast cells and cutaneous malignancies. | PubMed |
| Carcinoma | Mast cells correlate with angiogenesis and poor outcome in stage I lung adenocarcinoma. | PubMed |
| Carcinoma | Matrix metalloproteinase expression in the recurrence of superficial low grade bladder transitional cell carcinoma. | PubMed |
| Carcinoma | Matrix metalloproteinases (MMP9 and MMP2) induce the release of vascular endothelial growth factor (VEGF) by ovarian carcinoma cells: implications for ascites formation. | PubMed |
| Carcinoma | Mediastinal lymphangiomatosis coexisting with occult thymic carcinoma. | PubMed |
| Carcinoma | Mesenchymal stem cell transition to tumor-associated fibroblasts contributes to fibrovascular network expansion and tumor progression. | PubMed |
| Carcinoma | Metastatic clear cell carcinoma of the kidney: therapeutic role of bevacizumab. | PubMed |
| Carcinoma | Metastatic renal cell carcinoma: many treatment options, one patient. | PubMed |
| Carcinoma | Microvascular density and vascular endothelial growth factor immunoreactivity as predictors of regional lymph node metastasis from betel-associated oral squamous cell carcinoma. | PubMed |
| Carcinoma | Microvessel density (MVD) and vascular endothelial growth factor expression (VEGF) in human oral squamous cell carcinoma. | PubMed |
| Carcinoma | Microvessel density and expression of vascular endothelial growth factor, basic fibroblast growth factor, and platelet-derived endothelial growth factor in oral squamous cell carcinomas. | PubMed |
| Carcinoma | Microvessel density and vascular endothelial growth factor expression in infiltrating lobular mammary carcinoma. | PubMed |
| Carcinoma | Microvessel morphology and vascular endothelial growth factor expression in human colonic carcinoma with or without metastasis. | PubMed |
| Carcinoma | MiR-126 restoration down-regulate VEGF and inhibit the growth of lung cancer cell lines in vitro and in vivo. | PubMed |
| Carcinoma | Modulation of angiogenesis-related proteins synthesis by sodium butyrate in colon cancer cell line HT29. | PubMed |
| Carcinoma | Modulation of cellular invasion by VEGF-C expression in squamous cell carcinoma of the head and neck. | PubMed |
| Carcinoma | Molecular marker expression in oral and oropharyngeal squamous cell carcinoma. | PubMed |
| Carcinoma | Molecularly targeted therapy in renal cell carcinoma: where do we go from here? | PubMed |
| Carcinoma | Monitoring Anti-Angiogenic Therapy in Colorectal Cancer Murine Model using Dynamic Contrast-Enhanced MRI - Comparing Pixel-by-Pixel with Region of Interest Analysis. | PubMed |
| Carcinoma | Monocyte chemoattractant protein-1 expression correlates with macrophage infiltration and tumor vascularity in human esophageal squamous cell carcinomas. | PubMed |
| Carcinoma | Mucinous colon carcinomas with microsatellite instability have a lower microvessel density and lower vascular endothelial growth factor expression. | PubMed |
| Carcinoma | Neoadjuvant multidrug chemotherapy including high-dose methotrexate modifies VEGF expression in osteosarcoma: an immunohistochemical analysis. | PubMed |
| Carcinoma | Neoangiogenesis and relationship to nuclear p53 accumulation and vascular endothelial growth factor expression in advanced gastric carcinoma. | PubMed |
| Carcinoma | Neoangiogenesis in patients with gastric carcinoma in relation to the expression of vascular endothelial growth factor and thymidine phosphorylase. | PubMed |
| Carcinoma | Nerve growth factor and vascular endothelial growth factor: retrospective analysis of 63 patients with salivary adenoid cystic carcinoma. | PubMed |
| Carcinoma | New advancements and developments in treatment of renal cell carcinoma: focus on pazopanib. | PubMed |
| Carcinoma | Nitric oxide synthase II gene disruption: implications for tumor growth and vascular endothelial growth factor production. | PubMed |
| Carcinoma | Nitric oxide synthase, cyclooxygenase 2, and vascular endothelial growth factor in the angiogenesis of non-small cell lung carcinoma. | PubMed |
| Carcinoma | No association between serum levels of insulin-like growth factor-I, vascular endothelial growth factor, prolactin and clinicopathological characteristics of breast carcinoma after surgery. | PubMed |
| Carcinoma | Non-angiogenic functions of VEGF in breast cancer. | PubMed |
| Carcinoma | Non-clear cell renal cancer: features and medical management. | PubMed |
| Carcinoma | Norepinephrine up-regulates the expression of vascular endothelial growth factor, matrix metalloproteinase (MMP)-2, and MMP-9 in nasopharyngeal carcinoma tumor cells. | PubMed |
| Carcinoma | Normalization of the Ovarian Cancer Microenvironment by SPARC. | PubMed |
| Carcinoma | Notice of retraction: 'Therapy targeted at vascular endothelial growth factor in metastatic renal cell carcinoma: biology, clinical results and future development' (BJUI, Volume 96, Issue 3, pages 286 – 290). | PubMed |
| Carcinoma | Novel antiangiogenic therapies for renal cell cancer. | PubMed |
| Carcinoma | Novel anticancer agents in clinical trials for well-differentiated neuroendocrine tumors. | PubMed |
| Carcinoma | Oral Squamous Cell Carcinoma From Users and Nonusers of Tobacco and Alcohol: Clinicopathologic Features and Immunoreactivity of VEGF, Caspase-3, and P53. | PubMed |
| Carcinoma | Ovarian carcinoma cells and IL-1beta-activated human peritoneal mesothelial cells are possible sources of vascular endothelial growth factor in inflammatory and malignant peritoneal effusions. | PubMed |
| Carcinoma | Ovarian carcinoma cells effectively inhibit differentiation and maturation of dendritic cells derived from hematopoietic progenitor cells in vitro. | PubMed |
| Carcinoma | Ovarian serous carcinoma: relationship of p53 and bcl-2 with tumor angiogenesis and VEGF expression. | PubMed |
| Carcinoma | Over-expression of vascular endothelial growth factor after preoperative radiation therapy for rectal cancer. | PubMed |
| Carcinoma | Overexpression and Interactions of Interleukin-10, Transforming Growth Factor beta, and Vascular Endothelial Growth Factor in Esophageal Squamous Cell Carcinoma. | PubMed |
| Carcinoma | Overexpression of c-H-ras p21 is correlated with vascular endothelial growth factor expression and neovascularization in advanced gastric carcinoma. | PubMed |
| Carcinoma | Overexpression of Her-2/NEU in epithelial ovarian carcinoma induces vascular endothelial growth factor C by activating NF-kappa B: implications for malignant ascites formation and tumor lymphangiogenesis. | PubMed |
| Carcinoma | Overexpression of human papillomavirus type 16 oncoproteins enhances hypoxia-inducible factor 1 alpha protein accumulation and vascular endothelial growth factor expression in human cervical carcinoma cells. | PubMed |
| Carcinoma | Overexpression of Phosphorylated 4E-BP1 Predicts for Tumor Recurrence and Reduced Survival in Cervical Carcinoma Treated with Postoperative Radiotherapy. | PubMed |
| Carcinoma | Overexpression of the prostaglandin E2 receptor EP2 results in enhanced skin tumor development. | PubMed |
| Carcinoma | Overexpression of vascular endothelial growth factor and its receptors in bronchial dypslasia demonstrated by quantitative RT-PCR analysis. | PubMed |
| Carcinoma | Overexpression of vascular endothelial growth factor C is related to lymphogenous metastasis in early gastric carcinoma. | PubMed |
| Carcinoma | Overexpression of vascular endothelial growth factor is responsible for the hematogenous recurrence of early-stage gastric carcinoma. | PubMed |
| Carcinoma | Overproduction of vascular endothelial growth factor related to von Hippel-Lindau tumor suppressor gene mutations and hypoxia-inducible factor-1 alpha expression in renal cell carcinomas. | PubMed |
| Carcinoma | Oxidative stress regulates expression of VEGFR1 in myeloid cells: link to tumor-induced immune suppression in renal cell carcinoma. | PubMed |
| Carcinoma | p38 Signaling-mediated hypoxia-inducible factor 1alpha and vascular endothelial growth factor induction by Cr(VI) in DU145 human prostate carcinoma cells. | PubMed |
| Carcinoma | P53 and vascular endothelial growth factor expressions are two important indices for prognosis in gastric carcinoma. | PubMed |
| Carcinoma | p53 and vascular endothelial growth factor regulate tumor growth of NOS2-expressing human carcinoma cells. | PubMed |
| Carcinoma | p53 and vascular-endothelial-growth-factor (VEGF) expression predicts outcome in 833 patients with primary breast carcinoma. | PubMed |
| Carcinoma | Pancreatic carcinoma cells express neuropilins and vascular endothelial growth factor, but not vascular endothelial growth factor receptors. | PubMed |
| Carcinoma | Paraneoplastic symptoms: Cachexia, polycythemia, and hypercalcemia are, respectively, related to vascular endothelial growth factor (VEGF) expression in renal clear cell carcinoma. | PubMed |
| Carcinoma | Pathobiological significance of vascular endothelial growth factor and Maspin expressions in human gastric carcinoma. | PubMed |
| Carcinoma | Patterns of angiogenesis in nonsmall-cell lung carcinoma. | PubMed |
| Carcinoma | Pazopanib. | PubMed |
| Carcinoma | PDGF-D improves drug delivery and efficacy via vascular normalization, but promotes lymphatic metastasis by activating CXCR4 in breast cancer. | PubMed |
| Carcinoma | PECAM-1 (CD31) functions as a reservoir for and a modulator of tyrosine-phosphorylated beta-catenin. | PubMed |
| Carcinoma | Perfusion Estimated with Rapid Dynamic Contrast-Enhanced Magnetic Resonance Imaging Correlates Inversely with Vascular Endothelial Growth Factor Expression and Pimonidazole Staining in Head-and-Neck Cancer: A Pilot Study. | PubMed |
| Carcinoma | Peripheral blood dendritic cells and vascular endothelial growth factor in oral squamous cell carcinoma: correlation analysis and in vitro study. | PubMed |
| Carcinoma | Peritoneal VEGF burden as a predictor of cytoreductive surgery outcome in women with epithelial ovarian cancer. | PubMed |
| Carcinoma | Peritumoral lymphatic vessel density and vascular endothelial growth factor C expression in early-stage squamous cell carcinoma of the uterine cervix. | PubMed |
| Carcinoma | Pharmacotherapy options in advanced renal cell carcinoma: what role for pazopanib? | PubMed |
| Carcinoma | Phase 2 studies of sunitinib and AG013736 in patients with cytokine-refractory renal cell carcinoma. | PubMed |
| Carcinoma | Phase 3 trial of everolimus for metastatic renal cell carcinoma : final results and analysis of prognostic factors. | PubMed |
| Carcinoma | Phase I trial of bevacizumab plus escalated doses of sunitinib in patients with metastatic renal cell carcinoma. | PubMed |
| Carcinoma | Phase I/II Trial of Sunitinib Plus Gefitinib in Patients With Metastatic Renal Cell Carcinoma. | PubMed |
| Carcinoma | Phase II study of Aflibercept (VEGF-Trap) in patients with recurrent or metastatic urothelial cancer, a California Cancer Consortium Trial. | PubMed |
| Carcinoma | Phase II study of axitinib in sorafenib-refractory metastatic renal cell carcinoma. | PubMed |
| Carcinoma | Phase II study of interferon-alpha and doxycycline for advanced renal cell carcinoma. | PubMed |
| Carcinoma | Phase II trial of bevacizumab in the treatment of persistent or recurrent squamous cell carcinoma of the cervix: a gynecologic oncology group study. | PubMed |
| Carcinoma | Phase II Trial of Pemetrexed and Bevacizumab in Patients With Recurrent or Metastatic Head and Neck Cancer. | PubMed |
| Carcinoma | Phase III trial of bevacizumab plus interferon alfa versus interferon alfa monotherapy in patients with metastatic renal cell carcinoma: final results of CALGB 90206. | PubMed |
| Carcinoma | Phenotypic and functional characteristics of tumour-derived microvascular endothelial cells. | PubMed |
| Carcinoma | Phosphatidylinositol 3-kinase mediates angiogenesis and vascular permeability associated with ovarian carcinoma. | PubMed |
| Carcinoma | Phosphorylated KDR is expressed in the neoplastic and stromal elements of human renal tumours and shuttles from cell membrane to nucleus. | PubMed |
| Carcinoma | Plasma concentrations of VEGF and bFGF in patients with gastric carcinoma. | PubMed |
| Carcinoma | Plasma level and tissue expression of vascular endothelial growth factor in renal cell carcinoma: a prospective study of 50 cases. | PubMed |
| Carcinoma | Plasma vascular endothelial growth factor dysregulation in defining aggressiveness of head and neck squamous cell carcinoma. | PubMed |
| Carcinoma | Platelet-derived growth factor D is activated by urokinase plasminogen activator in prostate carcinoma cells. | PubMed |
| Carcinoma | Platelet-derived growth factor-AA is an essential and autocrine regulator of vascular endothelial growth factor expression in non-small cell lung carcinomas. | PubMed |
| Carcinoma | Poly-lactic-glycolic-acid surface nanotopographies selectively decrease breast adenocarcinoma cell functions. | PubMed |
| Carcinoma | Polymorphism of VEGF-2578C/A associated with the risk and aggressiveness of nasopharyngeal carcinoma in a Chinese population. | PubMed |
| Carcinoma | Poor prognostic clinicopathologic features correlate with VEGF expression but not with PTEN expression in squamous cell carcinoma of the larynx. | PubMed |
| Carcinoma | Post-transcriptional regulation of vascular endothelial growth factor mRNA by the product of the VHL tumor suppressor gene. | PubMed |
| Carcinoma | Potential autocrine function of vascular endothelial growth factor in head and neck cancer via vascular endothelial growth factor receptor-2. | PubMed |
| Carcinoma | Potential role for vascular endothelial growth factor-D as an autocrine factor for human gastric carcinoma cells. | PubMed |
| Carcinoma | Prediction of sites of recurrence in gastric carcinoma using immunohistochemical parameters. | PubMed |
| Carcinoma | Predictive factor for photodynamic therapy effects on oral squamous cell carcinoma and oral epithelial dysplasia. | PubMed |
| Carcinoma | Predictive value of baseline serum vascular endothelial growth factor and neutrophil gelatinase-associated lipocalin in advanced kidney cancer patients receiving sunitinib. | PubMed |
| Carcinoma | Predictors of Response to Targeted Therapy in Renal Cell Carcinoma. | PubMed |
| Carcinoma | Preoperative assessment of tumor angiogenesis by vascular endothelial growth factor mRNA expression in homogenate samples of breast carcinoma: fine-needle aspirates vs. resection samples. | PubMed |
| Carcinoma | Presurgical serum levels of matrix metalloproteinase-9 and vascular endothelial growth factor in oral squamous cell carcinoma. | PubMed |
| Carcinoma | Pretreatment serum endostatin as a prognostic indicator in metastatic gastric carcinoma. | PubMed |
| Carcinoma | Pretreatment serum levels of cytokines and cytokine receptors in patients with non-small cell lung cancer, and correlations with clinicopathological features and prognosis. M-CSF - an independent prognostic factor. | PubMed |
| Carcinoma | Proangiogenic effects of ionizing irradiation on squamous cell carcinoma of the hypopharynx. | PubMed |
| Carcinoma | Production of VEGF and expression of the VEGF receptors Flt-1 and KDR in primary cultures of epithelial and stromal cells derived from breast tumours. | PubMed |
| Carcinoma | Prognostic Factors for Overall Survival in Patients With Metastatic Renal Cell Carcinoma Treated With Vascular Endothelial Growth Factor-Targeted Agents: Results From a Large, Multicenter Study. | PubMed |
| Carcinoma | Prognostic importance of serum vascular endothelial growth factor in relation to platelet and leukocyte counts in human renal cell carcinoma. | PubMed |
| Carcinoma | Prognostic relevance of serum levels of the angiogenic peptide bFGF in advanced carcinoma of the head and neck treated by primary radiochemotherapy. | PubMed |
| Carcinoma | Prognostic role of Fuhrman grade and vascular endothelial growth factor in pT1a clear cell carcinoma in partial nephrectomy specimens. | PubMed |
| Carcinoma | Prognostic Role of Protease-Activated Receptors 1 and 4 in Resected Stage IB Non-Small-Cell Lung Cancer. | PubMed |
| Carcinoma | Prognostic role of tumor necrosis, microvessel density, vascular endothelial growth factor and hypoxia inducible factor-1alpha in patients with clear cell renal carcinoma after radical nephrectomy in a long term follow-up. | PubMed |
| Carcinoma | Prognostic significance of expression of cyclooxygenase-2 and vascular endothelial growth factor in human gastric carcinoma. | PubMed |
| Carcinoma | Prognostic significance of expression of cyclooxygenase-2, vascular endothelial growth factor, and epidermal growth factor receptor in nasopharyngeal carcinoma. | PubMed |
| Carcinoma | Prognostic significance of expression of thymidine phosphorylase and vascular endothelial growth factor in human gastric carcinoma. | PubMed |
| Carcinoma | Prognostic significance of HIF-1 alpha polymorphisms in transitional cell carcinoma of the bladder. | PubMed |
| Carcinoma | Prognostic significance of microvessel density and vascular endothelial growth factor expression in advanced ovarian serous carcinoma. | PubMed |
| Carcinoma | Prognostic significance of microvessel density and vascular endothelial growth factor expression in sinonasal carcinomas. | PubMed |
| Carcinoma | Prognostic significance of microvessel density, vascular cuffing and vascular endothelial growth factor expression in ovarian carcinoma: a special review for clear cell adenocarcinoma. | PubMed |
| Carcinoma | Prognostic significance of periodic acid-Schiff-positive patterns in clear cell renal cell carcinoma. | PubMed |
| Carcinoma | Prognostic significance of peritumoral lymphatic vessel density and vascular endothelial growth factor receptor 3 in invasive squamous cell cervical cancer. | PubMed |
| Carcinoma | Prognostic significance of serum hepatocyte growth factor in clear cell renal cell carcinoma: comparison with serum vascular endothelial growth factor. | PubMed |
| Carcinoma | Prognostic Significance of Serum Vascular Endothelial Growth Factor Per Platelet Count in Unresectable Advanced Gastric Cancer Patients. | PubMed |
| Carcinoma | Prognostic significance of the expression of vascular endothelial growth factor (VEGF) and VEGF-C in gastric carcinoma. | PubMed |
| Carcinoma | Prognostic significance of vascular endothelial growth factor and cyclooxygenase 2 expression in patients receiving preoperative chemoradiation for esophageal cancer. | PubMed |
| Carcinoma | prognostic significance of vascular endothelial growth factor C in systemic malignancies besides non-small cell lung carcinomas. | PubMed |
| Carcinoma | Prognostic significance of vascular endothelial growth factor D in breast carcinoma with long-term follow-up. | PubMed |
| Carcinoma | Prognostic significance of vascular endothelial growth factor D in gastric carcinoma. | PubMed |
| Carcinoma | Prognostic significance of vascular endothelial growth factor expression and microvessel density in carcinoma of ampulla of Vater. | PubMed |
| Carcinoma | Prognostic significance of vascular endothelial growth factor expression and microvessel density in esophageal squamous cell carcinoma: comparison with positron emission tomography. | PubMed |
| Carcinoma | Prognostic significance of vascular endothelial growth factor expression in clear cell renal cell carcinoma. | PubMed |
| Carcinoma | Prognostic significance of vascular endothelial growth factor expression in gastric carcinoma: a meta-analysis. | PubMed |
| Carcinoma | Prognostic significance of vascular endothelial growth factor expression in human ovarian carcinoma. | PubMed |
| Carcinoma | Prognostic significance of vascular endothelial growth factor immunohistochemical expression in head and neck squamous cell carcinoma: a meta-analysis. | PubMed |
| Carcinoma | Prognostic significance of vascular endothelial growth factor in squamous cell carcinomas of the tonsil in relation to human papillomavirus status and epidermal growth factor receptor. | PubMed |
| Carcinoma | Prognostic significance of vascular endothelial growth factor protein in node-negative breast carcinoma. | PubMed |
| Carcinoma | Prognostic significance of vascular endothelial growth factor protein levels in oral and oropharyngeal squamous cell carcinoma. | PubMed |
| Carcinoma | Prognostic Value of Epithelial Growth Factor Receptor, Vascular Endothelial Growth Factor, E-Cadherin, and p120 Catenin in Resected Non-Small Cell Lung Carcinoma. | PubMed |
| Carcinoma | Prognostic value of ERBB-1, VEGF, cyclin A, FOS, JUN and MYC in patients with squamous cell lung carcinomas. | PubMed |
| Carcinoma | Prognostic value of p53 protein expression and vascular endothelial growth factor expression in resected squamous cell carcinoma of the esophagus. | PubMed |
| Carcinoma | Prognostic value of the co-expression of carbonic anhydrase IX and vascular endothelial growth factor in patients with clear cell renal cell carcinoma. | PubMed |
| Carcinoma | Prognostic value of the expression of Ki-67, CD44 and vascular endothelial growth factor, and microvessel invasion, in renal cell carcinoma. | PubMed |
| Carcinoma | Prognostic value of vascular endothelial growth factor (VEGF) in head and neck squamous cell carcinomas. | PubMed |
| Carcinoma | Prognostic value of vascular endothelial growth factor and its receptor Flt-1 in squamous cell lung cancer. | PubMed |
| Carcinoma | Prognostic value of vascular endothelial growth factor expression in gastric carcinoma. | PubMed |
| Carcinoma | Prognostic value of vascular endothelial growth factor expression in primary lung carcinoma. | PubMed |
| Carcinoma | Prognostic value of vascular endothelial growth factor in Stage IB carcinoma of the uterine cervix. | PubMed |
| Carcinoma | Progranulin expression in breast cancer with different intrinsic subtypes. | PubMed |
| Carcinoma | Progress and contrasts of the development of tivozanib for therapy of kidney cancer. | PubMed |
| Carcinoma | Proliferation suppression and apoptosis of ovarian carcinoma cells induced by small interfering RNA against vascular endothelial growth factor. | PubMed |
| Carcinoma | Proliferation, angiogenesis and apoptosis-associated proteins are molecular targets for chemoprevention of MNNG-induced gastric carcinogenesis by ethanolic Ocimum sanctum leaf extract. | PubMed |
| Carcinoma | Prolonged complete responses and near-complete responses to sunitinib in metastatic renal cell carcinoma. | PubMed |
| Carcinoma | Prophylactic naked DNA vaccination with the human vascular endothelial growth factor induces an anti-tumor response in C57Bl/6 mice. | PubMed |
| Carcinoma | Prospective analysis of circulating endostatin levels in patients with renal cell carcinoma. | PubMed |
| Carcinoma | Prospective validation of the prognostic value of elevated serum vascular endothelial growth factor in patients with nasopharyngeal carcinoma: More distant metastases and shorter overall survival after treatment. | PubMed |
| Carcinoma | Protective effects of mastic oil from Pistacia lentiscus variation chia against experimental growth of lewis lung carcinoma. | PubMed |
| Carcinoma | Protein kinase C signalling pathway is involved in the regulation of vascular endothelial growth factor expression in human bladder transitional carcinoma cells. | PubMed |
| Carcinoma | Pulmonary tumor thrombotic microangiopathy caused by a gastric carcinoma expressing vascular endothelial growth factor and tissue factor. | PubMed |
| Carcinoma | pVHL19 is a biologically active product of the von Hippel-Lindau gene arising from internal translation initiation. | PubMed |
| Carcinoma | Quantification by competitive quantitative RT-PCR of VEGF121 and VEGF165 in renal cell carcinoma. | PubMed |
| Carcinoma | Quantifying the expression of VEGF using qRT-PCR, evaluation of MVD and their correlation with clinicopathological factors in laryngeal squamous cell carcinoma. | PubMed |
| Carcinoma | Quantitation by competitive PCR assay of vascular endothelial growth factor in non-small cell lung carcinomas. | PubMed |
| Carcinoma | Quantitative analysis of vascular endothelial growth factor in liver metastases from pancreatic carcinoma as a predictor of chemotherapeutic effect and prognosis. | PubMed |
| Carcinoma | Quinazoline-urea, new protein kinase inhibitors in treatment of prostate cancer. | PubMed |
| Carcinoma | Randomized phase III trial of tamoxifen versus thalidomide in women with biochemical-recurrent-only epithelial ovarian, fallopian tube or primary peritoneal carcinoma after a complete response to first-line platinum/taxane chemotherapy with an evaluation of serum vascular endothelial growth factor (VEGF): A Gynecologic Oncology Group Study. | PubMed |
| Carcinoma | Re: damien pouessel, stéphane culine. High frequency of intracerebral hemorrhage in metastatic renal carcinoma patients with brain metastases treated with tyrosine kinase inhibitors targeting the vascular endothelial growth factor receptor. Eur urol 2008;53:376-81. | PubMed |
| Carcinoma | Recent advances in small molecule inhibitors of VEGFR and EGFR signaling pathways. | PubMed |
| Carcinoma | Regulation by vascular endothelial growth factor of human colon cancer tumorigenesis in a mouse model of experimental liver metastasis. | PubMed |
| Carcinoma | Regulation of aminopeptidase A expression in cervical carcinoma: role of tumor-stromal interaction and vascular endothelial growth factor. | PubMed |
| Carcinoma | Regulation of endothelial growth factor expressions in breast cancer. | PubMed |
| Carcinoma | Regulation of invasive behavior by vascular endothelial growth factor is HEF1-dependent. | PubMed |
| Carcinoma | Regulation of the expression of pigment epithelium-derived factor, an anti-angiogenic factor in human oral squamous cell carcinoma cell lines. | PubMed |
| Carcinoma | Regulation of vascular endothelial growth factor (VEGF)-C and VEGF-D expression by the organ microenvironment in human colon carcinoma. | PubMed |
| Carcinoma | Regulation of vascular endothelial growth factor expression by insulin-like growth factor I in thyroid carcinomas. | PubMed |
| Carcinoma | Regulation of vascular endothelial growth factor expression in human colon carcinoma cells by activity of src kinase. | PubMed |
| Carcinoma | Regulation of vascular endothelial growth factor expression in human colon carcinoma cells by cell density. | PubMed |
| Carcinoma | Regulation of vascular endothelial growth factor transcription by endothelial PAS domain protein 1 (EPAS1) and possible involvement of EPAS1 in the angiogenesis of renal cell carcinoma. | PubMed |
| Carcinoma | Relationship of the K-ras/c-mos expression patterns with angiogenesis in non-small cell lung carcinomas. | PubMed |
| Carcinoma | Renal cell carcinoma. | PubMed |
| Carcinoma | Renal cell carcinoma: rationale and development of therapeutic inhibitors of angiogenesis. | PubMed |
| Carcinoma | Renal cell carcinoma: relevance of angiogenetic factors. | PubMed |
| Carcinoma | Resistance to targeted therapy in renal-cell carcinoma. | PubMed |
| Carcinoma | Response rates and adverse effects of continuous once-daily sunitinib in patients with advanced renal cell carcinoma: a single-center study in Turkey. | PubMed |
| Carcinoma | Resveratrol inhibits hypoxia-induced accumulation of hypoxia-inducible factor-1alpha and VEGF expression in human tongue squamous cell carcinoma and hepatoma cells. | PubMed |
| Carcinoma | Retraction: 'Effects of oxymatrine injection combined with low-dose paclitaxel on mRNA and protein expressions of vascular endothelial growth factor and CXC chemokine receptor 4 in human gastric carcinoma SGC-7901 cells'. | PubMed |
| Carcinoma | Reversible epithelial to mesenchymal transition and acquired resistance to sunitinib in patients with renal cell carcinoma: evidence from a xenograft study. | PubMed |
| Carcinoma | Reversion of deregulated expression of vascular endothelial growth factor in human renal carcinoma cells by von Hippel-Lindau tumor suppressor protein. | PubMed |
| Carcinoma | Rhein inhibits invasion and migration of human nasopharyngeal carcinoma cells in vitro by down-regulation of matrix metalloproteinases-9 and vascular endothelial growth factor. | PubMed |
| Carcinoma | Role of interleukin-17 in lymphangiogenesis in non-small-cell lung cancer: Enhanced production of vascular endothelial growth factor C in non-small-cell lung carcinoma cells. | PubMed |
| Carcinoma | Role of the hypoxia sensing system, acidity and reproductive hormones in the variability of vascular endothelial growth factor induction in human breast carcinoma cell lines. | PubMed |
| Carcinoma | Roles for hypoxia-regulated genes during cervical carcinogenesis: somatic evolution during the hypoxia-glycolysis-acidosis sequence. | PubMed |
| Carcinoma | S-1 inhibits tumorigenicity and angiogenesis of human oral squamous cell carcinoma cells by suppressing expression of phosphorylated Akt, vascular endothelial growth factor and fibroblast growth factor-2. | PubMed |
| Carcinoma | Scoring of p53, VEGF, Bcl-2 and APAF-1 immunohistochemistry and interobserver reliability in colorectal cancer. | PubMed |
| Carcinoma | Secretion of vascular endothelial growth factor by oral squamous cell carcinoma cells skews endothelial cells to suppress T-cell functions. | PubMed |
| Carcinoma | Secretion of vascular endothelial growth factor in adenocarcinoma and squamous cell carcinoma of the uterine cervix. | PubMed |
| Carcinoma | Selenium-induced inhibition of angiogenesis in mammary cancer at chemopreventive levels of intake. | PubMed |
| Carcinoma | Serologic angiogenesis factors and microvascular density in renal cell carcinoma: two independent parameters. | PubMed |
| Carcinoma | Serum basic fibroblast growth factor and vascular endothelial growth factor in metastatic renal cell carcinoma treated with interferon alfa-2b. | PubMed |
| Carcinoma | Serum levels of vascular endothelial growth factor (VEGF) and endostatin in renal cell carcinoma patients compared to a control group. | PubMed |
| Carcinoma | Serum prognostic markers in head and neck cancer. | PubMed |
| Carcinoma | Serum vascular endothelial growth factor (VEGF) and VEGF-C levels as tumor markers in patients with cervical carcinoma. | PubMed |
| Carcinoma | Serum vascular endothelial growth factor (VEGF), a prognostic indicator in sarcoma and carcinoma patients. | PubMed |
| Carcinoma | Serum vascular endothelial growth factor as a predictive factor in metronomic (weekly) Paclitaxel treatment for advanced head and neck cancer. | PubMed |
| Carcinoma | Serum vascular endothelial growth factor in patients with head and neck squamous cell carcinoma. | PubMed |
| Carcinoma | Serum vascular endothelial growth factor in patients with pharyngeal and laryngeal squamous cell carcinoma treated with radiotherapy. | PubMed |
| Carcinoma | Serum vascular endothelial growth factor is a candidate biomarker of metastatic tumor response to ex vivo gene therapy of renal cell cancer. | PubMed |
| Carcinoma | Serum vascular endothelial growth factor is a candidate biomarker of renal cell carcinoma in hemodialysis patients. | PubMed |
| Carcinoma | Serum vascular endothelial growth factor-C level in patients with primary nonsmall cell lung carcinoma: a possible diagnostic tool for lymph node metastasis. | PubMed |
| Carcinoma | Signal transducers and activators of transcription 3 up-regulates vascular endothelial growth factor production and tumor angiogenesis in head and neck squamous cell carcinoma. | PubMed |
| Carcinoma | Signaling inhibitors in metastatic renal cell carcinoma. | PubMed |
| Carcinoma | Significance and expression of vascular endothelial growth factor and E-cadherin in non-small cell lung Carcinomas. | PubMed |
| Carcinoma | Significance of Akt phosphorylation on tumor growth and vascular endothelial growth factor expression in human gastric carcinoma. | PubMed |
| Carcinoma | Significance of serum vascular endothelial growth factor, insulin-like growth factor-I levels and nitric oxide activity in breast cancer patients. | PubMed |
| Carcinoma | Significance of vascular endothelial growth factor messenger RNA expression in primary lung cancer. | PubMed |
| Carcinoma | Significance of VEGF and microvascular density in gastric carcinoma. | PubMed |
| Carcinoma | Significance of vessel count and vascular endothelial growth factor and its receptor (KDR) in intestinal-type gastric cancer. | PubMed |
| Carcinoma | Significance of vessel count and vascular endothelial growth factor in human esophageal carcinomas. | PubMed |
| Carcinoma | Simultaneous expression of furin and vascular endothelial growth factor in human oral tongue squamous cell carcinoma progression. | PubMed |
| Carcinoma | Simultaneous progression of oxidative stress, angiogenesis, and cell proliferation in prostate carcinoma. | PubMed |
| Carcinoma | Single nucleotide polymorphisms in the 3' untranslated region of vascular endothelial growth factor gene in Japanese population with or without renal cell carcinoma. | PubMed |
| Carcinoma | Single nucleotide polymorphisms of the vascular endothelial growth factor gene associated with incidence of oral squamous cell carcinoma. | PubMed |
| Carcinoma | Sirolimus Inhibits Human Pancreatic Carcinoma Cell Proliferation by a Mechanism Linked to the Targeting of mTOR/HIF-1 Alpha/VEGF Signaling. | PubMed |
| Carcinoma | Site-dependent expression of vascular endothelial growth factor, angiogenesis and proliferation in human gastric carcinoma. | PubMed |
| Carcinoma | Small renal masses: current concepts regarding the natural history and reflections on the American Urological Association guidelines. | PubMed |
| Carcinoma | Soluble isoforms of vascular endothelial growth factor are predictors of response to sunitinib in metastatic renal cell carcinomas. | PubMed |
| Carcinoma | Soluble vascular endothelial growth factor levels in patients with primary colorectal carcinoma. The Danish RANX05 Colorectal Cancer Study Group. | PubMed |
| Carcinoma | Sorafenib (BAY 43-9006) inhibits tumor growth and vascularization and induces tumor apoptosis and hypoxia in RCC xenograft models. | PubMed |
| Carcinoma | Sorafenib for treatment of renal cell carcinoma: Final efficacy and safety results of the phase III treatment approaches in renal cancer global evaluation trial. | PubMed |
| Carcinoma | Sorafenib has soluble epoxide hydrolase inhibitory activity, which contributes to its effect profile in vivo. | PubMed |
| Carcinoma | Sorafenib: scientific rationales for single-agent and combination therapy in clear-cell renal cell carcinoma. | PubMed |
| Carcinoma | Sp1 decoy transfected to carcinoma cells suppresses the expression of vascular endothelial growth factor, transforming growth factor beta1, and tissue factor and also cell growth and invasion activities. | PubMed |
| Carcinoma | STAT3 is a potential modulator of HIF-1-mediated VEGF expression in human renal carcinoma cells. | PubMed |
| Carcinoma | Stimulatory effect of endogenous tissue inhibitor of metalloproteinases-1 (TIMP-1) overexpression on type IV collagen and laminin gene expression in rat mammary carcinoma cells. | PubMed |
| Carcinoma | Strong immunohistochemical expression of vascular endothelial growth factor predicts overall survival in head and neck squamous cell carcinoma. | PubMed |
| Carcinoma | SU11248 and AG013736: current data and future trials in renal cell carcinoma. | PubMed |
| Carcinoma | SU5416 plus interferon alpha in advanced renal cell carcinoma: a phase II California Cancer Consortium Study with biological and imaging correlates of angiogenesis inhibition. | PubMed |
| Carcinoma | Sunitinib (Sutent, SU11248), a small-molecule receptor tyrosine kinase inhibitor, blocks function of the ATP-binding cassette (ABC) transporters P-glycoprotein (ABCB1) and ABCG2. | PubMed |
| Carcinoma | Sunitinib malate and sorafenib may be beneficial at the treatment of advanced bladder cancer due to their anti-angiogenic effects. | PubMed |
| Carcinoma | Sunitinib-induced macrocytosis in patients with metastatic renal cell carcinoma. | PubMed |
| Carcinoma | Suppression of vascular endothelial growth factor via siRNA interference modulates the biological behavior of human nasopharyngeal carcinoma cells. | PubMed |
| Carcinoma | Systemic interleukin-6 responses following administration of adenovirus gene transfer vectors to humans by different routes. | PubMed |
| Carcinoma | Systemic therapy for metastatic renal cell carcinoma in treatment naïve patients: a risk-based approach. | PubMed |
| Carcinoma | Targeted therapy for metastatic renal cell carcinoma. | PubMed |
| Carcinoma | Targeted therapy for metastatic renal cell carcinoma: current treatment and future directions. | PubMed |
| Carcinoma | Targeted therapy in renal cell carcinoma. | PubMed |
| Carcinoma | Targeted therapy in the treatment of metastatic renal cell cancer. | PubMed |
| Carcinoma | Targeting growth factor and antiangiogenic pathways in clear-cell renal cell carcinoma: rationale and ongoing trials. | PubMed |
| Carcinoma | Targeting of doxorubicin to ES-2 human ovarian cancers in nude mice by linking to an analog of luteinizing hormone-releasing hormone improves its effectiveness. | PubMed |
| Carcinoma | Targeting Slit-Roundabout signaling inhibits tumor angiogenesis in chemical-induced squamous cell carcinogenesis. | PubMed |
| Carcinoma | Targeting vascular endothelial growth factor (VEGF)-receptor-signaling in renal cell carcinoma. | PubMed |
| Carcinoma | Targeting vascular endothelial growth factor in renal cell carcinoma. | PubMed |
| Carcinoma | Temsirolimus : a safety and efficacy review. | PubMed |
| Carcinoma | TGF-alpha as well as VEGF, PD-ECGF and bFGF contribute to angiogenesis of esophageal squamous cell carcinoma. | PubMed |
| Carcinoma | Thalidomide down-regulates the expression of VEGF and bFGF in cisplatin-resistant human lung carcinoma cells. | PubMed |
| Carcinoma | The aggressiveness of urothelial carcinoma depends to a large extent on lymphovascular invasion--the prognostic contribution of related molecular markers. | PubMed |
| Carcinoma | The angiogenic and lymphangiogenic factor vascular endothelial growth factor-D exhibits a paracrine mode of action in cancer. | PubMed |
| Carcinoma | The angiogenic switch for vascular endothelial growth factor (VEGF)-A, VEGF-B, VEGF-C, and VEGF-D in the adenoma-carcinoma sequence during colorectal cancer progression. | PubMed |
| Carcinoma | The angiopoietins, tie2 and vascular endothelial growth factor are differentially expressed in the transformation of normal lung to non-small cell lung carcinomas. | PubMed |
| Carcinoma | The association between vascular endothelial growth factor, microvessel density and clinicopathological features in invasive cervical cancer. | PubMed |
| Carcinoma | The association of K-ras gene mutation and vascular endothelial growth factor gene expression in pancreatic carcinoma. | PubMed |
| Carcinoma | The carboxyl terminal trimer of procollagen I induces pro-metastatic changes and vascularization in breast cancer cells xenografts. | PubMed |
| Carcinoma | The differential regulation of human telomerase reverse transcriptase and vascular endothelial growth factor may contribute to the clinically more aggressive behavior of p63-positive breast carcinomas. | PubMed |
| Carcinoma | The double edged sword of bleeding and clotting from VEGF inhibition in renal cancer patients. | PubMed |
| Carcinoma | The effect of the expression of vascular endothelial growth factor (VEGF)-C and VEGF receptor-3 on the clinical outcome in patients with gastric carcinoma. | PubMed |
| Carcinoma | The effect of topiramate on tumor-related angiogenesis and on the serum proteome of mice bearing Lewis lung carcinoma. | PubMed |
| Carcinoma | The effects of vandetanib on paclitaxel tumor distribution and antitumor activity in a xenograft model of human ovarian carcinoma. | PubMed |
| Carcinoma | The effects of vascular endothelial growth factor C knockdown in esophageal squamous cell carcinoma. | PubMed |
| Carcinoma | The evolving role of surgery for advanced renal cell carcinoma in the era of molecular targeted therapy. | PubMed |
| Carcinoma | The expression of cyclooxygenase-2, VEGF and PGs in CIN and cervical carcinoma. | PubMed |
| Carcinoma | The expression of transforming growth factor-beta1 is significantly correlated with the expression of vascular endothelial growth factor and poor prognosis of patients with advanced gastric carcinoma. | PubMed |
| Carcinoma | The expression of vascular endothelial growth factor in transitional cell carcinoma of urinary bladder is correlated with cancer progression. | PubMed |
| Carcinoma | The expression pattern of vascular endothelial growth factor C and D in human esophageal normal mucosa, dysplasia and neoplasia. | PubMed |
| Carcinoma | The human papillomavirus type 18 E6 oncoprotein induces Vascular Endothelial Growth Factor 121 (VEGF121) transcription from the promoter through a p53-independent mechanism. | PubMed |
| Carcinoma | The hypoxia-inducible factor-responsive proteins semaphorin 4D and vascular endothelial growth factor promote tumor growth and angiogenesis in oral squamous cell carcinoma. | PubMed |
| Carcinoma | The impact of cyclooxygenase-2 and vascular endothelial growth factor C immunoexpression on the prognosis of penile carcinoma. | PubMed |
| Carcinoma | The impact of cytoreductive nephrectomy on survival of patients with metastatic renal cell carcinoma receiving vascular endothelial growth factor targeted therapy. | PubMed |
| Carcinoma | The impact of kidney function on the outcome of metastatic renal cell carcinoma patients treated with vascular endothelial growth factor-targeted therapy. | PubMed |
| Carcinoma | The influence of cyclooxygenase-1 expression on the efficacy of cyclooxygenase-2 inhibition in head and neck squamous cell carcinoma cell lines. | PubMed |
| Carcinoma | The intratumoral expression of vascular endothelial growth factor and interleukin-8 associated with angiogenesis in nonsmall cell lung carcinoma patients. | PubMed |
| Carcinoma | The low VEGF production allele of the +936C/T polymorphism is strongly associated with increased risk for oral cancer. | PubMed |
| Carcinoma | The lymphatic system and its specific growth factor vascular endothelial growth factor C in kidney tissue and in renal cell carcinoma. | PubMed |
| Carcinoma | The Monascus metabolite monacolin K reduces tumor progression and metastasis of Lewis lung carcinoma cells. | PubMed |
| Carcinoma | The mRNA expression of cyclo-oxygenase-2 (COX-2) and vascular endothelial growth factor (VEGF) in human breast cancer. | PubMed |
| Carcinoma | The natural progression of microvasculature in primary tumor and lymph node metastases in a breast carcinoma model: relationship between microvessel density, vascular endothelial growth factor expression, and metastatic invasion. | PubMed |
| Carcinoma | The oncogene phosphatidylinositol 3'-kinase catalytic subunit alpha promotes angiogenesis via vascular endothelial growth factor in ovarian carcinoma. | PubMed |
| Carcinoma | The peroxisome proliferator-activated receptor gamma ligand 15-deoxy-Delta12,14-prostaglandin J2 induces vascular endothelial growth factor in the hormone-independent prostate cancer cell line PC 3 and the urinary bladder carcinoma cell line 5637. | PubMed |
| Carcinoma | The place of VEGF inhibition in the current management of renal cell carcinoma. | PubMed |
| Carcinoma | The predictive value of p53, Ki-67 and angiogenetic factors in primary hypopharyngeal carcinoma. | PubMed |
| Carcinoma | The prognostic effect of VEGF expression in squamous cell carcinoma of the cervix treated with radiation therapy alone. | PubMed |
| Carcinoma | The prognostic value of angiogenesis factor expression for predicting recurrence and metastasis of bladder cancer after neoadjuvant chemotherapy and radical cystectomy. | PubMed |
| Carcinoma | The promise of biomarkers for personalized renal cancer care. | PubMed |
| Carcinoma | The redox protein thioredoxin-1 (Trx-1) increases hypoxia-inducible factor 1alpha protein expression: Trx-1 overexpression results in increased vascular endothelial growth factor production and enhanced tumor angiogenesis. | PubMed |
| Carcinoma | The relationship between microvessel count and the expression of vascular endothelial growth factor, p53, and K-ras in non-small cell lung cancer. | PubMed |
| Carcinoma | The relationship between microvessel density, the expression of vascular endothelial growth factor (VEGF), and the extension of nasopharyngeal carcinoma. | PubMed |
| Carcinoma | The Relationship of Vascular Endothelial Growth Factor and Coagulation Factor (Fibrin and Fibrinogen) Expression in Clear Cell Renal Cell Carcinoma. | PubMed |
| Carcinoma | The role of angiogenesis in the accumulation of peritoneal fluid in benign conditions and the development of malignant ascites in the female. | PubMed |
| Carcinoma | The role of macrophages in angiogenesis. Comparison between HIV+ and HIV- populations with anal dysplasia and anal cancer. | PubMed |
| Carcinoma | The role of the lymphatic system and its specific growth factor, vascular endothelial growth factor C, for lymphogenic metastasis in prostate cancer. | PubMed |
| Carcinoma | The role of vascular endothelial growth factor (VEGF) in oral dysplasia and oral squamous cell carcinoma. | PubMed |
| Carcinoma | The role of vascular endothelial growth factor and its receptor Flk-1/KDR in promoting tumour angiogenesis in feline and canine mammary carcinomas: a preliminary study of autocrine and paracrine loops. | PubMed |
| Carcinoma | The role of vascular endothelial growth factor in kidney and prostate cancer. | PubMed |
| Carcinoma | The role of VEGF-C/D and Flt-4 in the lymphatic metastasis of early-stage invasive cervical carcinoma. | PubMed |
| Carcinoma | The value of tumor marker and cytokine analysis for the assessment of regional lymph node status in cervical cancer patients. | PubMed |
| Carcinoma | The vascular endothelial growth factor receptor-2 tyrosine kinase inhibitor cediranib (Recentin; AZD2171) inhibits endothelial cell function and growth of human renal tumor xenografts. | PubMed |
| Carcinoma | The von Hippel-Lindau tumor suppressor protein and clear cell renal carcinoma. | PubMed |
| Carcinoma | The von Hippel-Lindau tumor suppressor protein: new insights into oxygen sensing and cancer. | PubMed |
| Carcinoma | Therapeutic efficacy of the suicide gene driven by the promoter of vascular endothelial growth factor gene against hypoxic tumor cells. | PubMed |
| Carcinoma | Therapeutic targeting of the endothelin a receptor in human ovarian carcinoma. | PubMed |
| Carcinoma | Therapy targeted at vascular endothelial growth factor in metastatic renal cell carcinoma: biology, clinical results and future development. | PubMed |
| Carcinoma | There is no increase in frequency of somatic mutations in metastases compared with primary colorectal carcinomas with microsatellite instability. | PubMed |
| Carcinoma | Third generation tyrosine kinase inhibitors and their development in advanced renal cell carcinoma. | PubMed |
| Carcinoma | Thrombospondin-1, vascular endothelial growth factor expression and microvessel density in renal cell carcinoma and their relationship with multifocality. | PubMed |
| Carcinoma | Thymidine phosphorylase induces carcinoma cell oxidative stress and promotes secretion of angiogenic factors. | PubMed |
| Carcinoma | Thymidine phosphorylase-mediated angiogenesis regulated by thymidine phosphorylase inhibitor in human ovarian cancer cells in vivo. | PubMed |
| Carcinoma | Time to disease progression to evaluate a novel protein kinase C inhibitor, UCN-01, in renal cell carcinoma. | PubMed |
| Carcinoma | Transfection of hypoxia-inducible factor-1 decoy oligodeoxynucleotides suppresses expression of vascular endothelial growth factor in oral squamous cell carcinoma cells. | PubMed |
| Carcinoma | Transient potential receptor channel 4 controls thrombospondin-1 secretion and angiogenesis in renal cell carcinoma. | PubMed |
| Carcinoma | Treatment of metastatic renal cell carcinoma with a combination of bevacizumab and erlotinib. | PubMed |
| Carcinoma | Tubulogenesis by microvascular endothelial cells is mediated by vascular endothelial growth factor (VEGF) in renal cell carcinoma. | PubMed |
| Carcinoma | Tumor angiogenesis in predicting the survival of patients with stage I lung cancer. | PubMed |
| Carcinoma | Tumor growth enhancing effects of vascular endothelial growth factor are associated with increased nitric oxide synthase activity and inhibition of apoptosis in human breast carcinoma xenografts. | PubMed |
| Carcinoma | Tumor growth of FGF or VEGF transfected MCF-7 breast carcinoma cells correlates with density of specific microvessels independent of the transfected angiogenic factor. | PubMed |
| Carcinoma | Tumor recovery by angiogenic switch from sprouting to intussusceptive angiogenesis after treatment with PTK787/ZK222584 or ionizing radiation. | PubMed |
| Carcinoma | Tumor-Infiltrating Lymphocytes Express Vascular Endothelial Growth Factor in Renal Cell Carcinomas. | PubMed |
| Carcinoma | Tumour vascular endothelial growth factor (VEGF) mRNA in relation to serum VEGF protein levels and tumour progression in human renal cell carcinoma. | PubMed |
| Carcinoma | UFT and its metabolite gamma-butyrolactone (GBL) inhibit angiogenesis induced by vascular endothelial growth factor in advanced cervical carcinoma. | PubMed |
| Carcinoma | Unexpected autocrine role of vascular endothelial growth factor in squamous cell carcinoma. | PubMed |
| Carcinoma | Up-regulation of delta-like 4 ligand in human tumor vasculature and the role of basal expression in endothelial cell function. | PubMed |
| Carcinoma | Up-Regulation of Vascular Endothelial Growth Factor-D Expression in Clear Cell Renal Cell Carcinoma by CD74: A Critical Role in Cancer Cell Tumorigenesis. | PubMed |
| Carcinoma | Upregulated EMMPRIN/CD147 might contribute to growth and angiogenesis of gastric carcinoma: a good marker for local invasion and prognosis. | PubMed |
| Carcinoma | Upregulation of hypoxia inducible factor 1alpha mRNA is associated with elevated vascular endothelial growth factor expression and excessive angiogenesis and predicts a poor prognosis in gastric carcinoma. | PubMed |
| Carcinoma | Upregulation of serum and tissue vascular endothelial growth factor correlates with angiogenesis and prognosis of oral squamous cell carcinoma. | PubMed |
| Carcinoma | Usefulness of contrast-enhanced magnetic resonance imaging for evaluating solitary pulmonary nodules. | PubMed |
| Carcinoma | Usefulness of plasma vascular endothelial growth factor in the diagnosis of pancreatic carcinoma: differential diagnosis, tumor progression, and patient survival. | PubMed |
| Carcinoma | Utilizing pre-therapy clinical schema and initial CT changes to predict progression-free survival in patients with metastatic renal cell carcinoma on VEGF-targeted therapy: A preliminary analysis. | PubMed |
| Carcinoma | Valsartan inhibits NPC cell line CNE-2 proliferation and invasion and promotes its sensitivity to radiation. | PubMed |
| Carcinoma | Vandetanib restores head and neck squamous cell carcinoma cells' sensitivity to Cisplatin and radiation in vivo and in vitro. | PubMed |
| Carcinoma | Vascular endothelial growth factor (VEGF) and microvessel density in squamous cell carcinomas of the larynx: an immunohistochemical study. | PubMed |
| Carcinoma | Vascular endothelial growth factor (VEGF) and ovarian carcinoma cell supernatant activate signal transducers and activators of transcription (STATs) via VEGF receptor-2 (KDR) in human hemopoietic progenitor cells. | PubMed |
| Carcinoma | Vascular endothelial growth factor (VEGF) concentration in sera and tumor effusions from patients with ovarian carcinoma. | PubMed |
| Carcinoma | Vascular endothelial growth factor (VEGF) enhances gastric carcinoma invasiveness via integrin alpha(v)beta6. | PubMed |
| Carcinoma | Vascular endothelial growth factor (VEGF) expression and survival in human epithelial ovarian carcinomas. | PubMed |
| Carcinoma | Vascular endothelial growth factor (VEGF) expression correlates with p53 and ki-67 expressions in tongue squamous cell carcinoma. | PubMed |
| Carcinoma | Vascular Endothelial Growth Factor (VEGF) Expression in Human Pituitary Adenomas and Carcinomas. | PubMed |
| Carcinoma | Vascular endothelial growth factor (VEGF) expression in operable gallbladder carcinomas. | PubMed |
| Carcinoma | Vascular endothelial growth factor (VEGF) expression in primary tumors and peritoneal metastases from patients with advanced ovarian carcinoma. | PubMed |
| Carcinoma | Vascular endothelial growth factor (VEGF) expression in prostatic tumours and its relationship to neuroendocrine cells. | PubMed |
| Carcinoma | Vascular endothelial growth factor (VEGF) expression is a prognostic factor for radiotherapy outcome in advanced carcinoma of the cervix. | PubMed |
| Carcinoma | Vascular endothelial growth factor (VEGF) expression is not associated with prognosis in patients with radically resected ampullary carcinoma. | PubMed |
| Carcinoma | Vascular endothelial growth factor (VEGF) in sera of oral and oropharyngeal squamous cell carcinoma patients. | PubMed |
| Carcinoma | Vascular endothelial growth factor (VEGF) receptor antibody bevacizumab (avastin) induces regression of renal cell carcinoma in an adolescent resulting in residual tumorectomy. | PubMed |
| Carcinoma | Vascular endothelial growth factor (VEGF), matrix metalloproteinase-9 (MMP-9), and thrombospondin-1 (TSP-1) expression in urothelial carcinomas. | PubMed |
| Carcinoma | Vascular endothelial growth factor - its relation to neovascularization and their significance as prognostic factors in renal cell carcinoma. | PubMed |
| Carcinoma | Vascular endothelial growth factor 936 C/T polymorphism is associated with vascular invasion in oral squamous cell carcinoma. | PubMed |
| Carcinoma | Vascular endothelial growth factor A (VEGF A) as individual prognostic factor in invasive breast carcinoma. | PubMed |
| Carcinoma | Vascular endothelial growth factor a and proliferation marker in prediction of lymph node metastasis in oral and pharyngeal squamous cell carcinoma. | PubMed |
| Carcinoma | Vascular endothelial growth factor activating matrix metalloproteinase in ascitic fluid during peritoneal dissemination of ovarian cancer. | PubMed |
| Carcinoma | Vascular endothelial growth factor and basic fibroblast growth factor are released by squamous cell carcinoma cells after irradiation and increase resistance to subsequent irradiation. | PubMed |
| Carcinoma | Vascular endothelial growth factor and basic fibroblast growth factor in primary lung carcinomas and the incidence of metastases. | PubMed |
| Carcinoma | Vascular endothelial growth factor and dendritic cells in human squamous cell carcinoma of the oral cavity. | PubMed |
| Carcinoma | Vascular endothelial growth factor and ki-67 antigen expression in relation to age and gender in oral squamous cell carcinoma. | PubMed |
| Carcinoma | Vascular endothelial growth factor and microvascular density in esophageal and gastric carcinomas. | PubMed |
| Carcinoma | Vascular endothelial growth factor and mTOR pathways in renal cell carcinoma: differences and synergies of two targeted mechanisms. | PubMed |
| Carcinoma | Vascular endothelial growth factor and prognosis of cervical carcinoma. | PubMed |
| Carcinoma | Vascular endothelial growth factor and social support in patients with ovarian carcinoma. | PubMed |
| Carcinoma | Vascular endothelial growth factor and survivin immunostaining in gastric adenocarcinoma. | PubMed |
| Carcinoma | Vascular endothelial growth factor and vascular endothelial growth factor receptor-2 tumor expression in patients with advanced laryngeal cancer after induction chemotherapy for organ preservation. | PubMed |
| Carcinoma | Vascular endothelial growth factor as prognostic factor in renal cell carcinoma. | PubMed |
| Carcinoma | Vascular endothelial growth factor C and microvessel density in gastric carcinoma: correlation with clinicopathological factors. Our experience and review of the literature. | PubMed |
| Carcinoma | Vascular endothelial growth factor C and vascular endothelial growth factor receptor 2 are related closely to the prognosis of patients with ovarian carcinoma. | PubMed |
| Carcinoma | Vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 expression in squamous cell carcinomas of the head and neck. | PubMed |
| Carcinoma | Vascular endothelial growth factor C expression correlates with lymphatic involvement and poor prognosis in patients with esophageal squamous cell carcinoma. | PubMed |
| Carcinoma | Vascular endothelial growth factor C promotes human gastric carcinoma lymph node metastasis in mice. | PubMed |
| Carcinoma | Vascular endothelial growth factor D and intratumoral lymphatics as independent prognostic factors in epithelial ovarian carcinoma. | PubMed |
| Carcinoma | Vascular endothelial growth factor enhances cancer cell adhesion to microvascular endothelium in vivo. | PubMed |
| Carcinoma | Vascular endothelial growth factor expression and neovascularization in Barrett's carcinoma. | PubMed |
| Carcinoma | Vascular Endothelial Growth Factor Expression and Neovascularization in Non-Small Cell Lung Carcinoma. | PubMed |
| Carcinoma | Vascular endothelial growth factor expression and tumor angiogenesis are regulated by androgens in hormone responsive human prostate carcinoma: evidence for androgen dependent destabilization of vascular endothelial growth factor transcripts. | PubMed |
| Carcinoma | Vascular endothelial growth factor expression correlates with p53 mutation and angiogenesis in squamous cell carcinoma of the head and neck. | PubMed |
| Carcinoma | Vascular endothelial growth factor expression in early stage ovarian carcinoma. | PubMed |
| Carcinoma | Vascular endothelial growth factor expression in head and neck squamous cell carcinoma. | PubMed |
| Carcinoma | Vascular endothelial growth factor expression in non-small-cell lung cancer: prognostic significance in squamous cell carcinoma. | PubMed |
| Carcinoma | Vascular endothelial growth factor expression in preoperative biopsy specimens correlates with disease recurrence in patients with early gastric carcinoma. | PubMed |
| Carcinoma | Vascular endothelial growth factor expression in primary esophageal squamous cell carcinoma. Association with angiogenesis and tumor progression. | PubMed |
| Carcinoma | Vascular endothelial growth factor expression in serous ovarian carcinoma: relationship with high mitotic activity and high FIGO stage. | PubMed |
| Carcinoma | Vascular endothelial growth factor expression in serous ovarian carcinoma: relationship with topoisomerase II alpha and prognosis. | PubMed |
| Carcinoma | Vascular endothelial growth factor expression in the basal subtype of breast carcinoma. | PubMed |
| Carcinoma | Vascular endothelial growth factor expression is an independent negative predictor in extrahepatic biliary tract carcinomas. | PubMed |
| Carcinoma | Vascular endothelial growth factor expression is increased in renal cell carcinoma. | PubMed |
| Carcinoma | Vascular endothelial growth factor expression predicts outcome after primary radiotherapy for head and neck squamous cell cancer. | PubMed |
| Carcinoma | Vascular endothelial growth factor expression predicts outcome and lymph node metastasis in squamous cell carcinoma of the esophagus. | PubMed |
| Carcinoma | Vascular endothelial growth factor expression, angiogenesis, and necrosis in renal cell carcinomas. | PubMed |
| Carcinoma | Vascular endothelial growth factor gene expression in colon cancer cells exposed to prostaglandin E2 is mediated by hypoxia-inducible factor 1. | PubMed |
| Carcinoma | Vascular endothelial growth factor immunoneutralization plus Paclitaxel markedly reduces tumor burden and ascites in athymic mouse model of ovarian cancer. | PubMed |
| Carcinoma | Vascular endothelial growth factor in cervical carcinoma. | PubMed |
| Carcinoma | Vascular endothelial growth factor in squamous cell head and neck carcinoma: expression and prognostic significance. | PubMed |
| Carcinoma | Vascular endothelial growth factor inhibits maturation of dendritic cells induced by lipopolysaccharide, but not by proinflammatory cytokines. | PubMed |
| Carcinoma | Vascular endothelial growth factor is a marker of tumor invasion and metastasis in squamous cell carcinomas of the head and neck. | PubMed |
| Carcinoma | Vascular endothelial growth factor is a promising therapeutic target for the treatment of clear cell carcinoma of the ovary. | PubMed |
| Carcinoma | Vascular endothelial growth factor is an autocrine survival factor for neuropilin-expressing breast carcinoma cells. | PubMed |
| Carcinoma | Vascular endothelial growth factor is associated with neovascularization and influences progression of non-small cell lung carcinoma. | PubMed |
| Carcinoma | Vascular endothelial growth factor is associated with the efficacy of endocrine therapy in patients with advanced breast carcinoma. | PubMed, PubMed |
| Carcinoma | Vascular endothelial growth factor is essential for initial but not continued in vivo growth of human breast carcinoma cells. | PubMed |
| Carcinoma | Vascular endothelial growth factor is of high prognostic value in node-negative breast carcinoma. | PubMed |
| Carcinoma | Vascular endothelial growth factor is upregulated by interleukin-1 beta in human vascular smooth muscle cells via the P38 mitogen-activated protein kinase pathway. | PubMed |
| Carcinoma | Vascular endothelial growth factor mediates intracrine survival in human breast carcinoma cells through internally expressed VEGFR1/FLT1. | PubMed |
| Carcinoma | Vascular endothelial growth factor mRNA levels quantified by reverse transcription-polymerase chain reaction in microdissected breast carcinoma tissues are correlated with histological type and grade of both invasive and intraductal components. | PubMed |
| Carcinoma | Vascular endothelial growth factor overexpression is correlated with von Hippel-Lindau tumor suppressor gene inactivation in patients with sporadic renal cell carcinoma. | PubMed |
| Carcinoma | Vascular endothelial growth factor promotes breast carcinoma invasion in an autocrine manner by regulating the chemokine receptor CXCR4. | PubMed |
| Carcinoma | Vascular endothelial growth factor receptor-3 is a favorable prognostic factor in advanced gastric carcinoma. | PubMed |
| Carcinoma | Vascular endothelial growth factor receptor-3 promotes breast cancer cell proliferation, motility and survival in vitro and tumor formation in vivo. | PubMed |
| Carcinoma | Vascular endothelial growth factor staining and elevated INR in advanced epithelial ovarian carcinoma. | PubMed |
| Carcinoma | Vascular endothelial growth factor targeted therapy in the perioperative setting: implications for patient care. | PubMed |
| Carcinoma | Vascular endothelial growth factor, CD68, and epidermal growth factor receptor expression and survival in patients with Stage II and Stage III colon carcinoma: a role for the host response in prognosis. | PubMed |
| Carcinoma | Vascular endothelial growth factor, p53, and the H-ras oncogene in Egyptian patients with bladder cancer. | PubMed |
| Carcinoma | Vascular endothelial growth factor-C expression and invasive phenotype in ovarian carcinomas. | PubMed |
| Carcinoma | Vascular endothelial growth factor-C expression predicts lymph node metastasis of human gastric carcinomas invading the submucosa. | PubMed |
| Carcinoma | Vascular endothelial growth factor-D expression is an independent prognostic marker for survival in colorectal carcinoma. | PubMed |
| Carcinoma | Vascular endothelial growth factor-D is a survival factor for human breast carcinoma cells. | PubMed |
| Carcinoma | Vascular endothelial growth factor-D is an independent prognostic factor in epithelial ovarian carcinoma. | PubMed |
| Carcinoma | Vascular endothelial growth factor-D promotes growth, lymphangiogenesis and lymphatic metastasis in gallbladder cancer. | PubMed |
| Carcinoma | Vascular endothelial growth factor-targeted therapies in advanced renal cell carcinoma. | PubMed |
| Carcinoma | Vascular endothelial growth factor-targeted therapy for the treatment of renal cell carcinoma. | PubMed |
| Carcinoma | Vascular endothelial growth factor-targeted therapy in renal cell carcinoma: current status and future directions. | PubMed |
| Carcinoma | Vascular endothelial growth factor/KDR activated microvessel density versus CD31 standard microvessel density in non-small cell lung cancer. | PubMed |
| Carcinoma | Vascular endothelial growth factor165-regulated nasopharyngeal carcinoma cell lines invasion and migration involve expression and activation of matrix metalloproteinase-2. | PubMed |
| Carcinoma | Vascular endothelial growth factors are differentially regulated by steroid hormones and antiestrogens in breast cancer cells. | PubMed |
| Carcinoma | Vascular endothelial growth-factor expression and angiogenesis in nonsmall cell lung carcinomas. | PubMed |
| Carcinoma | Vascularity and expression of vascular endothelial growth factor in oral squamous cell carcinoma, resection margins, and nodal metastases. | PubMed |
| Carcinoma | VEGF and ki 67 expression in squamous cell carcinoma of the tongue: An immunohistochemical and computerized image analysis study. | PubMed |
| Carcinoma | VEGF as a Predictor for Response to Definitive Chemoradiotherapy and COX-2 as a Prognosticator for Survival in Esophageal Squamous Cell Carcinoma. | PubMed |
| Carcinoma | VEGF elicits epithelial-mesenchymal transition (EMT) in prostate intraepithelial neoplasia (PIN)-like cells via an autocrine loop. | PubMed |
| Carcinoma | VEGF G-1154A is predictive of severe acute toxicities during chemoradiotherapy for esophageal squamous cell carcinoma in Japanese patients. | PubMed |
| Carcinoma | VEGF in physiological process and thyroid disease. | PubMed |
| Carcinoma | VEGF is differentially regulated in multiple myeloma-derived cell lines by norepinephrine. | PubMed |
| Carcinoma | VEGF spliced variants: possible role of anti-angiogenesis therapy. | PubMed |
| Carcinoma | VEGF, VEGFRs expressions and activated STATs in ovarian epithelial carcinoma. | PubMed |
| Carcinoma | VEGF-A, VEGF-C, and VEGF-D in colorectal cancer progression. | PubMed |
| Carcinoma | VEGF-C and VEGF-D expression is correlated with lymphatic vessel density and lymph node metastasis in oral squamous cell carcinoma: Implications for use as a prognostic marker. | PubMed |
| Carcinoma | VEGF-D expression and lymph vessels play an important role for lymph node metastasis in papillary thyroid carcinoma. | PubMed |
| Carcinoma | VEGF-targeted therapy in metastatic renal cell carcinoma. | PubMed |
| Carcinoma | VEGF-targeted Therapy in Renal Cell Carcinoma: Active Drugs and Active Choices. | PubMed |
| Carcinoma | VEGF145, a secreted vascular endothelial growth factor isoform that binds to extracellular matrix. | PubMed |
| Carcinoma | VEGF165b, an inhibitory splice variant of vascular endothelial growth factor, is down-regulated in renal cell carcinoma. | PubMed |
| Carcinoma | VEGFR1 and VEGFR2 immunohistochemical expression in oral squamous cell carcinoma: a morphometric study. | PubMed |
| Carcinoma | Vesnarinone inhibits angiogenesis and tumorigenicity of human oral squamous cell carcinoma cells by suppressing the expression of vascular endothelial growth factor and interleukin-8. | PubMed |
| Carcinoma | von Hippel-Lindau gene status and response to vascular endothelial growth factor targeted therapy for metastatic clear cell renal cell carcinoma. | PubMed |
| Carcinoma | Zebularine-induced reduction in VEGF secretion by HIF-1? degradation in oral squamous cell carcinoma. | PubMed |
| Carcinoma | [A study of correlation between the blood supply types of PHcc on spiral CT and the level of VEGF expression in PHcc] | PubMed |
| Carcinoma | [Antiangiogenesis of ginsenoside Rg3 in severe combined immunodeficient mice with human ovarian carcinoma] | PubMed |
| Carcinoma | [Antiangiogenic and antitumor effects of vascular endothelial growth factor small interfering RNA on Tca8113 human tongue squamous cell carcinoma xenografts in vivo] | PubMed |
| Carcinoma | [Change in vascular endothelial growth factor level in serum and urine of esophageal carcinoma patients] | PubMed |
| Carcinoma | [Clinical significance of quantitative analysis of serum VEGF, CD44s, and MMP-3 protein in nasopharyngeal carcinoma] | PubMed |
| Carcinoma | [Clinical value of vascular endothelial growth factor detection in forecasting distant metastasis risk of nasopharyngeal carcinoma] | PubMed |
| Carcinoma | [Clinico-pathological significance of microvessel density and vascular endothelial growth factor expression in adenoid cystic carcinoma of salivary glands] | PubMed |
| Carcinoma | [Clinicopathologic study of angiogenesis in human hepatocellular carcinoma] | PubMed |
| Carcinoma | [Cloning and sequencing of human vascular endothelial growth factor-C encoded cDNA] | PubMed |
| Carcinoma | [Constitutive activation of signal transducers and activators of transcription 3 and expression of its target gene products in human ESCC cell line] | PubMed |
| Carcinoma | [Correlation between expression of vascular endothelial growth factor and prognosis of patients with esophageal squamous cell carcinoma] | PubMed |
| Carcinoma | [Correlation between the vascular endothelial growth factor C expression and lymph node metastasis in human nasopharyngeal carcinoma] | PubMed |
| Carcinoma | [Correlation of angiogenesis with expression of vascular endothelial growth factor and its receptors in lung carcinoma] | PubMed |
| Carcinoma | [Correlation of multislice spiral CT findings with vascular endothelial growth factor expressions and microvessel density in renal cell carcinoma] | PubMed |
| Carcinoma | [Correlation of neovascularization and vascular endothelial growth factor in human renal cell carcinoma] | PubMed |
| Carcinoma | [Correlation of tissue factor expression to angiogenesis of gastric carcinoma and its clinical significance] | PubMed |
| Carcinoma | [Correlations of biomolecular markers, such as p53 protein and vascular endothelial growth factor, to radiosensitivity of nasopharyngeal carcinoma.] | PubMed |
| Carcinoma | [Correlative studies on uPAR receptor mRNA expressions with vascular endothelial growth factor, microvessel density, progression and survival time of gastric carcinomas] | PubMed |
| Carcinoma | [Effect of concurrent chemoradiotherapy on serum vascular endothelial growth factor in esophageal squamous cell carcinoma patients--a report of 43 cases] | PubMed |
| Carcinoma | [Effect of interferon-gamma on the expression of vascular endothelial growth factor C on Hep-2 laryngeal carcinoma cell lines] | PubMed |
| Carcinoma | [Effect of selective cyclooxygenase-2 inhibitor celebrex on expression of vascular endothelial growth factor (VEGF) in pancreatic carcinoma] | PubMed |
| Carcinoma | [Effects of anti-HPV16 E6-ribozyme on invasiveness of cervical carcinoma cell line CaSKi and vascular endothelial growth factor expression] | PubMed |
| Carcinoma | [Effects of antisense oligodeoxynucleotides on vascular endothelial growth factor expression in Lewis lung carcinoma cells in vitro.] | PubMed |
| Carcinoma | [Effects of Baihe Recipe on expressions of vascular endothelial growth factor and p53 proteins in tumor tissues of nude mice bearing orthotopically transplanted gastric carcinoma BGC-823.] | PubMed |
| Carcinoma | [Effects of green tea extract on expression of human papillomavirus type 16 oncoproteins-induced hypoxia-inducible factor-1alpha and vascular endothelial growth factor in human cervical carcinoma cells] | PubMed |
| Carcinoma | [Effects of HPV 16-E6/E7 oncogene on expression of vascular endothelial growth factor and matrix metalloproteinase 9 in human laryngeal squamous cell carcinoma cell line] | PubMed |
| Carcinoma | [Effects of oxymatrine injection combined with low-dose paclitaxel on mRNA and protein expressions of vascular endothelial growth factor and CXC chemokine receptor 4 in human gastric carcinoma SGC-7901 cells]. | PubMed |
| Carcinoma | [Effects of vascular endothelial growth factor (VEGF) antisense oligodeoxynucleotide on mRNA and expression of VEGF, flt-1, and kinase insert domain containing receptor and VEGF excretion in human gallbladder carcinoma cells] | PubMed |
| Carcinoma | [Evaluation of angiogenesis in the tumorigenesis and progression of breast cancer] | PubMed |
| Carcinoma | [Experimental study on the effect of VEGF165 antisense RNA on human squamous cell carcinoma of esophagus] | PubMed |
| Carcinoma | [Expression and clinical significance of endostatin and vascular endothelial growth factor in ovarian carcinoma] | PubMed |
| Carcinoma | [Expression and clinical significance of Endostatin, vascular endothelial growth factor and fibroblast growth factor basic-2 in laryngeal carcinoma] | PubMed |
| Carcinoma | [Expression and clinical significance of hypoxia inducible factor-1alpha, survivin and vascular endothelial growth factor in esophageal squamous cell carcinoma] | PubMed |
| Carcinoma | [Expression and clinical significance of matrix metalloproteinase-9 and vascular endothelial growth factor in oral squamous cell carcinomas] | PubMed |
| Carcinoma | [Expression and clinical significance of vascular endothelial growth factor C and D in nasopharyngeal carcinoma] | PubMed |
| Carcinoma | [Expression and clinical significance of vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 in non-small cell lung carcinoma] | PubMed |
| Carcinoma | [Expression and clinical significance of vascular endothelial growth factor in nasopharyngeal carcinoma] | PubMed |
| Carcinoma | [Expression and hypoxic regulation of vascular endothelial growth factor and matrix metalloproteinase-9 in esophageal carcinoma] | PubMed |
| Carcinoma | [Expression and relationship of EBV LMP1, COX-2 and VEGF-C in nasopharyngeal carcinoma] | PubMed |
| Carcinoma | [Expression of C-erb B-2 and its relation to angiogenesis in nasopharyngeal carcinoma.] | PubMed |
| Carcinoma | [Expression of hypoxia inducible factor-1? and correlated target genes in human laryngeal carcinoma]. | PubMed |
| Carcinoma | [Expression of hypoxia-inducible factor-1-alpha, hypoxia-inducible factor-2alpha and vascular endothelial growth factor in sporadic clear cell renal cell renal cell carcinoma and their significance in the pathogenesis thereof] | PubMed |
| Carcinoma | [Expression of inductive nitric oxide synthase and vascular endothelial growth factor in colonic carcinoma, and their effects on tumor angiogenesis] | PubMed |
| Carcinoma | [Expression of mRNA isoforms of vascular endothelial growth factor in ovarian carcinoma] | PubMed |
| Carcinoma | [Expression of p53 and vascular endothelial growth factor in esophageal squamous cell carcinoma and their clinical significance] | PubMed |
| Carcinoma | [Expression of vascular endothelial growth factor and its receptor (Flt-1) in breast carcinoma] | PubMed |
| Carcinoma | [Expression of vascular endothelial growth factor and its receptors in laryngeal carcinoma cell and its significance] | PubMed |
| Carcinoma | [Expression of vascular endothelial growth factor and its significance in pulmonary bronchoalveolar carcinoma.] | PubMed |
| Carcinoma | [Expression of vascular endothelial growth factor and nm23 as prognostic factors in nasopharyngeal carcinoma] | PubMed |
| Carcinoma | [Expression of vascular endothelial growth factor and tumor angiogenesis correlates with biological behaviors of nasopharyngeal carcinoma] | PubMed |
| Carcinoma | [Expression of vascular endothelial growth factor C and cyclooxygenase-2 in non-small-cell lung carcinoma and their clinical significance.] | PubMed |
| Carcinoma | [Expression of vascular endothelial growth factor C and survivin in gastric carcinoma and their clinical implications] | PubMed |
| Carcinoma | [Expression of vascular endothelial growth factor in different breast tissues and clinical significance thereof] | PubMed |
| Carcinoma | [Expression of vascular endothelial growth factor in oral squamous cell carcinoma] | PubMed |
| Carcinoma | [Expression of vascular endothelial growth factor in primary esophageal squamous cell carcinoma and its significance in angiogenesis and prognosis of the tumor] | PubMed |
| Carcinoma | [Expression of vascular endothelial growth factor, vascular endothelial growth factor receptor-3 and nm23-H1 in oral squamous cell carcinoma] | PubMed |
| Carcinoma | [Expression of VEGF and VEGF-C in laryngeal carcinoma and their clinical significance] | PubMed |
| Carcinoma | [Expression of VEGF, EGFR, p16 in lip cancers and oral squamous cell carcinomas and their clinic significance] | PubMed |
| Carcinoma | [Expression of VEGF-C and VEGF-D in gastric carcinoma and its relationship with lymph node metastases.] | PubMed |
| Carcinoma | [Expression related to vascular endothelial growth factor C and induced nitride oxide synthesizase in lymph node micrometastasis of oral squamous cell carcinoma] | PubMed |
| Carcinoma | [Expressions and correlation with radiotherapy's effect of five kinds of genes in nasopharyngeal carcinoma] | PubMed |
| Carcinoma | [Expressions of hypoxia inducible factor-1alpha and vascular endothelial growth factor in human renal cell carcinoma] | PubMed |
| Carcinoma | [Expressions of receptor-binding cancer antigen expressed on SiSo cells, vascular endothelial growth factor, and matrix metalloproteinase-9 in cervical carcinoma and correlation thereof with the invasion and metastasis of the cancerous tissues] | PubMed |
| Carcinoma | [Expressions of vascular endothelial growth factor C and matrix metalloproteinases-2 and prognosis of non-small cell lung carcinoma.] | PubMed |
| Carcinoma | [Expressions of VEGF-C and VEGF-D and their correlation with lymphangiogenesis and angiogenesis in gallbladder carcinoma] | PubMed |
| Carcinoma | [Inhibitation of tumor angiogenesis, growth and metastasis by blocking VEGF paracrine pathway] | PubMed |
| Carcinoma | [Inhibited proliferation and expression of human nasopharyngeal carcinoma line induced by celecoxib in vitro] | PubMed |
| Carcinoma | [Inhibition of bladder cancer cell growth and angiogenesis by co-blockage of vascular endothelial growth factor and its receptor kdr] | PubMed |
| Carcinoma | [Interaction of vascular endothelial growth factor-C over-expression with tongue squamous cell carcinoma cell line Tca8113 with peri-carcinoma lymphatics] | PubMed |
| Carcinoma | [Metastatic renal cell carcinoma treated with everolimus--data from the RENIS Clinical Registry]. | PubMed |
| Carcinoma | [Microvessel count and vascular endothelial growth factor in renal cell carcinoma] | PubMed |
| Carcinoma | [Microvessel density and expression of vascular endothelial growth factor in adenoid cystic carcinoma of salivary gland] | PubMed |
| Carcinoma | [Microvessel density, epithelial-stromal vascular cuffing and expression of vascular endothelial growth factor in human cervical carcinoma] | PubMed |
| Carcinoma | [Molecular markers of carcinogenesis in the diagnostics of cervical cancer] | PubMed |
| Carcinoma | [Mutation of von Hippel-Lindau gene and expression of vascular endothelial growth factor in sporadic clear cell renal cell carcinoma and their relationships to angiogenesis] | PubMed |
| Carcinoma | [Pathologic study of expression and significance of matrix metalloproteinases-9, tissue inhibitor of metalloproteinase-1, vascular endothelial growth factor and transforming growth factor beta-1 in papillary carcinoma and follicular carcinoma of thyroid.] | PubMed |
| Carcinoma | [Phosphorylation of signal transducer and activators of transcription 3 induced by vascular endothelial growth factor in ovarian carcinoma cell line in vitro] | PubMed |
| Carcinoma | [Predictive value of serum levels of basic fibroblast growth factor, vascular endothelial growth factor and matrix metalloproteinase-2 in advanced carcinomas of the head and neck] | PubMed |
| Carcinoma | [Preliminary effect of VEGF promoter-driven recombinant adenovirus containing double suicide genes on apoptosis of human gastric carcinoma cells] | PubMed |
| Carcinoma | [Prognostic role of vascular endothelial growth factor in oral carcinoma: a meta analysis]. | PubMed |
| Carcinoma | [Prognostic significance of VEGF receptors, VEGFR-1 (Flt-1) and VEGFR-2 (KDR/Flk-1) in breast carcinoma] | PubMed |
| Carcinoma | [Prokaryotic expression of vascular endothelial growth factor-C] | PubMed |
| Carcinoma | [Relation between vascular endothelial growth factor and reoccurence-metastasis after transcatheter arterial chemoembolization in hepatocellar carcinoma] | PubMed |
| Carcinoma | [Relation between vascular endothelial growth factor expression and clinical pathological character in laryngeal squamous cell carcinoma] | PubMed |
| Carcinoma | [Relationship among expression of the VEGF gene and MVD with cervical lymph nodes metastasis in laryngeal squamous cell carcinoma] | PubMed |
| Carcinoma | [Relationship between fluorodeoxyglucose uptake and vascular endothelial growth factor in early-stage nasophygeal carcinoma.] | PubMed |
| Carcinoma | [Relationship between the expression of vascular endothelial growth factor, fms-like tyrosine kinase-1 and biological behavior in gastric carcinoma] | PubMed |
| Carcinoma | [Relationship between the expressions of KaI1, nm23, ETS-1, VEGF and microvascular density and clinical significance in nasopharyngeal carcinoma] | PubMed |
| Carcinoma | [Relationships of human laryngeal squamous cell carcinomas with the expression of VEGF-C and VEGFR-3] | PubMed |
| Carcinoma | [Renal cell carcinoma and antiangiogenic therapies] | PubMed |
| Carcinoma | [Research on the correlation of vascular endothelial growth factor and dendritic cell in patients with oral squamous cell carcinoma] | PubMed |
| Carcinoma | [Retraction: Effects of oxymatrine injection combined with low-dose paclitaxel on mRNA and protein expressions of vascular endothelial growth factor and CXC chemokine receptor 4 in human gastric carcinoma SGC-7901 cells]. | PubMed |
| Carcinoma | [Roles of vascular endothelial growth factor and platelet-derived growth factor in lymphangiogenesis in epithelial ovarian carcinoma.] | PubMed |
| Carcinoma | [Screening of anti-tumor parts from the seeds of Livistona chinensis and its anti-angiogenesis effect] | PubMed |
| Carcinoma | [Significance of serum vascular endothelial growth factor test before radiotherapy in patients with nasopharyngeal carcinoma] | PubMed |
| Carcinoma | [Study of mRNA expression of vascular endothelial growth factor-(A, C, D) genes and its effect on prognosis of breast cancer] | PubMed |
| Carcinoma | [Study of the anti-tumor effect of anti-vascular endothelial growth factor McAb 5-fluorouracil loaded polylactic acid nanoparticles] | PubMed |
| Carcinoma | [Study on serum vascular endothelial growth factor level in ovarian malignant tumors] | PubMed |
| Carcinoma | [Study on the relationship between angiogenesis and cervical lymphatic metastasis in head and neck squamous cell carcinomas] | PubMed |
| Carcinoma | [Study on the relationship between vascular endothelial growth factor and syndrome type of traditional Chinese medicine in patients with gastric carcinoma] | PubMed |
| Carcinoma | [The correlation of vascular endothelial growth factor with angiogenesis and p53 gene in laryngeal squamous cell carcinoma] | PubMed |
| Carcinoma | [The expression of vascular endothelial growth factor, CD44v6 in non-small cell lung carcinoma] | PubMed |
| Carcinoma | [The relationship between vascular endothelial growth factor, microvascular density, lymph node metastasis and prognosis of breast carcinoma] | PubMed |
| Carcinoma | [The relationship of vascular endothelial growth factor and angiogenesis to the progression of gastric carcinoma] | PubMed |
| Carcinoma | [The roles of VEGF and C-myc in occurrence, development and metastasis of gallbladder carcinoma] | PubMed |
| Carcinoma | [The study of vascular endothelial growth factor in nasopharyngeal carcinoma patients before and after radiotherapy] | PubMed |
| Carcinoma | [Therapeutic effect of angiogenesis inhibitors on liver metastases of human colorectal carcinoma] | PubMed |
| Carcinoma | [Tumor angiogenesis in node-negative breast carcinoma] | PubMed |
| Carcinoma | [Tumor-infiltrating dendritic cells in epithelial ovarian carcinoma and correlation with the expression of vascular endothelial growth factor] | PubMed |
| Carcinoma | [Vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF) expression in superficial transitional cell bladder carcinoma] | PubMed |
| Carcinoma | [Vascular endothelial growth factor D promoting the growth of lymphatic vessel in gastric carcinoma] | PubMed |
| Carcinoma | [Vascular endothelial growth factor gene expression in nasopharyngeal carcinoma cell line induced by hypoxia in vitro] | PubMed |
| Carcinoma | [Vascular endothelial growth factor in non-small cell lung carcinoma expression and its significance] | PubMed |
| Carcinoma | [Vascular endothelial growth factor inhibits dendritic cells from patients with non-small cell lung carcinoma] | PubMed |
| Carcinoma | [Vascular endothelial growth factor-C (VEGF-C) and vascular endothelial growth factor-D (VEGF-D) in ovarian carcinomas] | PubMed |
| Carcinoma | [VEGF-D expression in lung adenocarcinoma with or without acquired resistance to gefitinib and normal lung tissue.] | PubMed |
| Carcinoma in Situ | Angiogenesis and VEGF expression in pre-invasive lesions of the human breast. | PubMed |
| Carcinoma in Situ | Angiogenic growth factors in preinvasive breast disease. | PubMed |
| Carcinoma in Situ | Cyclooxygenase-2 expression in an adenoid cystic carcinoma of the uterine cervix. | PubMed |
| Carcinoma in Situ | Effect of mitomycin C on concentrations of vascular endothelial growth factor and its receptors in bladder cancer cells and in bladders of rats intravesically instilled with mitomycin C. | PubMed |
| Carcinoma in Situ | [Expression of vascular endothelial growth factor in different breast tissues and clinical significance thereof] | PubMed |
| Carcinoma, Acinar Cell | Expression of p53 oncoprotein increases intratumoral microvessel formation in human salivary gland carcinomas. | PubMed |
| Carcinoma, Adenoid Cystic | A phase II study of sunitinib in recurrent and/or metastatic adenoid cystic carcinoma (ACC) of the salivary glands: current progress and challenges in evaluating molecularly targeted agents in ACC. | PubMed |
| Carcinoma, Adenoid Cystic | Concomitant inhibition of epidermal growth factor and vascular endothelial growth factor receptor tyrosine kinases reduces growth and metastasis of human salivary adenoid cystic carcinoma in an orthotopic nude mouse model. | PubMed |
| Carcinoma, Adenoid Cystic | Expression of p53 oncoprotein increases intratumoral microvessel formation in human salivary gland carcinomas. | PubMed |
| Carcinoma, Adenoid Cystic | Expressions of nuclear factor kappaB, inducible nitric oxide synthase, and vascular endothelial growth factor in adenoid cystic carcinoma of salivary glands: correlations with the angiogenesis and clinical outcome. | PubMed |
| Carcinoma, Adenoid Cystic | Levels and patterns of expression of hypoxia-inducible factor-1?, vascular endothelial growth factor, glucose transporter-1 and CD105 in adenoid cystic carcinomas with high-grade transformation. | PubMed |
| Carcinoma, Adenoid Cystic | Lymphatic vessels and related factors in adenoid cystic carcinoma of the salivary gland. | PubMed |
| Carcinoma, Adenoid Cystic | Nerve growth factor and vascular endothelial growth factor: retrospective analysis of 63 patients with salivary adenoid cystic carcinoma. | PubMed |
| Carcinoma, Adenoid Cystic | [Clinico-pathological significance of microvessel density and vascular endothelial growth factor expression in adenoid cystic carcinoma of salivary glands] | PubMed |
| Carcinoma, Adenoid Cystic | [Microvessel density and expression of vascular endothelial growth factor in adenoid cystic carcinoma of salivary gland] | PubMed |
| Carcinoma, Adenosquamous | The relationship between microvessel count and the expression of vascular endothelial growth factor, p53, and K-ras in non-small cell lung cancer. | PubMed |
| Carcinoma, Basal Cell | Expression of basic fibroblast growth factor, vascular endothelial growth factor, and thrombospondin-1 related to microvessel density in nonaggressive and aggressive basal cell carcinomas. | PubMed |
| Carcinoma, Basal Cell | Expression of vascular endothelial growth factor in basal cell carcinoma and cutaneous squamous cell carcinoma of the head and neck. | PubMed |
| Carcinoma, Basal Cell | Mast cells and cutaneous malignancies. | PubMed |
| Carcinoma, Bronchogenic | Increased levels of vascular endothelial growth factor in bronchoalveolar lavage of patients with bronchial carcinoma effect of tumour activity and oxidative stress due to radio-chemotherapy? | PubMed |
| Carcinoma, Ductal | Angiogenic profile of breast carcinoma determines leukocyte infiltration. | PubMed |
| Carcinoma, Ductal | COX-2 expression in DCIS: correlation with VEGF, HER-2/neu, prognostic molecular markers and clinicopathological features. | PubMed |
| Carcinoma, Ductal | Expression of hypoxia-inducible factor (HIF-1alpha), VEGF-C and VEGF-D in non-invasive and invasive breast ductal carcinomas. | PubMed |
| Carcinoma, Ductal | Expression of vascular endothelial growth factor in invasive ductal carcinoma of the breast and the relation to angiogenesis and p53 and HER-2/neu protein expression. | PubMed |
| Carcinoma, Ductal | Immunohistochemical expression of vascular endothelial growth factor and its correlation with tumor grade in breast ductal carcinoma. | PubMed |
| Carcinoma, Ductal | Inactivation of the PTEN gene protein product is associated with the invasiveness and metastasis, but not angiogenesis, of breast cancer. | PubMed |
| Carcinoma, Ductal | Infiltrating ductal and lobular breast carcinomas are characterised by different interrelationships among markers related to angiogenesis and hormone dependence. | PubMed |
| Carcinoma, Ductal | Invasive lobular and invasive ductal carcinoma of the breast show distinct patterns of vascular endothelial growth factor expression and angiogenesis. | PubMed |
| Carcinoma, Ductal | Macrophage infiltration and its prognostic implications in breast cancer: the relationship with VEGF expression and microvessel density. | PubMed |
| Carcinoma, Ductal | Occult breast cancer presenting as axillary metastases. | PubMed |
| Carcinoma, Ductal | The angiogenic and lymphangiogenic factor vascular endothelial growth factor-D exhibits a paracrine mode of action in cancer. | PubMed |
| Carcinoma, Ductal | The assessment of angiogenesis and fibroblastic stromagenesis in hyperplastic and pre-invasive breast lesions. | PubMed |
| Carcinoma, Ductal | [Dynamic MRI and tumor angiogenesis of breast cancer] | PubMed |
| Carcinoma, Endometrioid | A case of adenocarcinoma of the endometrial type mixed with a clear cell component that metastasized to the vagina. | PubMed |
| Carcinoma, Endometrioid | Expression of aquaporin-1 in normal, hyperplasic, and carcinomatous endometria. | PubMed |
| Carcinoma, Endometrioid | Possible involvement of adipocyte-derived leucine aminopeptidase via angiotensin II in endometrial carcinoma. | PubMed |
| Carcinoma, Hepatocellular | (-)-Epigallocatechin gallate suppresses the growth of human hepatocellular carcinoma cells by inhibiting activation of the vascular endothelial growth factor-vascular endothelial growth factor receptor axis. | PubMed |
| Carcinoma, Hepatocellular | 1,2-dioleoyl-3-trimethylammonium-propane (DOTAP)-formulated, immune-stimulatory vascular endothelial growth factor a small interfering RNA (siRNA) increases antitumoral efficacy in murine orthotopic hepatocellular carcinoma with liver fibrosis. | PubMed |
| Carcinoma, Hepatocellular | A phase I/II trial of the oral antiangiogenic agent TSU-68 in patients with advanced hepatocellular carcinoma. | PubMed |
| Carcinoma, Hepatocellular | A single nucleotide polymorphism in the vascular endothelial growth factor gene is associated with recurrence of hepatocellular carcinoma after transplantation. | PubMed |
| Carcinoma, Hepatocellular | Activin A stimulates vascular endothelial growth factor gene transcription in human hepatocellular carcinoma cells. | PubMed |
| Carcinoma, Hepatocellular | Alpha-ketoglutarate (AKG) inhibits proliferation of colon adenocarcinoma cells in normoxic conditions. | PubMed |
| Carcinoma, Hepatocellular | Altered expression of vascular endothelial growth factor, fibroblast growth factor-2 and endostatin in patients with hepatocellular carcinoma. | PubMed |
| Carcinoma, Hepatocellular | Angiopoietin 2 displays a vascular endothelial growth factor dependent synergistic effect in hepatocellular carcinoma development in mice. | PubMed |
| Carcinoma, Hepatocellular | Angiotensin II type 1 receptor antagonist prevents hepatic carcinoma in rats with nonalcoholic steatohepatitis. | PubMed |
| Carcinoma, Hepatocellular | Angiotensin-I-converting enzyme inhibitors may be an alternative anti-angiogenic strategy in the treatment of liver fibrosis and hepatocellular carcinoma. Possible role of vascular endothelial growth factor. | PubMed |
| Carcinoma, Hepatocellular | Anti-angiogenic activity of inositol hexaphosphate (IP6). | PubMed |
| Carcinoma, Hepatocellular | Antiangiogenic activity of a concentrated effective microorganism fermentation extract. | PubMed |
| Carcinoma, Hepatocellular | Antihepatoma activity of chaetocin due to deregulated splicing of hypoxia-inducible factor 1? pre-mRNA in mice and in vitro. | PubMed |
| Carcinoma, Hepatocellular | Antitumor effect of vascular endothelial growth factor inhibitor sunitinib in preclinical models of hepatocellular carcinoma. | PubMed |
| Carcinoma, Hepatocellular | Antitumor effects of 2-oxoglutarate through inhibition of angiogenesis in a murine tumor model. | PubMed |
| Carcinoma, Hepatocellular | Apparent diffusion coefficient value of diffusion-weighted imaging for hepatocellular carcinoma: correlation with the histologic differentiation and the expression of vascular endothelial growth factor. | PubMed |
| Carcinoma, Hepatocellular | Assessment of the clinical significance of serum vascular endothelial growth factor and matrix metalloproteinase-9 in patients with hepatocellular carcinoma. | PubMed |
| Carcinoma, Hepatocellular | Association between increment of serum VEGF level and prognosis after transcatheter arterial chemoembolization in hepatocellular carcinoma patients. | PubMed |
| Carcinoma, Hepatocellular | Association between vascular endothelial growth factor and metastasis after transcatheter arterial chemoembolization in patients with hepatocellular carcinoma. | PubMed |
| Carcinoma, Hepatocellular | Association between vascular endothelial growth factor gene polymorphisms and survival in hepatocellular carcinoma patients. | PubMed |
| Carcinoma, Hepatocellular | Bevacizumab and rapamycin induce growth suppression in mouse models of hepatocellular carcinoma. | PubMed |
| Carcinoma, Hepatocellular | Black tea polyphenols target matrix metalloproteinases, RECK, proangiogenic molecules and histone deacetylase in a rat hepatocarcinogenesis model. | PubMed |
| Carcinoma, Hepatocellular | Both antiangiogenesis- and angiogenesis-independent effects are responsible for hepatocellular carcinoma growth arrest by tyrosine kinase inhibitor PTK787/ZK222584. | PubMed |
| Carcinoma, Hepatocellular | Branched-chain amino acid deficiency stabilizes insulin-induced vascular endothelial growth factor mRNA in hepatocellular carcinoma cells. | PubMed |
| Carcinoma, Hepatocellular | Cancer gene therapy with iCaspase-9 transcriptionally targeted to tumor endothelial cells. | PubMed |
| Carcinoma, Hepatocellular | CD44 and VEGF expression in extrahepatic metastasis of human hepatocellular carcinoma. | PubMed |
| Carcinoma, Hepatocellular | Cediranib (AZD2171) in Patients With Advanced Hepatocellular Carcinoma: A Phase II North Central Cancer Treatment Group Clinical Trial. | PubMed |
| Carcinoma, Hepatocellular | Circulating levels of VEGF family and their receptors in hepatocellular carcinoma. | PubMed |
| Carcinoma, Hepatocellular | Circulating vascular endothelial growth factor (VEGF) is a possible tumor marker for metastasis in human hepatocellular carcinoma. | PubMed |
| Carcinoma, Hepatocellular | Clinical and prognostic implications of plasma insulin-like growth factor-1 and vascular endothelial growth factor in patients with hepatocellular carcinoma. | PubMed |
| Carcinoma, Hepatocellular | Clinical significance of microvessel density and vascular endothelial growth factor expression in hepatocellular carcinoma and surrounding liver: possible involvement of vascular endothelial growth factor in the angiogenesis of cirrhotic liver. | PubMed |
| Carcinoma, Hepatocellular | Clinical significance of the expression of isoform 165 vascular endothelial growth factor mRNA in noncancerous liver remnants of patients with hepatocellular carcinoma. | PubMed |
| Carcinoma, Hepatocellular | Clinical value of apoptosis and angiogenesis factors in estimating the prognosis of hepatocellular carcinoma. | PubMed |
| Carcinoma, Hepatocellular | Clinicopathological features of hepatocellular carcinoma evaluated by vascular endothelial growth factor expression. | PubMed |
| Carcinoma, Hepatocellular | Co-expression of Bcl-2 protein and vascular endothelial growth factor in hepatocellular carcinomas treated by chemoembolization. | PubMed |
| Carcinoma, Hepatocellular | Coexpression of PDGFR-alpha, PDGFR-beta and VEGF as a prognostic factor in patients with hepatocellular carcinoma. | PubMed |
| Carcinoma, Hepatocellular | Combination therapy of interferon-alpha and 5-fluorouracil inhibits tumor angiogenesis in human hepatocellular carcinoma cells by regulating vascular endothelial growth factor and angiopoietins. | PubMed |
| Carcinoma, Hepatocellular | Combined endostatin/sFlt-1 antiangiogenic gene therapy is highly effective in a rat model of HCC. | PubMed |
| Carcinoma, Hepatocellular | Copper-dependent activation of hypoxia-inducible factor (HIF)-1: implications for ceruloplasmin regulation. | PubMed |
| Carcinoma, Hepatocellular | Correlation of four vascular specific growth factors with carcinogenesis and portal vein tumor thrombus formation in human hepatocellular carcinoma. | PubMed |
| Carcinoma, Hepatocellular | Correlation of vascular endothelial cell proliferation with microvessel density and expression of vascular endothelial growth factor and basic fibroblast growth factor in hepatocellular carcinoma. | PubMed |
| Carcinoma, Hepatocellular | Correlations of the expression of vascular endothelial growth factor B and its isoforms in hepatocellular carcinoma with clinico-pathological parameters. | PubMed |
| Carcinoma, Hepatocellular | Correlative study of angiogenesis and dynamic contrast-enhanced magnetic resonance imaging features of hepatocellular carcinoma. | PubMed |
| Carcinoma, Hepatocellular | Curcumin inhibits hypoxia-inducible factor-1 by degrading aryl hydrocarbon receptor nuclear translocator: a mechanism of tumor growth inhibition. | PubMed |
| Carcinoma, Hepatocellular | Cyclooxygenase-2 pathway correlates with vascular endothelial growth factor expression and tumor angiogenesis in hepatitis B virus-associated hepatocellular carcinoma. | PubMed |
| Carcinoma, Hepatocellular | Decreased ID2 promotes metastatic potentials of hepatocellular carcinoma by altering secretion of vascular endothelial growth factor. | PubMed |
| Carcinoma, Hepatocellular | Detection of vascular endothelial growth factor and its receptor expression in human hepatocellular carcinoma biopsy specimens. | PubMed |
| Carcinoma, Hepatocellular | Development of sunitinib in hepatocellular carcinoma: rationale, early clinical experience, and correlative studies. | PubMed |
| Carcinoma, Hepatocellular | Different cascades in the signaling pathway of two vascular endothelial growth factor (VEGF) receptors for the VEGF-mediated murine hepatocellular carcinoma development. | PubMed |
| Carcinoma, Hepatocellular | Differential role of circulating endothelial progenitor cells in cirrhotic patients with or without hepatocellular carcinoma. | PubMed |
| Carcinoma, Hepatocellular | Differential vascular endothelial growth factor A protein expression between small hepatocellular carcinoma and cirrhosis correlates with serum vascular endothelial growth factor A and alpha-fetoprotein. | PubMed |
| Carcinoma, Hepatocellular | Disruption of hepatocellular tight junctions by vascular endothelial growth factor (VEGF): a novel mechanism for tumor invasion. | PubMed |
| Carcinoma, Hepatocellular | Downregulation of the Notch signaling pathway inhibits hepatocellular carcinoma cell invasion by inactivation of matrix metalloproteinase-2 and -9 and vascular endothelial growth factor. | PubMed |
| Carcinoma, Hepatocellular | Dual action of a selective cyclooxygenase-2 inhibitor on vascular endothelial growth factor expression in human hepatocellular carcinoma cells: novel involvement of discoidin domain receptor 2. | PubMed |
| Carcinoma, Hepatocellular | Dual mechanism of vascular endothelial growth factor upregulation by hypoxia in human hepatocellular carcinoma. | PubMed |
| Carcinoma, Hepatocellular | Effect of c-fos antisense probe on prostaglandin E2-induced upregulation of vascular endothelial growth factor mRNA in human liver cancer cells. | PubMed |
| Carcinoma, Hepatocellular | Effective angiostatic treatment in a murine metastatic and orthotopic hepatoma model. | PubMed |
| Carcinoma, Hepatocellular | Effective treatment of advanced cholangiocarcinoma by hepatic arterial infusion chemotherapy combination with sorafenib: one case report from China. | PubMed |
| Carcinoma, Hepatocellular | Effects of PI3K and p42/p44 MAPK on overexpression of vascular endothelial growth factor in hepatocellular carcinoma. | PubMed |
| Carcinoma, Hepatocellular | Establishment of a sandwich ELISA method for detection of vascular endothelial growth factor in serum samples of hepatocellular carcinoma patients. | PubMed |
| Carcinoma, Hepatocellular | Exploration of the relationship between the tumor burden and the concentration of vascular endothelial growth factor in liver-cancer-bearing animals using immunomagnetic reduction assay. | PubMed |
| Carcinoma, Hepatocellular | Exploring stemness gene expression and vasculogenic mimicry capacity in well- and poorly-differentiated hepatocellular carcinoma cell lines. | PubMed |
| Carcinoma, Hepatocellular | Expression and localization of vascular endothelial growth factor receptors in human hepatocellular carcinoma and non-HCC tissues. | PubMed |
| Carcinoma, Hepatocellular | Expression of angiogenic factors in hepatocellular carcinoma after transcatheter arterial chemoembolization. | PubMed |
| Carcinoma, Hepatocellular | Expression of angiopoietins, Tie2 and vascular endothelial growth factor in angiogenesis and progression of hepatocellular carcinoma. | PubMed |
| Carcinoma, Hepatocellular | Expression of hypoxia-inducible factor 1alpha and vascular endothelial growth factor in hepatocellular carcinoma: Impact on neovascularization and survival. | PubMed |
| Carcinoma, Hepatocellular | Expression of plasma vascular endothelial growth factor in patients with hepatocellular carcinoma and effect of transcatheter arterial chemoembolization therapy on plasma vascular endothelial growth factor level. | PubMed |
| Carcinoma, Hepatocellular | Expression of platelet-derived endothelial cell growth factor and vascular endothelial growth factor in hepatocellular carcinoma and portal vein tumor thrombus. | PubMed |
| Carcinoma, Hepatocellular | Expression of vascular endothelial growth factor and matrix metalloproteinase-2 correlates with the invasion and metastasis of hepatocellular carcinoma. | PubMed |
| Carcinoma, Hepatocellular | Expression of vascular endothelial growth factor in hepatocellular carcinoma and its relationship to tumor growth and metastasis. | PubMed |
| Carcinoma, Hepatocellular | Expression of vascular endothelial growth factor in hepatocellular carcinoma and the surrounding liver and correlation with MRI findings. | PubMed |
| Carcinoma, Hepatocellular | Expression of vascular endothelial growth factor in hepatocellular carcinoma and the surrounding liver: correlation with angiographically assisted CT. | PubMed |
| Carcinoma, Hepatocellular | Expression of vascular endothelial growth factor in hepatocellular carcinoma and the surrounding liver: correlation with MR imaging and angiographically assisted CT. | PubMed |
| Carcinoma, Hepatocellular | Expression of vascular endothelial growth factor in human hepatocellular carcinoma. | PubMed |
| Carcinoma, Hepatocellular | Expression of vascular endothelial growth factor in normal liver and hepatocellular carcinoma: an immunohistochemical study. | PubMed |
| Carcinoma, Hepatocellular | Expression of vascular endothelial growth factor in surgical specimens of hepatocellular carcinoma. | PubMed |
| Carcinoma, Hepatocellular | Expression of vascular endothelial growth factor receptors is closely related to the histological grade of hepatocellular carcinoma. | PubMed |
| Carcinoma, Hepatocellular | Gene therapy targeting for hepatocellular carcinoma: selective and enhanced suicide gene expression regulated by a hypoxia-inducible enhancer linked to a human alpha-fetoprotein promoter. | PubMed |
| Carcinoma, Hepatocellular | Hammerhead ribozyme specifically inhibits vascular endothelial growth factor gene expression in a human hepatocellular carcinoma cell line. | PubMed |
| Carcinoma, Hepatocellular | Hepatitis B virus X protein activates expression of IGF-IR and VEGF in hepatocellular carcinoma cells. | PubMed |
| Carcinoma, Hepatocellular | Hepatocellular carcinoma: correlation between vascular endothelial growth factor level and degree of enhancement by multiphase contrast-enhanced computed tomography. | PubMed |
| Carcinoma, Hepatocellular | High doses of tyrosine kinase inhibitor PTK787 enhance the efficacy of ischemic hypoxia for the treatment of hepatocellular carcinoma: dual effects on cancer cell and angiogenesis. | PubMed |
| Carcinoma, Hepatocellular | High expressions of vascular endothelial growth factor and platelet-derived endothelial cell growth factor predict poor prognosis in alpha-fetoprotein-negative hepatocellular carcinoma patients after curative resection. | PubMed |
| Carcinoma, Hepatocellular | High serum levels of vascular endothelial growth factor after hepatectomy are associated with poor prognosis in hepatocellular carcinoma. | PubMed |
| Carcinoma, Hepatocellular | High serum levels of vascular endothelial growth factor predict poor response to transarterial chemoembolization in hepatocellular carcinoma: a prospective study. | PubMed |
| Carcinoma, Hepatocellular | High serum vascular endothelial growth factor levels predict poor prognosis after radiofrequency ablation of hepatocellular carcinoma: importance of tumor biomarker in ablative therapies. | PubMed |
| Carcinoma, Hepatocellular | Immunohistochemical assessment of angiogenesis in hepatocellular carcinoma and surrounding cirrhotic liver tissues. | PubMed |
| Carcinoma, Hepatocellular | Implications of human macrophage metalloelastase and vascular endothelial growth factor gene expression in angiogenesis of hepatocellular carcinoma. | PubMed |
| Carcinoma, Hepatocellular | Increased expression of vascular endothelial growth factor in hepatocellular carcinoma after transcatheter arterial chemoembolization. | PubMed |
| Carcinoma, Hepatocellular | Increased expression of vascular endothelial growth factor in human hepatocellular carcinoma. | PubMed |
| Carcinoma, Hepatocellular | Increased expression of vascular endothelial growth factor in small hepatocellular carcinoma. | PubMed |
| Carcinoma, Hepatocellular | Increased expression of vascular endothelial growth factor is associated with tumor progression in hepatocellular carcinoma. | PubMed |
| Carcinoma, Hepatocellular | Increased vascular endothelial growth factor transcription in residual hepatocellular carcinoma after open versus laparoscopic hepatectomy in a small animal model. | PubMed |
| Carcinoma, Hepatocellular | Inducible nitric oxide synthase expression is related to angiogenesis, bcl-2 and cell proliferation in hepatocellular carcinoma. | PubMed |
| Carcinoma, Hepatocellular | Induction of vascular endothelial growth factor by nitric oxide in human glioblastoma and hepatocellular carcinoma cells. | PubMed |
| Carcinom |